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Dissertation Abstract 
Gram-negative bacteria are distinguished from Gram-positive bacteria by the 
secondary membrane that surrounds their peptidoglycan cell wall. The outer leaflet of 
this membrane is primarily composed of the glycolipid lipopolysaccharide (LPS), which 
has lipid A, core oligosaccharide, and O-antigen portions. LPS helps protect Gram-
negative bacteria from hydrophobic toxins and, in pathogenic bacteria, from the host 
immune system. The membrane anchor portion of LPS (lipid A) is responsible for 
stimulation of the inflammatory response of the mammalian immune system by LPS via 
activation of the Toll-like receptor 4/myeloid differentiation factor 2 complex. In 
systemic infections, overstimulation of this receptor causes acute inflammation, which 
can cause septic shock. Modifications to the LPS, particularly to the lipid A portion, can 
help bacteria evade the host immune system by disguising the bacteria, modulating the 
inflammatory response, and inhibiting interactions with antimicrobial host factors.  
Lipid A is synthesized in the well characterized and largely conserved Raetz 
pathway in the cytosol and at the cytosolic face of the inner membrane. The non-
repeating core oligosaccharide is synthesized on lipid A at the cytoplasmic face of the 
inner membrane, and the repeating O-antigen polysaccharide is attached to the core-lipid 
A molecule at the periplasmic face of the inner membrane. The completed LPS molecules 
are then transported to the extracellular leaflet of the outer membrane. Structures of 
proteins involved in LPS synthesis have proved critical to our understanding of LPS 
synthesis and transport. Moreover, these structures provide targets for rational design of 
antibiotics targeting Gram-negative bacteria. As the Raetz pathway is the most conserved 
part of LPS synthesis, the enzymes of the Raetz pathway provide particularly promising 
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targets for development of broad spectrum antibiotics, such as those needed to treat 
sepsis. Therefore, I studied the structures of two enzymes in the Raetz pathway (LpxH 
and LpxB).  
In the crystal structure of E. coli LpxH, crystal packing captured LpxH with the α-
helical substrate-binding cap domain in a displaced conformation, suggesting that this 
domain is highly mobile. The structural dynamics of this domain and their relevance to 
substrate binding were further explored by hydrogen-deuterium exchange mass 
spectrometry, molecular dynamics simulations, and activity assays. These data supported 
a model in which a loop in the core hydrolase domain acts as a wedge to promote an 
opening motion of the capping helices wherein bending and partial unwinding of the 
helices exposes the active site. This opening may allow facile substrate binding between 
these helices. 
The first structure of LpxB was determined showing a Glycosyltransferase B 
superfamily (GT-B) fold modified by the formation of a novel C-terminally swapped 
dimer wherein the last 87 residues of one subunit complete the GT-B fold of the other 
subunit. Furthermore, the binding site of the sugar-donor substrate was identified by a 
structure of LpxB with the UDP product bound. Activity assays supported the formation 
of this C-terminally swapped dimer in solution and showed that a surface-exposed 
hydrophobic patch is critical for LpxB activity, which suggested this patch allows 
productive membrane association required for substrate binding. Thus, the present 
research has expanded our understanding of two enzymes important in Gram-negative 
bacterial physiology. These enzymes are potential targets for antibiotic development. 
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1.1 Background and Significance 
Gram-negative bacteria are distinguished from Gram-positive bacteria by the 
secondary lipid bilayer that surrounds their peptidoglycan cell wall (1). In the majority of 
Gram-negative bacteria, this outer membrane is an asymmetric bilayer with 
phospholipids on the inner leaflet and lipopolysaccharide (LPS) on the outer leaflet (1, 2). 
LPS is a glycolipid composed of a lipid A membrane anchor, a core oligosaccharide, and 
a repeating O antigen polysaccharide (Figure 1.1) (1, 3). This layer of LPS provides a 
permeability barrier to environmental toxins. When this layer of LPS is disrupted by 
invasion of phospholipids (2), loss of LPS synthesis or transport (4), or loss of 
glycosylation (5), the bacteria show increased sensitivity to hydrophobic toxins, such as 
detergent or bile salts, or antibiotics. Furthermore, complete loss of LPS by mutation of 
lipid A synthesis genes made bacteria less virulent to Caenorhabditis elegans and human 
epithelial cells (6). Likely in part because of these deleterious effects, loss of lipid A 
synthesis has only been characterized in Acinetobacter baumannii (4, 6), and four of the 
five enzymes responsible for synthesis of the base tetra-acylated  disaccharide are 
conserved in all but the specialized Gram-negative bacteria, such as Sphingomonads, that 
use alternative lipids (7, 8). 
The role of LPS in disease is related not only to its protective function in Gram-
negative bacteria but also to its interaction with the host’s innate immune system. 
Humans possess a cohort of proteins that allow rapid response to the presence of LPS (9). 
LPS binding protein is thought to extract LPS from bacterial membranes and present an 
LPS molecule to CD14 (9, 10). 
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Figure 1.1: LPS chemical structure. Chemical structures of the canonical lipid A of E. coli, the core 
oligosaccharide of E. coli K-12, and the E. coli O9 O-antigen (showing one repeat unit) (1). The text for the 
distal glucosamine of lipid A attached to the core oligosaccharide is colored blue. The text for the residues 
at each end of the core oligosaccharide is colored red. The text for the ends of the O-antigen is colored 
green, and that for the repeat region is colored purple. In the core oligosaccharide, atom and bond coloring 
indicates different core structures (11). Black indicates the conserved structure, and purple, red, and green 
indicate moieties present in three different variants of the K-12 core. Note that other K-12 core structures 
have also been characterized (12). Dual coloring of moieties indicates their presence in both variants. 
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CD14, which may be secreted or lipid-linked to the extracellular face of cells, transfers 
this LPS to the complex of myeloid differentiation factor 2 and Toll-like receptor 4 
(MD2/TLR4) (9, 13–15). Activation of TLR4 by LPS leads to the production and 
secretion of pro-inflammatory cytokines and type I interferon (9, 16). While this response 
is beneficial for clearing small bacterial infections, overstimulation of the inflammatory 
response during systemic infection, such as sepsis (presence of bacteria in the blood), is 
potentially fatal and can cause permanent organ damage or neurological problems (17, 
18). Because of the severity of this condition, rapid treatment with broad-spectrum 
antibiotics before the causative bacteria can be identified is recommended for patients 
with sepsis (17). The highly conserved and (in most cases) essential enzymes involved in 
the synthesis of the lipid A portion of LPS are promising targets for the development of 
new broad-spectrum antibiotics to treat sepsis and infections by antimicrobial resistant 
Gram-negative strains (1, 5, 7, 19). 
Extensive biochemical studies have described the contribution of the different 
moieties of lipid A to the induction of the inflammatory response by LPS (20–23). The 
number and position of acyl chains is the most important factor in determining 
inflammatory potential in humans (20–23). Canonical hexa-acylated lipid A from E. coli 
(Figure 1.1) induced interleukin-1 production at concentrations as low as 10 pg/mL (20). 
Removal of the secondary acyl chain (an acyl chain attached to an acyl chain directly 
linked to glucosamine) from the distal 3'-position increased the concentration required for 
induction 100-fold, and addition of an acyl chain to the proximal 2-position also 
increased active concentration 100-fold (20, 22). These effects were multiplicative: a 
hexa-acylated lipid A derivative with secondary chains at the 2/2'-positions of both 
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proximal and distal glucosamines only induced the inflammatory response at 10,000-fold 
higher concentration (20, 22). Little activity was observed with a penta-acylated 
derivative with the only secondary chain at the proximal 2-position, and lipid A 
derivatives with 4 or fewer chains showed no inflammatory induction (20–22). In fact, 
tetra-acylated lipid A derivatives could competitively inhibit the inflammatory activity of 
lipid A or LPS (20–23). Interestingly, this effect is not conserved among mammals as 
tetra-acylated lipid A derivatives retained inflammatory activity in mice (21, 23). In 
addition, the 1- and 4'-phosphates are important for induction of inflammation (20–22). 
Removal of one of the phosphates increased the active concentration 100-fold (20, 22). 
Replacing the 1-phosphate with a phosphonooxyethyl group had little effect, but 
changing the position of the phosphonooxyethyl group from the axial to the equatorial 
position (changing from the α- to the β-anomer of the proximal glucosamine) increased 
the minimum active concentration to 1 μg/mL (21, 22). 
The structural basis of the inflammatory potential of differentially substituted lipid A 
moieties has been revealed by crystal structures of LPS and tetra-acylated lipid A 
derivatives (competitive inhibitors) bound to MD2 and the MD2/TLR4 complex (13, 14, 
24). The LPS-bound complex was crystallized as a dimer of MD2/TLR4-extracellular 
domain heterodimers (Figure 1.2) (14). MD2 forms a β-cup fold wherein two β-sheets are 
separated to form a large, hydrophobic pocket that accommodates 5 of the 6 acyl chains 
of lipid A (14, 24). The acyl chain in the proximal 2-position binds outside of the MD2 
pocket and interacts with the TLR4 subunit of the other heterodimer (Figure 1.2) (14). 
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Figure 1.2: TLR4/MD2 complex with LPS. A. Heterotetramer of TLR4 and MD2 bound to LPS with the 
core oligosaccharide resolved out to the third Hep (PDB: 3FXI) (14). B. Zoom-in of one LPS in A. showing 
long distance electrostatic and hydrogen-bonding interactions. Distances of interactions in Ångstroms are 
as follows: 9.0 from 1-phosphate O2 to K122C Nζ, 7.3 from 1-phosphate O4 to K388B Nζ, 5.6 from 1-
phosphate O3 to K341A Nζ, 8.3 from 1-phosphate O3 to K362A Nζ, 3.0 from 4'-phosphate O2 to S118C Oγ, 
3.4 from 4'-phosphate O3 to R264A Nη2, 3.3 from 4'-phosphate O3 to R264A Nε, 10.4 from distal 
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glucosamine 4'O to K58C ζ, and 7.6 from 4'-phosphate O4 to K362A Nζ. Figure generation and structure 
analysis were performed in UCSF Chimera (25). 
The base glucosamine disaccharide is bound by MD2 while the inner core 
oligosaccharide, consisting of two 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) residues 
and three L-glycero-D-mannoheptose (Hep) residues, interacts with the TLR4 of the 
same heterodimer, and the remaining sugar residues extend into solvent and are not 
visible (14). The 1-phosphate forms long distance (>4 Å) electrostatic interactions with 
K122 of MD2, K341 and K362 of the TLR4 in the same heterodimer, and K388 of the 
other TLR4 subunit (Figure 1.2) (14). The 4'-phosphate forms a hydrogen-bond with 
S118 of MD2, forms a salt-bridge with R264 of the TLR4 in the same heterodimer, and 
forms long distance electrostatic interactions with K58 of MD2 and K362 of the TLR4 in 
the same heterodimer (14). However, when the MD2/TLR4 complex was bound by the 
tetra-acylated lipid A derivative and competitive inhibitor Eritoran, all 4 acyl chains, 
including the chain at the proximal 2-position, were bound in  the pocket MD2 (24). The 
tetra-acylated precursor of lipid A (lipid IVA) bound similarly to MD2 (13). Furthermore, 
Eritoran bound more deeply in the pocket precluding interactions between the phosphates 
and TLR4 (14, 24). This structure was crystallized as a heterodimer, and the lack of 
heterotetramer formation was supported by solution behavior of the Eritoran-bound 
MD2/TLR4 complex on a gel filtration column (24).  On the other hand, the addition of 
LPS led to the formation of an oligomer consistent with a heterotetramer (24). As 
oligomerization of TLR4 is thought to be required for activation of downstream 
signaling, these structures provide a simple explanation for how tetra-acylated lipid A 
derivatives inhibit induction of inflammation by lipid A/LPS: tetra-acylated lipid A 
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derivatives occupy the MD2 pocket without triggering heterotetramer formation and 
downstream signaling and thus block binding of lipid A molecules that can trigger 
downstream signaling (9, 13, 14, 24). 
However, interactions between LPS and the host’s immune system are not limited to 
the inflammatory response. In addition, modifications to the acylation and charge of LPS 
can protect bacteria from being killed by cationic antimicrobial peptides (CAMPs) and 
the complement system, which both act to disrupt bacterial membranes (3, 8, 18, 26–29). 
CAMPs act by interacting with anionic groups in LPS, particularly the lipid A 
phosphates, and inserting a hydrophobic tail into the membrane to disrupt the 
permeability barrier (8, 18). The complement system acts by antibody-targeted, lectin-
targeted, or spontaneous binding of complement system factors to the bacterial surface 
that ultimately leads to the insertion of pore-forming proteins into the bacterial membrane 
(26). The bacterial outer membrane protein (PagP) adds a secondary palmitate to the β-
hydroxyl group of the proximal 2-acyl chain and sometimes, as in Bordetella 
parapertussis, also adds palmitate to an available β-hydroxyl group of the distal 3'-acyl 
chain (8, 30, 31). PagP activity has been found to increase resistance to some CAMPs and 
the complement system (30, 31). In addition, PagP activity has been linked to biofilm 
formation in several bacterial species and to E. coli biofilm persistence in rats (32, 33). 
Another bacterial outer membrane protein (PagL) removes the acyl chain from the 3-
hydroxyl of the proximal glucosamine (8, 29). PagL was found to contribute to the 
resistance to polymyxin B (a CAMP) in a resistant strain of Pseudomonas aeruginosa, 
and neutron reflectometry indicated that polymyxin B failed to penetrate into a bilayer 
with PagL-modified lipid A (29). Addition of cationic moieties to mask the negative 
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charge of LPS can also decrease susceptibility to CAMPs and the complement system (6, 
8, 18, 28, 33–35). EptA transfer of phosphoethanolamine to the lipid A phosphates 
increased resistance to polymyxin B (8, 35). In addition, the periplasmic transferase ArnT 
transfers 4-amino-4-deoxy-L-arabinose (L-Ara4N) to the lipid A 4'-phosphate, and 
addition of this positively charged sugar increased resistance to the CAMPs polymyxin B 
and LL-37 (8, 33, 36). Finally, changes in the glycosylation of the core oligosaccharide or 
O-antigen can help bacteria evade the host’s immune system (3, 18, 26). In Helicobacter 
pylori, the O-antigen can be modified with fucose to resemble host antigens, and in 
Pseudomonas aeruginosa, the O-antigen may be completely lost during chronic 
infections (3). Likewise, Neisseria meningitidis can alter its core oligosaccharide to 
resemble an erythrocyte antigen, or N. meningitidis can add sialic acid to its core 
oligosaccharide to recruit host factor H, which inhibits killing by the complement system 
(18, 26). 
 
1.2 Determination of the Structure of Lipid A  
Research describing the relevance of lipid A moieties to induction of inflammation 
could not have been accomplished prior to the elucidation of the structure of lipid A. This 
section describes how the structure of Kdo2-lipid A presented in Figure 1.1 was 
determined.  
Some of the earliest research into the structure of lipid A identified the glucosamine 
disaccharide as the central component, and the glycosidic linkage was assigned as β1-6 
on the basis of reactivity of the N-acetylated disaccharide with  p-
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dimethylaminobenzaldehyde (in Ehrlich reagent) and non-stereospecific and β-linkage-
specific acetylglucosaminidases (37). The identity of the central disaccharide was further 
supported by comparison with β1-6 and β1-4 glucosamine disaccharide standards by thin 
layer chromatography (TLC) (38). Nuclear magnetic resonance (NMR) of Kdo-lipid A 
showed that 13C chemical shifts and JCH coupling constants were consistent with the α-
anomer of the proximal (reducing end) glucosamine and the β-anomer of the distal 
glucosamine (39). Finally, NMR of lipid A precursors showed a change in the chemical 
shift of C6 of the proximal glucosamine consistent with formation of the 1-6 linkage and 
showed that 1H chemical shifts and J1,2 coupling constants were also consistent with the 
above anomer assignments (40, 41). 
In addition, early research established the positions of the phosphate groups (37, 42). 
Protection of the reducing end of the disaccharide by an acid labile phosphate established 
the presence of phosphate attached to the anomeric carbon of the proximal glucosamine 
(37). Protection of the distal glucosamine by a less labile phosphate group from periodate 
cleavage in the presence (but not absence) of N-acetylation indicated the presence of 
phosphate at the 4'-position (37, 42). 31P NMR showed that 1-diphosphate is sometimes 
present on the proximal glucosamine (39). 
Determination of the positions of the acyl chain substituents required the combination 
of several studies performed over several years. Because amides are less labile than 
esters, the β-hydroxymyristate at the 2- and 2'-amino groups of the glucosamine residues 
were the first acyl chains located (43). Selective removal of these acyl chains by fatty 
acyl amidases further demonstrated that β-hydroxymyristate is present at the amino group 
of both glucosamines (38). Iodomethane-based cleavage of amides followed by analysis 
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of released fatty acids by gas-liquid chromatography showed the presence of β-
hydroxymyristate substituted at the β-hydroxyl group with a secondary fatty acid chain, 
primarily laurate, myristate, and palmitate (44). More selective release of laurate and 
palmitate substituted β-hydroxymyristate by iodomethane suggested that these were 
released from the 2- and 2'-amino groups while myristate substituted β-hydroxymyristate 
was ester-linked to glucosamine (44). A breakthrough in the understanding of the 
structure of lipid A was brought about by the fortuitous discovery of the lipid A precursor 
lipid X (45). Characterization of lipid X by mild alkaline hydrolysis and 1H NMR located 
β-hydroxymyristate esterified at position 3 in addition to the amide-linked β-
hydroxymyristate at position 2 (46, 47). This led Takayama et al. (47) to propose a semi-
symmetrical model of lipid A with β-hydroxymyristate or β-acyloxymyristate at the 2-,  
3-, 2'-, and 3'-positions of the glucosamine disaccharide and with the Kdo residues 
attached at the 6'-hydroxyl. This was an important change to the lipid A model because it 
correctly described the sites of acylation and the attachment site of the core 
oligosaccharide, which was previously placed at the 3'-position (42, 47). Selective ester 
hydrolysis in combination with mass spectrometry showed that the laurate and myristate 
substituted β-hydroxymyristates both reside on the distal glucosamine of lipid A and that 
the proximal glucosamine has one amide-linked and one ester-linked β-hydroxymyristate 
(48, 49). Selective ester hydrolysis in combination with 13C NMR confirmed that the acyl 
groups are attached at the 2-, 3-, 2'-, and 3'-positions of the glucosamine disaccharide in 
Kdo-lipid A and showed that one of the two amide-linked β-hydroxymyristates is 
substituted with a normal fatty acid (50). Thus, the positions of the acyl chains shown in 
Figure 1.1 were established. However, as mentioned above, palmitate substituted β-
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hydroxymyristate was also a major component of lipid A (44). Mass spectrometry in 
addition to selective ester hydrolysis placed this moiety at the 2-position of the proximal 
glucosamine, but mass spectrometry also showed that this modification is present in 
Salmonella but not Escherichia under optimal growth conditions (49, 51). 
Finally, early research into the structure of lipid A determined that 2 or 3 Kdo 
residues are attached to the glucosamine disaccharide (37). As shown in Figure 1.1, it is 
possible for 3 Kdo residues to be present in the inner core oligosaccharide; however, the 
inner core is more variable between bacterial species than lipid A (1). Two relatively well 
conserved Kdo residues are added early in LPS synthesis (1, 52, 53). As stated above, 
Kdo was initially thought to be attached at the 3'-hydroxyl of the glucosamine 
disaccharide, but this was later suggested to be a site of acylation (42, 46). 13C NMR 
chemical shifts and integrations and 1H NMR chemical shifts from multiple studies were 
consistent with the attachment of 2 Kdo residues at the 6'-hydroxyl of lipid A (39, 50, 54, 
55). 13C NMR and 1H NMR chemical shifts and JCH coupling constants indicated that 
both Kdo residues are α-anomers with an α2-4 glycosidic bond linking them and an α2-6 
bond between the first Kdo and the distal glucosamine (50, 55). The α2-4 glycosidic bond 
was further corroborated by gas-liquid chromatography-tandem mass spectrometry (56). 
 
1.3 Raetz Pathway 
The canonical Raetz pathway of lipid A synthesis is a 9 enzyme pathway that 
produces Kdo2-lipid A (Figure 1.3) (1). While some variation exists between species, 
particularly with regards to acylation, the Raetz pathway, especially the first 4 enzymes, 
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is well conserved in Gram-negative bacteria, excluding specialized species that do not 
produce LPS (7, 8). Most of these enzymes have been characterized at the biochemical 
and structural level, and the following summarizes what is known about the enzymes of 
the Raetz pathway. 
LpxA 
 Early experiments with radiolabeled substrates indicated that UDP-N-
acetylglucosamine is incorporated into the lipid A synthesis pathway and suggested that 
acylation of the 3-hydroxyl of glucosamine precedes the removal of acetate (57). The 
acyltransferase responsible for the addition of this acyl chain was denoted LpxA and was 
found to be specific for UDP-N-acetylglucosamine and R-3-hydroxymyristoyl-acyl 
carrier protein (ACP), with little activity toward the S-enantiomer or the coenzyme A 
adduct of β-hydroxymyristate or toward palmitoyl-ACP, myristoyl-ACP, or acyl chain 
acceptors with chains more than 3 carbons long at the 2-amine of glucosamine or with 
uracil substituted with any base other than thymine (58, 59). Furthermore, radiolabeled 
LpxA product was converted to other intermediates of lipid A synthesis (58). 
Crystal structures of LpxA revealed that LpxA is composed of an unusual N-terminal 
left-handed parallel β-helix domain and a C-terminal α-helical domain and forms a trimer 
with 3-fold symmetry (Figure 1.4) (60). Each β-helix approximates an equilateral 
triangular prism, and these helices come together in the trimer to form a large cleft 
between each pair of subunits (60). Extended loops within helical repeats 4 and 5 form 
additional contacts between adjacent subunits (61).
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Figure 1.3: Raetz pathway of lipid A synthesis. The moieties added in each step are shown in red (1). 
Crystal structures with UDP-N-acetylglucosamine or the product bound show that 
substrates bind in this cleft between subunits with the uridine and N-acetylglucosamine 
moieties contacting adjacent subunits and with the R-3-hydroxymyristoyl chain 
extending up the cleft toward the C-terminal domain (Figure 1.4) (61, 62). The extended 
loop within helical repeat 4 provides part of the contacts for N-acetylglucosamine (61, 
62).  
 
Figure 1.4: LpxA. A. Ribbon diagram of the LpxA trimer bound to its 3-O-(R3-hydroxymyristoyl)-N-
acetylglucosamine product (PDB: 2QIA) (62). B. Residues involved in product binding from A. Subscripts 
are used below to distinguish subunits in the trimer. Hydrogen-bonding interactions are shown. Distances 
of interactions in Ångstroms are as follows: 3.3 from 3'-acyl carbonyl O to G1430.3 N, 3.2 from uracil O4 to 
N1980.1 Nδ, 3.0 from uracil O4 to R2050.1 Nη2 2.7 from uracil N3 to N1980.1 Oδ, 2.9 from water to H990.3 
Nδ, 2.8 from same water to β-hydroxyl, 2.8 from β-hydroxyl to H1220.3 Nε, 3.0 from β-hydroxyl to Q730.3 
Nε, 3.3 from glucosamine 3'O to H1250.3, 2.8 from H1250.3 Nδ to D1260.3, 2.9 from glucosamine 6'-
hydroxyl to H1440.3 Nε, 3.0 from glucosamine ring O to K760.3 Nζ, 3.0 from 2'-acetyl carbonyl to L750.3 N, 
and 2.6 from α-phosphate to Q1610.3 Nε. 
Furthermore, these crystal structures provide insight into the mechanism and 
selectivity of LpxA (61, 62). LpxA is thought to catalyze the nucleophilic attack of the 
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glucosamine 3-hydroxyl on the thioester of R-3-hydroxymyristoyl-ACP, and a conserved 
His (H125 in E. coli LpxA) is positioned to act as the catalytic base and accept the proton 
from this hydroxyl while the backbone amide of G143 is positioned to stabilize the 
oxyanion intermediate (61, 62). The role of H125 was supported by activity assays that 
showed it to be critical for activity (63). D126 hydrogen-bonds with and stabilizes the 
position of H125 forming a catalytic dyad similar to that observed in other 
acyltransferases (61). In addition, the product-bound structure suggests that H191 of E. 
coli LpxA limits the length of the acyl chain by capping the channel wherein the chain 
binds, and mutation of another residue that lines this channel (G173) to larger residues 
decreased activity toward the natural acyl donor substrate and increased activity toward 
the 10 carbon chain analogue (62, 64). Moreover, selection of the R-3-hydroxylated fatty 
acid may be controlled by hydrogen-bonding interactions between this functional group 
and H122, Q73, and an ordered water bound to H99 (62). Finally, UDP-N-
acetylglucosamine selectivity is governed by extensive hydrogen-bonding as well as the 
stereospecific architecture of the N-acetylglucosamine binding pocket that would 
interfere with the binding of a sugar with axial substituents (Figure 1.4) (61). 
LpxC 
 LpxC catalyzes the second step in the Raetz pathway, the deacetylation of UDP-
3-O-(R3-hydroxymyristoyl)-N-acetylglucosamine (65, 66). Early experiments showed 
that the LpxA product is deacetylated when incubated with E. coli extracts and that the 
deacetylated product can be converted into other intermediates in the pathway (65). 
Furthermore, LpxC was found to have poor activity toward UDP-N-acetylglucosamine 
(67). Because the reaction catalyzed by LpxA is freely reversible and, surprisingly, 
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thermodynamically unfavorable, LpxC catalyzes the committed step of lipid A synthesis 
(59). In accordance with the thermodynamic importance of this step, LpxC is also an 
important point of regulation for lipid A synthesis (68, 69). LpxC activity is regulated by 
proteolytic degradation by FtsH, which may be controlled by the levels of acyl-ACP or 
Raetz pathway intermediates (68, 69). 
 LpxC is a Zn2+-dependent metalloenzyme though it displays higher activity in the 
presence of Ni2+ or Co2+, which may be due to inhibition by Zn2+ binding at a second site 
(67). Consistent with these enzymatic assays, the crystal structure of Aquifex aeolicus 
LpxC was solved with two Zn2+ in the active site, representing the zinc-inhibited state, 
and the crystal structure of E. coli LpxC in complex with the lipidic product, which was 
crystallized in a high concentration of phosphate, was solved with a single high-affinity 
Zn2+ in the active site (70, 71). Native mass spectrometry was also consistent with the 
binding of one high-affinity Zn2+ (71).  
Solution NMR and crystal structures of LpxC revealed that the enzyme is 
composed of two α/β-domains with a conserved topology that form a five-stranded β-
sheet and two α-helices (70, 72). The α-helices of the conserved fold are packed together 
giving LpxC an overall pseudo-two-fold symmetry (Figure 1.5) (70, 72). The domains 
contain divergent insertions between the fourth β-strand and first α-helix: the N-terminal 
domain’s insertion forms a three-stranded β-sheet, and the C-terminal domain’s insertion 
contributes a short helix to the helical core and forms an α/β-subdomain (70–72).  
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Figure 1.5: LpxC. A. Ribbon structure of LpxC bound to its UDP-3-O-(R3-hydroxymyristoyl)-
glucosamine product (PDB: 4MDT) (71). Spectrum coloring begins with blue at the N-terminus. B. 
Hydrophobicity surface of structure in A. with orange-blue scale. Orange is more hydrophobic. C. Residues 
involved in product binding from A. Zinc coordination is shown in purple, and hydrogen-bond and salt-
bridge interactions are shown in pink. Distances of interactions in Ångstroms are as follows: 1.9 from Zn2+ 
to H238 Nε, 2.0 from Zn2+ to H79 Nε, 2.0 from Zn2+ to D242 Oδ1, 1.9 from Zn2+ to phosphate O2, 2.5 
from water to β-phosphate and 3.2 to α-phosphate and 3.0 to A266 N, 3.2 from pyrophosphate bridging O 
and 2.8 from β-phosphate and 3.5 from glucosamine 6'-hydroxyl to K239 Nζ, 2.8 from β-hydroxyl to 
phosphate O1, 3.2 from water to F194 N and 2.9 to glucosamine 4'-hydroxyl, 3.1 from glucosamine 2'-
amine to phosphate O3 and 2.7 to L62 O, 2.6 from E78 Oε2 to phosphate O4,2.4 from H265 Nε to 
phosphate O3, 3.5 from uracil O4 to D160 N, 2.7 from D246 Oδ2 to H265 Nδ, and 3.5 from uracil N3 to 
D160 O. 
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The structure of E. coli LpxC with UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine and 
phosphate bound in the active site shows that the product primarily binds to the insertions 
and the C-terminal domain with the first helix of the N-terminal domain contributing one 
Zn2+-coordinating residue and the putative catalytic base (71). Zn2+ is coordinated with 
tetrahedral geometry by two His side chains, one Asp side chain (H79, H238, and D242 
in E. coli LpxC), and a molecule from the crystallization solution (70–72). The 
importance of these residues was supported by enzymatic assays that showed decreased 
activity in mutants of any one of these residues as well as greatly decreased Zn2+-binding 
in the His to Ala mutants (73). 
In the product-bound structure of E. coli LpxC, the fourth ligand of Zn2+ was 
modeled as phosphate, and it may approximate the tetrahedral transition state of the 
leaving group, hydrogen-bonding with the glucosamine amine (71). The phosphate forms 
hydrogen-bonds with E78, T191, and H265 implicating these residues in catalysis, and 
mutants of these residues were indeed found to have decreased activity (71, 73, 74). 
Specifically, E78 is positioned to accept a proton from a Zn2+-coordinated hydrolytic 
water, and this role was supported by the greater reduction in activity of E78Q in 
comparison to E78A as E78Q cannot act as a catalytic base but likely blocks the 
compensatory positioning of another residue or solvent molecule (71, 73). On the other 
hand, H265 is positioned to donate a proton to the glucosamine amine, and D246, which 
hydrogen-bonds with the opposite nitrogen of the H265 azole thus tuning the pKa of 
H265, was also critical for activity (71, 73). 
As stated above, the product primarily interacts with the insertions and the C-
terminal domain (71). The UDP moiety binds to the C-terminal domain: uracil hydrogen-
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bonds with the backbone of D160 and forms a π-stacking interaction with F161, and the 
pyrophosphate interacts with K239 and the backbone of H265 (Figure 1.5) (71). 
Recognition of the glucosamine moiety involves all three subdomains (71). The 6'-
hydroxyl also hydrogen-bonds with K239, and the 2'-amine hydrogen-bonds with the 
backbone of L62 (Figure 1.5). The importance of K239 was confirmed by enzymatic 
assays showing a slightly increased KM and greatly decreased kcat in the K239A mutant 
(74). In addition, the 4'-hydroxyl hydrogen-bonds to an ordered water bound to the F194 
backbone (71). Finally, the acyl chain binds in a hydrophobic channel formed by the C-
terminal domain insertion with the chain terminus extending into solvent, suggesting that, 
while presence of the chain is critical for activity, LpxC has little specificity for chain 
length (Figure 1.5) (67, 70, 71). 
LpxD 
 Early experiments indicated that addition of the second R3-hydroxymyristoyl 
group at the glucosamine 2-amino group precedes the hydrolysis of the phospho-
anhydride of UDP (57). This structural gene for the UDP-3-O-(R3-hydroxymyristoyl)-
glucosamine N-acyltransferase (lpxD) was identified by homology to lpxA and its 
position in the same operon, and enzymatic assays showed LpxD is highly specific for β-
hydroxymyristoyl-ACP, showing no activity for myristoyl-ACP and 10-fold reduced 
activity for β-hydroxylauroyl-ACP (75, 76). Furthermore, steady-state kinetic 
experiments showed that LpxD follows an ordered sequential mechanism wherein R3-
hydroxymyristoyl-ACP binds first, and ACP dissociates last (76). 
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Figure 1.6: LpxD. A. Heterohexamer of LpxD and R3-hydroxymyristoyl-ACP (PDB: 4IHF) (77). ACP 
chains are colored red, yellow, and chartreuse, and LpxD chains are colored blue, cyan, and sea green. B. 
LigPlot+ diagram of acyl donor substrate from A. (78). Distances of hydrogen-bond and salt-bridge 
interactions shown in Ångstroms are as follows: 3.2 from acyl chain β-hydroxyl to Q236 Nε and 2.6 to 
D232 Oδ2, 3.0 from acyl chain carbonyl to G257 N, 3.0 from phosphate to N310 Nδ and 2.7 and 2.9 
respectively to R314 Nη and Nε. C. Acyl chain binding in LpxD/ACP heterohexamer (PDB: 4IHG) (77). 
Subscripts are used below to distinguish protein chains in the complex. Hydrogen-bonds are shown, 
corresponding distances in Ångstroms are as follows: 2.9 from putative 2'-R3-hydroxymyristate 
carboxylate to G257C N, 2.1 from putative 2'-R3-hydroxymyristate carboxylate to H239C Nε, 3.0 from 
putative 2'-R3-hydroxymyristate β-hydroxyl to D232B Oδ2 and 3.6 to F183C N, and 2.8 from putative 3'-
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R3-hydroxymyristate carboxylate to F183C O and 3.2 to S of phosphopantetheine attached to ACP S36H. D. 
UDP-N-acetylglucosamine and palmitate binding to LpxD trimer (PDB: 2IU9) (79). Hydrogen-bonds are 
shown with the following distances in Ångstroms: 2.8 from palmitate carboxylate to Q244A Nε and 2.9 to 
D240B Oδ2, 2.6 from 2'-acetyl carbonyl to H247A Nε, 2.8 from uracil O2 to I33B N, 2.7 from uracil N3 to 
F43B O, 2.8 from uracil O4 to D45B N, 2.6 from ribose 3'-hydroxyl to E32B Oε2 and 2.9 to Q248A Oε, 3.0 
from ribose 2'-hydroxyl to E34B Oε1, 2.4 from β-phosphate to Y49B Oη and 3.2 to N46B Nδ, 2.7 from α-
phosphate to H284A Nε, and 3.1 from glucosamine 6'-hydroxyl to N46B Nδ. 
Crystal structures of LpxD reveal many similar features shared with LpxA (79, 
80). In particular, LpxD has a very similar left-handed β-helix domain that includes two 
elongated loops (within helical repeats 5 and 6) that contribute additional interactions 
with the adjacent subunit in the trimer (79). Moreover, LpxD also has an α-helical C-
terminal domain; though in LpxD, the C-terminal helices of the subunits come together to 
form a trimeric helix bundle (79). However, LpxD has an additional N-terminal domain 
composed of a five-stranded β-sheet surrounded by α-helices and a two-stranded β-sheet 
(Figure 1.6) (79). Furthermore, crystal structures of LpxD bound to substrates and 
substrate analogues have revealed conserved catalytic residues and mechanisms of 
substrate specificity (77, 79). Specifically, a conserved His (H239 in E. coli) is positioned 
to accept a proton from the glucosamine amine while the G257 amide is positioned to 
stabilize the oxyanion intermediate (77, 79, 80). As in LpxA, the substrates bind at the 
cleft between subunits (77, 79). 
In the structure of Chlamydia trachomatis LpxD, UDP-N-acetylglucosamine 
binds to the N-terminal domain and the left-handed β-helix domain of the adjacent 
subunit with the N-terminal domain primarily binding the uridine moiety (79). At the 
A+B chain active site, uracil is sandwiched in π-stacking interactions with F43B and 
Y49B (F41 and Y47 in E. coli) and forms hydrogen-bonds with the backbone of residues 
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33B and 43B, and 45B (Figure 1.6) (79). Ribose is hydrogen-bonded to E32B and E34B 
(S30 and Q32 in E. coli) and Q248A (Q240 in E. coli) while the pyrophosphate is 
engaged by Y49B, N46B, and H284A (N44 and H276 in E. coli), and N-acetylglucosamine 
binds to N46B and H247A (H239 in E. coli, the predicted catalytic base) (79). Kinetic 
assays in E. coli LpxD confirmed that H239 was critical for catalysis: H239A decreased 
kcat almost 3 orders of magnitude with a moderate decrease of acyl acceptor KM (76). In 
addition, F41 was confirmed to be critical for acyl acceptor binding: F41A increased 
acceptor KM 29-fold with only a small decrease in kcat (76). Conversely, Y47A had little 
effect, and H276A decreased kcat 32-fold (76). 
E. coli LpxD crystallized in complex with ACP yielded structures with R3-
hydroxymyristoyl-ACP and with holo-ACP and two β-hydroxymyristate molecules 
bound to LpxD (77). ACP primarily binds to the C-terminal domain with the 
pantathionine arm on ACP S36 extending up the active site cleft (Figure 1.6) (77). 
Association with ACP is largely electrostatic with an acidic patch on ACP contacting a 
basic patch on LpxD (77). For example, the Ala mutant of R193, which forms an ion pair 
with E41 of ACP, was found to cause a 23-fold increase of the R3-hydroxymyristoyl-
ACP KM (76, 77). In the intact substrate structure, the R3-hydroxymyristoyl chain turns 
180o and extends back toward the C-terminus of LpxD deeper in the cleft (77). 
Specificity for the length of the acyl chain attached to ACP is conferred by the length of 
the hydrophobic pocket that accommodates the chain (76, 77, 79).  In E. coli LpxD, the 
~13 Å deep pocket is terminated by M290, and M290A allowed incorporation of 16 and 
18 carbon acyl chains in vivo (80). Moreover, in C. trachomatis LpxD, which transfers a 
β-hydroxyarachidoyl chain, the corresponding residue is G298, and the hydrophobic 
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pocket is ~18 Å deep (79). In the B+C active site, the β-hydroxyl group of the transferred 
chain is recognized by hydrogen-bonds to D232B and Q236C of E. coli LpxD, and the 
acyl chain carboxylate hydrogen-bonds to the G257C amide, consistent with its proposed 
stabilization of the oxyanion (Figure 1.6) (76, 77, 80). Finally, the structure of E. coli 
LpxD bound to holo-ACP and two β-hydroxymyristates reveals the binding pocket for 
the 3'-acyl chain of the acceptor substrate: this pocket is formed by the left-handed β-
helix of the subunit that contributes the N-terminal domain, the elongated loop of repeat 5 
from the adjacent subunit, and the pantathionine group (Figure 1.6), consistent with 
kinetic experiments that showed R3-hydroxymyristoyl-ACP binds first (76, 77). 
LpxH and LpxG 
 LpxH is a hydrolase that cleaves the pyrophosphate of UDP-2,3-bis(3R-
hydroxymyristoyl)-glucosamine (UDP-DAG) in the fourth step of the Raetz pathway (1, 
57, 81). Around 70% of Gram-negative bacteria utilize LpxH while Chlamydiae utilize 
the distantly related LpxG, and the rest utilize the nonhomologous enzyme LpxI (82, 83). 
LpxH was one of the primary focuses of my thesis research; therefore, further discussion 
of LpxH is reserved for Chapter 2.  
LpxG was identified as a gene from Chlamydia trachomatis that could 
complement a ΔlpxH strain of E. coli (83). Activity assays showed that, like LpxH, LpxG 
is a Mn2+-dependent pyrophosphatase that catalyzes the nucleophilic attack of water on 
the α-phosphate of UDP-DAG (83, 84). Consistently, mutation of the predicted metal-
coordinating residue D59 to Ala significantly decreased activity (83). Also like LpxH, 
homology suggests that LpxG is a member of the Calcineurin-like metal-dependent 
phosphoesterase family (83). However, LpxG is predicted to have an additional N-
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terminal transmembrane helix, and the sequence identity with LpxH is very low (11%) 
(83). Furthermore, while sequence alignments suggest that LpxG has a similarly located 
insertion in the Calcineurin-like metal-dependent phosphoesterase fold, the length and 
sequence of the insertions in LpxH and LpxG are different, suggesting that these proteins 
either diverged early in their evolution or arose by convergent evolution from different 
phylogenetic clades within the same enzyme family (85). The structure of LpxG has not 
been determined.  
Another gene called lpxH2 because of its sequence homology to lpxH is present in 
some Gram-negative bacteria without lpxH but can also be present in addition to lpxH (7, 
86). Expression of LpxH2 could not complement the a ΔlpxH strain of E. coli, and the 
sequence of the substrate-binding helical cap domain of LpxH is not conserved in LpxH2 
(85, 86). Thus, the function of lpxH2 and its relevance to lipid A synthesis remains 
unknown. 
LpxI 
 LpxI is a non-homologous alternative to LpxH present in some Gram-negative 
bacteria that lack LpxH and LpxG, particularly α-proteobacteria (7, 82). LpxI was 
discovered as a gene of unknown function present in the same operon as lpxA, lpxD, and 
lpxB in bacteria lacking lpxH (82). Unlike LpxH, LpxI does not utilize a catalytic metal 
center; though, it did require divalent cations, specifically Mg2+, Mn2+, or Co2+, for 
optimal activity (82, 87). Furthermore, 18O incorporation from H218O indicated that LpxI 
catalyzes the nucleophilic attack of water on the β-phosphate of UDP-DAG (82). 
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Figure 1.7: LpxI. A. LpxI dimer bound to lipid X (PDB: 4GGM) (87). B. LpxI-D225A dimer bound to 
UDP-DAG (PDB: 4J6E) (87). C. Residues involved in UDP-DAG binding to LpxI-D225A from B. 
Hydrogen-bond and salt-bridge interactions are show, and the distance between A225 and the β-phosphate 
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is highlighted. Distances in Ångstroms are as follows: 3.3 from 3'-acyl carbonyl to L226 N, 2.5 from ribose 
2'-hydroxyl to D188 Oδ2, 2.3 from ribose 3'-hydrxyl to D188 Oδ1 and 3.0 to T233 Oγ, 3.3 from α-
phosphate to T187 N and 2.8 to T187 Oγ and 3.3 to K214 Nζ, 2.6 from β-phosphate to K214 Nζ and 2.9 to 
Q169 Nε, 2.5 from glucosamine 4'-hydroxyl to T228 Oγ, 3.3 from uracil O2 to A232 N, 2.9 from 
glucosamine ring O to N74 Nδ, 3.4 from uracil O4 to A12 N, and 3.1 from 2'-acyl carbonyl to V75 N. 
 Crystal structures of Caulobacter crescentus LpxI and LpxI-D225A bound 
respectively to 2,3-bis(3R-hydroxymyristoyl)-glucosaminyl-1-phosphate (lipid X) and 
UDP-DAG revealed that LpxI has a novel two-domain fold wherein the N-terminal 
domain forms the binding pocket for the majority of the lipid substrate and the C-terminal 
domain forms the pyrophosphatase active site (87). The N-terminal domain is composed 
of a parallel β-sheet surrounded by 4 α-helices, and the C-terminal domain is composed 
of a six-stranded β-sheet surrounded by 4 α-helices and a small two-stranded β-sheet 
(87). The two domains are connected by a flexible linker that undergoes secondary 
structure rearrangement to allow the domains to come together and bring the substrate 
into the active site (Figure 1.7) (87). In the crystal structures, LpxI forms a dimer with 
two-fold symmetry (Figure 1.7), and LpxI also appeared to form a dimer in solution (87). 
However, the functional relevance of dimerization is unclear (87). 
 In the structure of LpxI-D225A in complex with UDP-DAG, uracil is bound by 
the backbone amides of residues 12 and 232, and ribose is hydrogen-bonded to D188 and 
T233 (87). The pyrophosphate forms an ion pair with K214 and hydrogen-bonds with 
Q169 and T187 (Figure 1.7) (87). Furthermore, the importance of T187 was supported by 
activity assays that showed T187A had 175-fold less activity than wild-type LpxI (87). 
Glucosamine is hydrogen-bonded to N74 and T288, and the carbonyls of the acyl chains 
are hydrogen-bonded to the backbone amides of residues 75 and 226 while the 
hydrocarbon chains bind in the complementary hydrophobic pocket of the N-terminal 
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domain (87). Although LpxI activity was stimulated by divalent cations, none are bound 
to the pyrophosphatase domain of either crystal structure nor are putative nucleophilic 
waters apparent (82, 87). Therefore, the exact mechanism of catalysis remains unclear. 
However, positioning of A225 suggests that D225 may position the nucleophilic water 
for attack on the β-phosphate and/or act as the catalytic base; in which case, the divalent 
cation may simply coordinate the unengaged side of the pyrophosphate to balance the 
negative charge to allow nucleophilic attack (87). 
LpxB 
 LpxB is the glycosyltransferase that forms the base glucosamine disaccharide of 
lipid A, catalyzing the formation of the glycosidic bond between the anomeric carbon of 
the UDP-DAG glucosamine and the 6-hydroxyl of lipid X to form lipid A disaccharide 
(40). LpxB was one of the primary focuses of my thesis research; therefore, further 
discussion of LpxB is reserved for Chapter 3. 
LpxK 
 LpxK is the kinase that phosphorylates the 4'-hydroxyl of the distal glucosamine 
of lipid A disaccharide to form lipid IVA (88, 89). LpxK has been proposed to be the 
second regulatory point of the Raetz pathway: LpxK may be stimulated by unsaturated 
fatty acids, and its lipid A disaccharide substrate may stimulate the proteolysis of LpxC 
by FtsH (69). This regulation allows Gram-negative bacteria to balance phospholipid and 
LPS synthesis as both pathways compete for β-hydroxymyristoyl-ACP (68). High flux 
through the Raetz pathway depletes β-hydroxymyristoyl-ACP, limiting the production of 
unsaturated fatty acids, and decreased unsaturated fatty acid production leads to 
decreased LpxK activity, which causes a buildup of lipid A disaccharide (68, 69). 
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Buildup of this intermediate then leads to the proteolysis of LpxC, decreasing 
consumption of β-hydroxymyristoyl-ACP by the Raetz pathway (68, 69). In addition, 
LpxK is the final absolutely required step of the Raetz pathway as E. coli could transport 
lipid IVA to the outer membrane and remain viable (5). 
 LpxK was most active with ATP and an equimolar concentration of divalent 
cation, showing little activity when divalent cations were removed with EDTA (88, 90). 
For the lipid substrate, LpxK was specific for the glucosamine disaccharide head-group, 
showing no activity for lipid X, UDP-DAG, or substrates already containing Kdo core 
oligosaccharide sugars (89). However, LpxK had little specificity for the number of acyl 
chains attached to the glucosamine disaccharide: LpxK could phosphorylate substrates 
with 2-6 acyl chains and substrates wherein the ester-linked chains were replaced with 
amide-linked chains (88, 89). 
Apo, substrate analogue-bound, and product-bound crystal structures of Aquifex 
aeolicus LpxK have been determined (90–92). These structures reveal that LpxK is 
composed of two Rossmann-like domains with β-sheets surrounded by α-helices, and 
these domains are connected by two β-strands that are coextensive with the β-sheets of 
both domains (Figure 1.8) (91). The larger N-terminal domain contains the P-
loop/Walker A and Walker B motifs thus binding ATP, and the C-terminal domain binds 
the lipid substrate (90–92). A hinge-like movement of the domains closes the distance 
between the binding pockets observed in the apo structure to bring the substrates into 
position for phosphoryl transfer (91).   
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Figure 1.8: LpxK. A. LpxK bound to AMP-PCP ATP analogue (PDB: 4ITL) (90). Spectrum coloring 
begins with blue at the N-terminus. B. Residues involved in AMP-PCP binding from A. Distances for 
hydrogen-bond and salt-bridge interactions are shown with distances in Ångstroms as follows: 3.0 from 
adenine N6 to Q240 Oε and 3.5 to R206 Nη1, 3.0 from adenine N7 to Q240 Nε, 2.8 from ribose 3'-
hydroxyl to T52 Oγ, 2.9 from β-phosphate to S49 N and 3.1 to K51 N and 2.7 to T52 N and 2.6 to T52 Oγ, 
3.0 from α-phosphate to G50 N and 2.6 to Y187 Oη, 3.4 from ribose 2'-hydroxyl to K280 N, 2.8 from D99 
Oδ1 to H261 Nδ, 3.0 from K51 Nζ to D139 Oδ1 and 2.7 to γ-phosphate, 2.9 and 2.8 from γ-phosphate to 
E100 Oε2/1, 3.2 from K280 Nζ to water, and 2.2, 3.0, and 3.0 from this water to the phosphates. C. 
Hydrophobicity surface of LpxK bound to lipid IVA (PDB: 4LKV) (92). Hydrophobicity is shown in an 
orange-blue scale with blue representing the hydrophilic end. D. Residues involved in binding lipid IVA 
from C. Distances in Ångstroms for hydrogen-bonds and salt-bridges are as follows: 2.4 from 6'-hydroxyl 
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to R72 Nη2 and 3.2 from the distal glucosamine ring O, 3.4 from 1-phosphate to R119 Nη1 and 3.2 to 
H143 Nδ and 2.9 from R72 Nη1, and 3.3 from 4-hydroxyl to E117 Oε. 
In addition, LpxK has an N-terminal amphipathic helix and adjacent basic patch, which 
likely mediate membrane association; consistent with the presence of these structural 
elements, LpxK was optimally active at the critical micelle concentration of Triton X-
100, and surface dilution of LpxK activity was observed at higher concentrations (90, 
91). Moreover, the amphipathic helix was required for activity (92). LpxK was the first 
membrane active kinase of the P-loop-containing NTPase superfamily to be identified 
(91). 
The AMP-PCP-bound structure of A. aeolicus LpxK shows that adenine is 
recognized by hydrogen-bonding to Q240 and R206 while ribose is bound by T52 and the 
backbone amide of K280 (90). Furthermore, the α- and β-phosphates are engaged in 
extensive hydrogen-bonding interactions with T52, Y187, the backbone amides of 
residues 49-52, and an ordered water bound to K280 (90). The γ-phosphate is positioned 
for transfer by a salt-bridge with K51 and hydrogen bonds to E100 and the ordered water 
(Figure 1.8) (90). Homology suggests that T52, E100, and D138 will coordinate Mg2+ in 
the complex with ATP-Mg (90, 91). The role of E100 in Mg2+ coordination rather than 
simply in hydrogen-bonding is supported by E100A/D/Q mutants wherein E100Q 
showed the greatest decrease in kcat and E100D showed the least as Asp can also 
coordinate Mg2+, and Ala may allow binding of a compensatory water (90). In addition, 
H261 is positioned to accept a proton from the attacking 4'-hydroxyl of lipid A 
disaccharide, and D99, which is hydrogen-bonded to H261, likely serves to increase its 
pKa (90). Consistent with this role, D99A/E/N mutants showed the same trend as the 
E100 mutants (90). Kinetic experiments also confirmed the importance of K51, T52, and 
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H261, showing 3000-fold decreases in kcat for K51A and T52A and an 850-fold decrease 
for H261A, and the Walker B motif residues D138 and D139 were observed to be critical 
for catalysis and ATP-Mg binding, decreasing kcat 4700- and 8100-fold and increasing 
KM 3.3- and 4-fold, respectively (90). 
 The structure of LpxK bound to its lipid IVA product shows that LpxK binds the 
lipid IVA glucosamines with the acyl chains extending into solvent and largely 
disordered, which explains the minimal specificity for the extent of acylation (88, 89, 92). 
The lipidic substrate binding site is on the same face as the N-terminal amphipathic helix, 
which suggests that LpxK may only partially extract lipid A disaccharide from the 
membrane during catalysis (92). Even with glucosamine disaccharide, there are relatively 
few interactions (92). The 1-phosphate is recognized by R72, R119, and H143; however, 
the proximal glucosamine is only hydrogen-bonded to E117, and the distal glucosamine 
is only hydrogen-bonded to R72 (Figure 1.8) (92). Kinetic experiments confirmed the 
importance for lipid A disaccharide binding of R72 and H143, as Ala mutants increased 
KM 4- and 7-fold, respectively, but R119 was largely dispensable, showing no change in 
KM and only a 67-fold decrease in kcat (92). Finally, R171A increased KM 20-fold, but 
R171 was not directly bound to lipid IVA, which suggests that the lipid IVA-bound 
structure may not fully recapitulate productive lipid A disaccharide binding (92). 
WaaA (KdtA) 
 WaaA, also called KdtA, is the glycosyltransferase that, in E. coli, transfers two 
Kdo residues from CMP-Kdo: first to the 6'-hydroxyl of the distal glucosamine and then 
to the 4'-hydroxyl of the first Kdo (52, 53). While E. coli WaaA is thus a bifunctional 
glycosyltransferase, WaaA variants from different species transfer 1-4 Kdo residues (1, 
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93, 94). Activity assays also showed that, like LpxK, WaaA had little specificity for the 
extent of acylation, accepting substrates with 3-6 acyl chains, nor was the 1-phosphate 
required (52, 53, 94). However, the 4'-phosphate was important as lipid A disaccharide 
was a poor substrate for E. coli WaaA though even lipid A disaccharide could be 
glycosylated to a lesser extent by Aquifex aeolicus WaaA (52, 53, 94). Conversely, WaaA 
was highly specific for the donor substrate, showing activity and specific binding for 
CMP but no other nucleoside monophosphates (53, 94). Interestingly, WaaA is another 
point of regulation in the Raetz pathway as WaaA was also degraded by the FtsH 
protease that targets LpxC (95). 
 Crystal structures of the monofunctional WaaA from A. aeolicus revealed that 
WaaA has a typical glycosyltransferase B superfamily (GT-B) fold with two Rossmann-
like domains (Figure 1.9) (96). Moreover, the N-terminal domain of WaaA has a basic 
and hydrophobic surface as observed for other membrane surface-active GT-B enzymes 
(including LpxB as discussed in Chapter 3), which is thought to be required for 
productive membrane association (96–100). As expected for a GT-B enzyme, CMP was 
observed to bind to the C-terminal domain, and a putative lipid IVA binding pocket was 
identified on the N-terminal domain (96, 98). WaaA appears to have been crystallized in 
an open conformation with a wide cleft separating the domains; therefore, a hinge-like 
movement of the domains may be required to bring the substrates into position for 
nucleophilic attack (96–99, 101, 102). 
 The CMP-bound structure of A. aeolicus WaaA shows that cytosine binds in a 
hydrophobic pocket formed by F247 and L250 and is recognized by hydrogen-bonds with 
the backbone carbonyl of P211 and amide of G248 (96).  
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Figure 1.9: WaaA. A. WaaA bound to CMP product (PDB: 2XCU) (96). Spectrum coloring ends with red 
at the C-terminus. B. Columbic surface of WaaA from A. Charge is shown with a blue-red scale with blue 
at positive end. Bound polyethylene glycol molecules are shown. C. Hydrophobicity surface of WaaA from 
A. Hydrophobicity is shown on an orange-blue scale with orange as the hydrophobic end. The putative 
lipid IVA-binding pocket is circled. D. Residues involved in CMP binding from A. Hydrogen-bond and 
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salt-bridge interactions are shown with the following distances in Ångstroms: 3.0 from phosphate to N273 
N and 2.6 and 3.2 to R212 Nη1/2, 2.5 from E276 Oε1 to ribose 3'-hydroxyl and 2.8 to the 2'-hydroxyl, 2.9 
from cytosine O2 to G248 N, and 3.1 from cytosine N4 to P211 O. 
Ribose is hydrogen-bonded to E276, and the phosphate is engaged by R212 and N273 
(Figure 1.9) (96). Activity assays confirmed the importance of R212, which may stabilize 
the negative charge of the CMP leaving group during catalysis (96). In addition, activity 
assays of Ala mutants confirmed the importance of residues G30, E31, E98, and K162 in 
the putative lipid IVA binding pocket (96). E31 appears well positioned to act as the 
catalytic base by accepting a proton from the 6'-hydroxyl of the distal glucosamine, and 
G30 could prevent steric clash from residue 30 that could interfere with proper alignment 
for nucleophilic attack (96). If this role is correct for E31, then E98 and K162 may be 
important for positioning Kdo for transfer, possibly by contacting its 1'-carboxlyate, and 
residues S28, S54, and R56 may bind the 1-phosphate of lipid IVA (96). Mutation of all 3 
of these putative 1-phosphate binding residues to Ala significantly reduced activity (96). 
Finally, increase in Trp-fluorescence upon lipid IVA binding in wild-type but not W102A 
WaaA suggested that the acyl chains bind on top of W102, shielding it from solvent 
quenching (96). 
LpxL and LpxP 
 In E. coli, LpxL is the acyltransferase that adds a lauroyl group to the β-hydroxyl 
of the 2'-β-hydroxymyristate on the distal glucosamine of Kdo2-lipid IVA (103, 104). 
Enzymatic assays showed that LpxL was a membrane surface active enzyme, and a 
predicted N-terminal transmembrane helix was required for activity in vivo (104). In 
addition, enzymatic assays showed that LpxL was selective for the presence of the Kdo 
residues, as its activity for lipid IVA was 6000-fold lower (104). Furthermore, LpxL was 
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selective for lauroyl-ACP: LpxL was 5% as active with lauroyl-coenzyme A (CoA), 
showed further reduced activity with decanoyl-CoA and myristoyl-CoA, and 
incorporated little or no acyl chains 16 carbons or longer from acyl-CoA (104). 
 Conservation of catalytic residues suggested that LpxL is related to the glycerol-
3-phosphate acyltransferase (GPAT) family (104). Consistent with this hypothesis, 
mutation to Ala of H132 and E137 of the predicted catalytic dyad in E. coli LpxL 
decreased activity 1000- and 3000-fold, respectively (104). Moreover, Ala mutations of 
conserved R169 and D200 residues decreased activity 170- and 15-fold (104). However, 
P238A had little effect even though this Pro is important in the GPAT family, and this 
Pro was not conserved in the related enzyme LpxP (104). 
 E. coli also have a cold-shock inducible alternative to lpxL (lpxP) that replaces 
LpxL when cells are grown at 12oC (105). Like LpxL, LpxP was specific for the presence 
of the Kdo groups of Kdo2-lipid IVA as LpxP failed to acylate lipid IVA (105). However, 
LpxP transfers a palmitoleoyl chain from ACP instead of a lauroyl chain (105). In 
addition, LpxP was highly specific for (16:1) palmitoleoyl-ACP, showing little activity 
with shorter or saturated acyl chains or with palmitoleoyl-CoA (105). While LpxL could 
substitute for LpxP at 12oC in a ΔlpxP E. coli strain, this strain showed increased 
sensitivity to rifampicin and vancomycin at 12oC, which suggests that incorporation of 
unsaturated acyl chains into the outer leaflet of the outer membrane by LpxP maintains 
the selective barrier at low temperature (106). Neither LpxL nor LpxP have been 
structurally characterized, but the related enzyme LpxM has been (107). 
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LpxM 
 In E. coli, LpxM is the acyltransferase that attaches a myristoyl group to the β-
hydroxyl of the 3'-β-hydroxymyristate on the distal glucosamine of the LpxL product 
(Kdo2-lipid VA) to produce the end product of the Raetz pathway, hexa-acylated Kdo2-
lipid A (108). Enzymatic assays suggested that E. coli LpxM was specific for the penta-
acylated substrate as LpxM acylated Kdo2-lipid IVA and lipid IVA much more slowly 
(108). However, while LpxM showed poor activity for decanoyl-ACP, β-
hydroxymyristoyl-ACP, palmitoyl-ACP, and palmitoleoyl-ACP, LpxM appeared to only 
have a slight preference for myristoyl-ACP over lauroyl-ACP (108). 
The crystal structure of LpxM from Acinetobacter baumannii reveals that LpxM 
has a unique fold with a twisted, 7-stranded β-sheet surrounded by 10 α-helices that form 
a deep hydrophobic pocket and with an N-terminal transmembrane/membrane-
association helix (107). Unlike E. coli LpxM, A. baumannii LpxM transfers lauroyl 
chains to the β-hydroxyls of the acyl chains at the 2- and 3'-positions of the glucosamine 
disaccharide; therefore, A. baumannii LpxM is a bifunctional acyltransferase that 
transfers secondary lauroyl groups to both glucosamines to produce hepta-acylated lipid 
A (107). Kinetic experiments showed substrate inhibition by lauroyl-ACP, suggesting 
that LpxM utilizes an ordered sequential mechanism in which the acyl acceptor must bind 
first (107). Consistent with the bifunctionality of A. baumannii LpxM, substrate 
inhibition was best fit by a two-site binding model wherein only one lauroyl-ACP is 
inhibitory, and substrate inhibition was alleviated in the K282E/K285E double mutant of 
a putative ACP-binding site at the top of the lipid-binding pocket (107). 
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Figure 1.10: LpxM. A. Ribbon diagram of LpxM (PDB: 5KN7) (107). Spectrum coloring ends with red at 
the C-terminus. Interactions between putative catalytic residues are shown. Distances in Ångstroms are 2.6 
from H122 Nδ to D192 Oδ1, 2.4 from E127 Oε1 to R159 Nη2 and 3.4 to Nη1, and 3.2 from E127 Oε2 to 
R159 Nη2. B. Ligplot+ diagram of fatty acid binding to LpxM (PDB: 5KNK) with distance shown in 
Ångstroms (78, 107). Hydrophobicity surface of LpxM (PDB: 5KNK). Hydrophobicity is shown on an 
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orange-blue scale with blue as the hydrophilic end. The entrances to putative hydrocarbon-ruler channels 
are circled. 
 Like LpxL, LpxM has a conserved His and Glu (H122 and E127 in A. baumannii) 
that, in distantly related acyltransferases, form the catalytic dyad with the His acting as 
the catalytic base that accepts a proton from the nucleophilic hydroxyl (107, 109). Kinetic 
experiments confirmed that E127 was critical for activity (107). In addition, LpxM has a 
conserved Arg and Asp (R159 and D192); R159 was also confirmed to be critical for 
activity (107). The crystal structure of A. baumannii LpxM reveals the location of these 
residues in the hydrophobic pocket, and the positions of these residues suggest that, at 
least in this bifunctional LpxM, the roles of the conserved HX4E/D motif have been 
separated to form two catalytic dyads that catalyze acyl transfer to the 2- and 3'-β-
hydroxymyristoyl chains (Figure 1.10) (107). In the glycerol-3-phosphate acyltransferase 
from Cucurbita moschata, the His and Asp of the HX4E/D catalytic dyad are hydrogen-
bonded, suggesting that Asp increases the pKa of His (110). However, in A. baumannii 
LpxM, H122 and E127 are separated by 7.6 Å, and H122 is hydrogen-bonded to D192 
(107). Moreover, R159 forms an ion pair with E127 (107). Therefore, H122 and D192 
may serve as the catalytic dyad for the transfer of one lauroyl group, and E127 and R159 
may act form the catalytic dyad for the transfer of the second lauroyl group. Finally, the 
structure of the A. baumannii LpxM E127A mutant was resolved with an acyl chain 
(modeled as undecanoic acid) bound in one of two particularly deep, narrow channels in 
the active site (Figure 1.10) (107). These channels may act as hydrocarbon rulers to 
control the length of the transferred acyl chains similar to those in LpxA and LpxD as 
discussed above (107). Consistent with the hypothesis that H122/D192 and R159/E127 
form two catalytic dyads for separate acyl transfer reactions, one of these putative 
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hydrocarbon-ruler channels is near H122 and D192, and the other channel is near R159 
and E127 (Figure 1.10). 
LpxJ and LpxN 
 Some bacteria encoding lpxL but not lpxM instead encode a distant homologue of 
lpxL, lpxM, and lpxP designated lpxJ (111). LpxJ enzymes from three ε-proteobacteria 
species, Helicobacter pylori, Campylobacter jejuni, and Wolinella succinogenes, were 
characterized, showing a range of substrate specificities (111). Ultraviolet photon 
disassociation mass spectrometry combined with activity assays confirmed that H. pylori 
LpxJ acylated the β-hydroxyl of the 3'-acyl chain, like E. coli LpxM, and not the acyl 
chains of the proximal glucosamine (111). However, none of these enzymes required the 
presence of the Kdo groups, and H. pylori LpxJ was not specific for the presence of the 
2'-secondary acyl chain added by LpxL while the other LpxJ variants were only active on 
Kdo2-lipid IVA or lipid IVA, not the LpxL product (111). H. pylori and W. succinogenes 
LpxJ were most active with lauroyl-ACP, but H. pylori LpxJ also utilized myristoyl-ACP 
(111). On the other hand, C. jejuni LpxJ was most active with palmitoyl- or stearoyl-ACP 
(111). In addition, Vibrio cholerae utilizes another alternative to LpxM, designated 
LpxN, that transfers a β-hydroxylauroyl chain to the β-hydroxyl of the 3'-acyl chain (36). 
Thus, the different activities and substrate specificities of the lpxL/M homologues 
encoded by different bacterial species result in diversity in the length, extent, and position 
of acylation in the final lipid A product of the Raetz pathway in different species (1). 
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1.4 LPS Synthesis and Transport 
Core Oligosaccharide Synthesis 
 Following the completion of the Raetz pathway, the core oligosaccharide is 
completed at the cytoplasmic side of the inner membrane (1, 112). The core 
oligosaccharide can be divided into inner and outer cores, and the inner core tends to be 
conserved within a species or genus while species typically have a small number of 
different outer cores synthesized in different strains (1, 112). As described above, the first 
two Kdo residues are added during the Raetz pathway, and these sugar residues are the 
most conserved moiety of the inner core with all known core oligosaccharides containing 
Kdo (1, 52, 53). In addition, the inner core typically contains L-glycero-D-mannoheptose 
(Hep) or, less frequently, the D-glycero-D-mannoheptose isomer (1). In E. coli, the first 
and second Hep residues (Figure 1.11) are added sequentially to the first Kdo by WaaC 
and WaaF, respectively, and a branching Hep is added to the second Hep by WaaQ (1, 
113). The first and second Hep residues are phosphorylated by WaaP and WaaY, 
respectively, and the activity of these kinases is dependent on the addition of the first 
outer core residue by WaaG (1, 114). These phosphorylated inner core residues are 
thought to be important for crosslinking of LPS molecules by divalent cations, and loss of 
phosphorylation increases sensitivity of E. coli to detergent and some antibiotics (1, 114). 
Moreover, the second Hep is the attachment site of this first outer core residue, which is 
glucose in E. coli (1, 115). In E. coli K-12 the first glucose is the site of attachment of a 
branching galactose by WaaB and a second glucose residue by WaaO (115). This WaaO 
product is a branch point in core synthesis in E. coli K-12: either WaaR adds a third 
glucose to the second glucose, or WaaZ adds a third Kdo to the second Kdo (11).
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Figure 1.11: Core oligosaccharide synthesis. Coloring of core oligosaccharide is the same as in Figure 1.1. Transferases responsible for the formation of bonds 
linking residues in the K-12 core oligosaccharide are marked in orange (1, 11, 12, 113–118).
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Competition between these pathways appears to be controlled by the relative levels of 
WaaR and WaaZ, which are dependent on growth conditions with phosphate limitation 
favoring WaaZ and optimal growth conditions favoring WaaR (11). Following addition 
of the third Kdo, WaaS can attach L-rhamnose (Rha) to the second Kdo or, if the second 
Kdo has already been modified with phosphoethanolamine by EptB, to the third Kdo 
(11). In the WaaR pathway, a fourth heptose is attached to the third glucose to complete 
the outer core (Figure 1.11) (1). Sequence similarity with other heptosyltransferases 
suggests that this reaction is catalyzed by WaaU (117). 
Transport of Core-Lipid A across the Inner Membrane by MsbA 
 Following the completion of the core oligosaccharide, the core-lipid A molecule 
is flipped across the inner membrane by the ATP-binding cassette (ABC) transporter 
MsbA (5, 112, 119). Decreased activity of MsbA for earlier intermediates of LPS 
synthesis lacking core sugars or secondary acyl chains likely helps to prevent premature 
transport (5). Structures of MsbA obtained by cryogenic electron microscopy (cryo-EM) 
and x-ray crystallography have provided insight into the mechanism of transport (120, 
121). These structures show that MsbA forms a functional dimer wherein the 
transmembrane domains are comprised of 4 transmembrane helices from one subunit and 
2 transmembrane helices (TM4 and TM5) from the opposite subunit (Figure 1.12) (120, 
121). A cytoplasmic P-loop containing ATPase domain is appended to TM6, and 
cytoplasmic helices between TM2 and TM3 and between TM4 and TM5 contact the 
ATPase domains (120, 121). The helix between TM2 and TM3 contacts its own ATPase 
domain at the ATP-binding site, and the helix between TM4 and TM5 contacts the 
ATPase domain of the opposite subunit (Figure 1.12) (120, 121).  
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 The ATPase domains also act as a functional dimer: the 3.7 Å crystal structure of 
Salmonella MsbA bound to a non-hydrolyzable ATP analogue (AMP-PNP) shows that 
ATP binds between the ATPase domains (Figure 1.12C) (120). One half of the ATPase 
active site formed by the loops of two β-sheets and an α-helix sandwiched between them 
from one ATPase domain, and the other half is contributed by the α-helical side of the 
other ATPase domain (120). In this structure, the transmembrane domain assumes a 
periplasmic open conformation (Figure 1.12C) (120). 
A 4.2 Å cryo-EM structure of E. coli MsbA in the cytoplasmic open conformation 
shows core-lipid A bound inside the transmembrane domains with partially resolved acyl 
chains and core oligosaccharide resolved out to the three inner core Hep residues (Figure 
1.12) (121). The core-lipid A binding pocket is separated into hydrophobic lipid A-
binding and hydrophilic oligosaccharide-binding regions by a ring of primarily basic 
residues that recognize the phosphorylated glucosamine disaccharide of lipid A (121). 
The acyl chains are directed toward the periplasm suggesting that suggesting that flipping 
occurs after a conformational change to open the periplasmic side of MsbA; however, 
examination of the hydrophobicity of MsbA (Figure 1.12B) suggests that the requisite 
translation has already occurred with the acyl chains already extending to the periplasmic 
leaflet of the inner membrane (121). A second 4.8 Å cryo-EM structure, determined in 
the presence of ADP and vanadate, shows MsbA in an occluded conformation with 
parallel transmembrane helices (121). 
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Figure 1.12: MsbA. A. Cytoplasmic-open conformation of MsbA bound to LPS (PDB: 5TV4) (121). B. 
Hydrophobicity surface of MsbA in A. Orange is the hydrophobic end of the scale, and blue is the 
hydrophilic end. C. Periplasmic-open conformation of MsbA bound to AMP-PNP ATP analogue (PDB: 
3B60) (120). 
Therefore, the structures of MsbA suggest a mechanism wherein core-lipid A 
binds the cytoplasmic open conformation, and ATP binding brings the ATPase domains 
together, which is coupled to a conformational change in the transmembrane domains 
from cytoplasmic open to periplasmic open (120, 121). Core-lipid A then flips and 
diffuses into the periplasmic leaflet (120, 121). Next, ATP hydrolysis is coupled to a 
periplasmic open to occluded conformational change, which prevents the transporter 
from acting in reverse (121). Finally, release of phosphate and/or ADP allows MsbA to 
return to the starting cytoplasmic open conformation (120, 121). 
O-antigen Polysaccharide Synthesis and Transport 
 The O-antigen is a repeating polysaccharide that varies between bacterial strains 
(1). Different O-antigens are synthesized by one of three divergent pathways: Wzy 
dependent, ABC transporter dependent, and synthase dependent (1, 112). However, O-
antigen synthesis has a few conserved features: O-antigen is built on undecaprenol 
phosphate (und-P), and sugar residues are transferred to this lipid from nucleotide-
charged sugar donors at the cytoplasmic face of the inner membrane (1, 112). 
Furthermore, a sugar-1-phosphate [1-phospho-N-acetyl-glucosamine (P-GlcNAc) in E. 
coli] is transferred to und-P to form a phospho-anhydride product (GlcNAc-PP-und in E. 
coli) (1). Finally, the completed O-antigen is ligated to core-lipid A at the periplasmic 
face of the inner membrane to form completed LPS by WaaL, which is specific for core 
oligosaccharides but not O-antigens (1). The lack of polysaccharide specificity of WaaL 
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also allows it to attach other capsular polysaccharides (K-antigens and colonic acid in E. 
coli) to core-lipid A (118, 122). Moreover, while E. coli K-12 does not synthesize O-
antigen, conservation of the machinery shared with other polysaccharide synthesis 
pathways still enables this strain to synthesize GlcNAc-PP-und and transport it across the 
inner membrane (117, 122, 123). Therefore, WaaL may also transfer N-acetyl-
glucosamine to the terminal Hep of the K-12 outer core (Figure 1.11) (117, 118). Studies 
of the topology of WaaL indicated that the ligase contained 12 transmembrane segments 
and 2 major periplasmic segments, and enzymatic assays showed that a conserved Arg in 
a short periplasmic segment and a conserved His in the largest periplasmic segment were 
essential for activity (124, 125). Examination of the reactants and products of the WaaL 
reaction suggest that WaaL catalyzes an SN2 substitution reaction wherein the terminal 
residue of the core oligosaccharide (7'-hydroxyl of the fourth Hep in E. coli K-12) attacks 
the anomeric carbon of the basal residue of the O-antigen with und-PP acting as the 
leaving group (125). The positions of these residues and the metal-independent activity of 
WaaL make it tempting to speculate that the conserved Arg and His could bind the 
pyrophosphate of O-antigen-PP-und and act as the catalytic base for the attacking 
hydroxyl, respectively (124, 125). 
 The Wzy dependent pathway is unique from the other pathways in that single 
repeat units are synthesized and transported across the inner membrane (1). Once the 
repeat unit has been synthesized by its specific glycosyltransferases, the repeat unit-PP-
und is flipped across the inner membrane by a Wzx flippase (126). Little is known about 
the mechanism of Wzx flippases; even whether they require energy is a matter of 
contention though in vitro transport of a soluble analogue of GlcNAc-PP-und was not 
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affected by the addition of ATP, NADH, or ionophores (123, 126). However, Wzx 
flippases are thought to have 12 transmembrane segments, and they tend to be specific 
for a particular O-antigen repeat unit with the first sugar attached to und-PP playing the 
most important role in substrate specificity (124, 126). Next, the O-antigen repeat units 
are polymerized at the periplasmic face of the inner membrane on a single und-PP by 
Wzy, which catalyzes the transfer of the growing polysaccharide to the free end of the 
new repeat unit-PP-und (1). Topology studies of Wzy from Pseudomonas aeruginosa 
PAO1 suggested that the polymerase contained 14 transmembrane segments and 4 major 
periplasmic segments (124). Two of these periplasmic segments were found to contain 
RX10G motifs with highly conserved Arg residues that were essential for activity (127, 
128).  
 
Figure 1.13: Proteins that control O-antigen modal length. A. Octamer of WzzB periplasmic domains 
(PDB:4E29) (129). B. WbdD trimer (PDB: 4UW0) with the location of the unresolved extended coiled-coil 
domain and uncharacterized C-terminal domain marked by a rectangle and oval, respectively (130, 131). 
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The presence of two similar motifs in Wzy corresponding with two similar substrates and 
the conservation of Arg suggests that the Arg residues could be involved in binding a 
common motif in Wzy substrates such as the pyrophosphate of oligo-PP-und (124, 127, 
128). In addition to a specific sugar composition, O-antigens have a strain specific modal 
length, and this is controlled by Wzz (1, 129, 132). While crystal and cryo-EM structures 
of Wzz length regulators from multiple species have been determined, the mechanism of 
length regulation has remained obscure (129, 132, 133). Wzz is primarily a periplasmic 
protein with N- and C-terminal transmembrane helices, and the periplasmic region forms 
bell-shaped oligomers with 5-12 subunits though open trimers have also been observed 
(129, 132, 133). The periplasmic region has an α/β-domain that forms the base of Wzz 
adjacent to the membrane and an extended α-helical domain that forms a twisted helix 
bundle in oligomers (Figure 1.13) (129, 132, 133). In vivo assays of Wzz mutants and 
chimeras indicated that surface-exposed residues at the top of the α-helical domain 
controlled O-antigen length, but the role of oligomerization in length regulation (if any) 
has not been established (129, 132). 
 In the ABC transporter dependent pathway, the O-antigen is synthesized 
continuously on a single und-P carrier at the cytosolic face of the inner membrane (1, 
134). Consequently, the initial 1-phospho-sugar and second adaptor residue are not 
repeated, forming the adaptor region before the repeat region of the O-antigen (1, 134). 
Moreover, ABC transporter dependent O-antigens can contain terminal modifications to 
the free end of the O-antigen that act as a form of quality control to ensure only 
completed O-antigen is transported across the inner membrane (1, 134, 135). In 
terminally modified O-antigens synthesized by the ABC transporter dependent pathway, 
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the strain specific modal length of the O-antigen is controlled by the enzyme that makes 
the terminal modifications, which halt the activity of the glycosyltransferases that add the 
repeat units (130, 134). Crystal structures and small angle x-ray scattering (SAXS) data 
of terminating enzyme of E. coli O9a (WbdD) revealed that the catalytic domain of 
WbdD is separated from a structurally uncharacterized C-terminal domain by an 
extended α-helical domain that forms a ~200 Å coiled-coil in WbdD trimers (Figure 1.13) 
(130). The C-terminal domain mediated association with the membrane and the 
glycosyltransferase that synthesizes the O9a repeat units (WbdA) (131). Deletions that 
decreased the length of the coiled-coil domain decreased the modal length of the O-
antigen in vivo, and the opposite effect was observed for insertions designed to increase 
the length of the coiled-coil (130). Therefore, these data support a model wherein O-
antigen is lengthened by WbdA until long enough to reach from the membrane to the 
catalytic domain of WbdD at which point termination depends on competition between 
WbdA and WbdD for the free end of O-antigen (130). However, some ABC transporter-
dependent O-antigens lack terminal modifications, and in this case, the modal length is 
controlled by the stoichiometry of the glycosyltransferases that synthesize the repeat units 
and of the ABC transporter (134). Finally, the completed O-antigen is transported across 
the membrane by the ABC transporter (1, 134). The structure of the heterotetramer 
complex of the Wzm permease and the N-terminal ATPase domain of Wzt from Aquifex 
aeolicus and the structure of the C-terminal carbohydrate-binding domain of Wzt from E. 
coli O9a have been solved by x-ray crystallography (135, 136). 
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Figure 1.14: O-antigen ABC transporter. A. Wzm-Wzt heterotetramer ABC transporter from Aquifex 
aeolicus (PDB: 6AN7) (136). The Wzm subunits are shown in red and yellow, and the ATPase domain of 
the Wzt subunits are shown in cyan and blue. B. Hydrophobicity surface of Wzm-Wzt heterotetramer from 
A. showing periplasmic end of continuous channel. Hydrophobicity is shown on an orange-blue scale with 
orange as the hydrophobic end. The minimum radius of the channel is 3.5 Å (136). C. C-terminal 
carbohydrate-binding domain of Wzt from E. coli O9a (PDB: 2R5O) (135). The domain was crystallized as 
a C-terminally swapped dimer, but this C-terminal swap may not occur in the full Wzm-Wzt complex. 
Residues found to be involved in specific recognition of terminally modified O9a O-antigen are shown 
(135). 
The Wzm-Wzt ABC transporter complex was solved in an open conformation and forms 
a continuous channel with a minimum radius of 3.5 Å, suggesting that the polysaccharide 
can occupy the channel through multiple rounds of ATP hydrolysis (Figure 1.14) (136). 
The Wzm channel is lined with several aromatic residues that may form stacking 
interactions with the sugar rings (136). The Wzt C-terminal domain forms an 
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immunoglobulin-like β-sandwich with a groove containing several residues that were 
shown to be involved in recognition of the terminally modified O9a polysaccharide in 
vivo and in vitro (Figure 1.14) (135). 
 As in the ABC transporter dependent pathway, synthase-dependent O-antigen is 
synthesized on a single und-P carrier and thus contains an unrepeated adaptor region (1). 
The synthase (WbbF) is thought to simultaneously add repeat units and transport the 
growing O-antigen across the membrane (1). However, only O:54 O-antigen of 
Salmonella enterica is known to be synthesized by this pathway, and it has thus not been 
studied extensively (1). 
Transport of LPS to the Outer Membrane 
 Completed LPS is transported from the periplasmic leaflet of the inner membrane 
to the outer leaflet of the outer membrane by the Lpt complex, which is comprised of 
proteins LptA-G and spans from the cytoplasmic face of the inner membrane to the 
extracellular face of the outer membrane (137–140). This complex, which is formed by β-
jellyroll domains in LptF, LptG, LptC, LptA, and LptD, forms a continuous hydrophobic 
slide for LPS across the periplasm, and transport is driven by the ATPase activity of LptB 
(139–148). Extensive structural and functional data have been obtained to support this 
transenvelope protein bridge mechanism. 
 Some of the earliest functional evidence for the transport of LPS via a 
transenvelope bridge was obtained by the study of lipid transport from inner membrane 
spheroplasts (149). These spheroplasts were found to contain pieces of outer membrane 
that could be separated by centrifugation (149). Newly synthesized (14C-labeled) LPS 
was transported to the outer membrane in an MsbA-dependent, periplasmic extract-
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independent manner, and this contrasted with the transport of lipoproteins, which could 
be released from spheroplasts by the addition of the soluble periplasmic carrier protein 
LolA, and with the transport of newly synthesized phospholipids, which could not be 
transported to the outer membrane outside of intact cells (149). Further studies utilized 
lipid A modifying enzymes to demonstrate that LPS accumulated at the periplasmic face 
of the inner membrane when the soluble periplasmic protein LptA was inactivated thus 
identifying a putative LPS carrier for this process (137). The idea of a protein bridge was 
further supported by crystal structures of LptA (145). The crystal structures revealed that 
LptA is primarily comprised of two 8-stranded β-sheets that fold into a β-jellyroll with a 
hydrophobic cleft at one edge (Figure 1.15). Moreover, in the presence of LPS (though 
LPS is not visible in the electron density), LptA crystallized as a chain of head-to-tail 
interacting subunits that formed two continuous β-sheets and a continuous hydrophobic 
groove suggestive of a hydrophobic slide for LPS (145).  
Next, the crystal structure of the LptC periplasmic domain showed a very similar 
structure to that of LptA (Figure 1.15) supporting the model of a continuous β-jellyroll 
slide for LPS (146). Moreover, LptA could abstract LPS from LptC but not vice versa 
thus supporting affinity-based directional transport between proteins in the Lpt system 
though these results are also consistent with a soluble carrier mechanism of LptA (146). 
However, the stable protein bridge model was supported by the ability of the cytosolic 
protein LptB and inner membrane proteins LptC and LptF to pull down LptA and the 
outer membrane proteins LptD and LptE and by the ability of LptA to cause the 
association of liposomes containing the LptBCFG complex with liposomes containing the 
LptDE complex (138, 140). 
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Figure 1.15: LptA and LptC. A. LptA tetramer with subunits interacting in a head-to-tail fashion (PDB: 
2R1A) (145). The tetramer is shown with the N-terminal end at the bottom. B. Hydrophobicity surface of 
LptA tetramer in A. Hydrophobicity is show on an orange-blue scale with blue as the hydrophilic end. The 
arrow indicates the continuous, helical, hydrophobic groove (145). C. Ribbon structure of LptC periplasmic 
domain (PDB: 3MY2) (146). 
Interactions between the Lpt proteins were further characterized by site-specific 
crosslinking with the non-natural amino acid p-benzoyl-L-phenylalanine (Bph) (143). 
Crosslinking suggested that the C-terminal end of the LptC β-jellyroll interacted with the 
N-terminal end of the LptA β-jellyroll, and the C-terminal end of the LptA β-jellyroll 
interacted with the N-terminal end of the LptD β-jellyroll (143). In addition, C-terminal 
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mutants of the LptC β-jellyroll were found to be nonfunctional in vivo and unable to pull 
down LptA, LptD, or LptE (141, 142). On the other hand, the N-terminal transmembrane 
domain of LptC (a predicted transmembrane helix) seemed to be of limited functional 
importance as it could be functionally replaced by unrelated transmembrane helices 
(141). 
Crosslinking with Bph was also utilized to provide evidence for binding and 
directional transfer of LPS (139, 140). LPS was cross-linked to LptA and LptC when Bph 
was incorporated in the hydrophobic cleft of their β-jellyrolls but not when Bph was 
incorporated on the outer surface of their β-jellyrolls thus supporting transport along a 
continuous hydrophobic slide (139, 140).  In addition, ATP-dependent transfer of LPS 
from LptBFG to LptC and LptA was observed in vivo and in liposomes, and transfer to 
LptA was enhanced by the inclusion of LptC (139, 140). Furthermore, LPS was 
transferred from liposomes containing LptBCFG to liposomes containing LptDE in an 
ATP- and LptA-dependent manner (140). Moreover, increase in ATP concentration 
resulted in LPS crosslinking to LptD at earlier time points and decreased crosslinking to 
LptD at later time points, which strongly indicated that transfer through the Lpt system 
was an active process that could be accelerated by an increased rate of ATP hydrolysis by 
LptB (140). Therefore, these data support a model wherein each new LPS molecule 
pushes the previous LPS molecules along the hydrophobic slide of the Lpt complex until 
they reach the outer leaflet of the outer membrane (140). 
Crystal structures of the LptB2FG ABC transporter and of the LptB ATPase dimer 
bound to ATP have been solved and provides some insight into how ATP hydrolysis 
drives LPS through the Lpt system (144, 148, 150).  
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Figure 1.16: LptB2FG ABC transporter. A. Ribbon structure LptB2FG ABC transporter (PDB: 5X5Y) 
(144). LptF is shown in red while LptG is shown in yellow, and LptB subunits are shown in cyan and blue. 
B. Hydrophobicity surface of A. Hydrophobicity is shown on an orange-blue scale with orange as the most 
hydrophobic. Quadrilaterals mark spaces between LptF TM1 and LptG TM5. C. Comparison of ATP-
bound LptB dimer (PDB: 4P33) (150) with LptB subunits in nucleotide-free LptB2FG complex from A. 
Subunits from ATP-bound LptB-E163Q dimer are colored cyan and green, and the LptB2FG complex is 
colored light blue. Cyan LptB-E163Q was overlaid with LptB chain B of complex (25). Curved arrow 
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shows movement of other LptB subunit from nucleotide-free conformation in LptB2FG complex to ATP-
bound conformation in LptB-E163Q dimer. D. Rotated view of B. showing opening to V-shaped pocket on 
top/periplasmic side of LptB2FG complex. Ellipse marks the opening. 
The structure of the LptB2FG complex was solved in the nucleotide-free state and shows 
that the transmembrane helices of LptF and LptG form a V-shaped pocket at the 
periplasmic face of the inner membrane (Figure 1.16) (144, 148). There are minimal 
contacts at the interface between TM1 of LptF and TM5 of LptG suggesting that these 
helices may separate to allow LPS to enter by lateral diffusion (Figure 1.16) (144, 148). 
The V-shaped pocket is lined by highly conserved hydrophobic residues that were found 
to be important for function in vivo (144). In addition, LptF and LptG have periplasmic β-
jellyroll domains similar to those of LptA, LptC, and LptD (144–148). Mutation of the C-
terminal strands of the LptF or LptG β-jellyroll domains caused growth defects in E. coli, 
which suggested that these domains may interact with the N-terminal end of the LptC β-
jellyroll to form the first unit in the hydrophobic slide (148). 
The LptB-E163Q dimer was crystallized with ATP bound showing that ATP binds 
between the ATPase subunits (Figure 1.16) (150). E163 is the predicted catalytic base, 
and mutation to Gln eliminated ATPase activity (150). Comparison of the ATP-bound 
LptB dimer and the nucleotide-free LptB dimer of the LptB2FG ABC transporter suggests 
that ATP binding to the transporter will cause the LptB subunits to rotate ~15o (144, 
150). Interactions of LptB with TM1 and the short α-helix between TM2 and TM3 of 
LptF and LptG likely serve to transmit this motion into the further opening of the space 
between LptF TM1 and LptG TM5 to allow LPS binding (144). Other conformational 
changes associated with the catalytic cycle presumably act to push LPS into the β-
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jellyroll domain of LptF or LptG, but more work is required to elucidate this mechanism 
(144). 
Finally, crystal structures of the LptDE outer membrane complex increase our 
understanding of how LPS is transported across the outer membrane and inserted into the 
extracellular leaflet (147, 151). The structures reveal that LptD forms a 26-stranded β-
barrel, and LptE forms a 4-stranded β-sheet and 2 α-helices (Figure 1.17) (147, 151, 152). 
LptE acts as a plug for this β-barrel, and the extracellular side of the β-barrel is occluded 
by LptE and the extracellular loops of LptD (147, 151). On the other hand, the 
periplasmic side of the β-barrel is open to reveal a large, hydrophilic lumen that may 
accommodate the polysaccharide of LPS (Figure 1.17) (147, 151). LptE has been shown 
to bind LPS, and conserved basic residues of LptE that were found to be important for 
LPS binding are located at the extracellular side of the LptDE complex (144, 151, 152). 
Therefore, movement of LptE upon LPS binding may allow these residues to interact 
with the polysaccharide, and this interaction with LptE may help feed the polysaccharide 
through the β-barrel (147, 151, 152). The LptDE structures also revealed that the 
interactions of the first and final strands in the β-barrel are a weak point in the barrel 
structure thus suggesting that these strands may separate to allow the lipid A moiety of 
LPS to enter the membrane (147, 151). As mentioned above, LptD also has an N-
terminal, periplasmic β-jellyroll domain that likely forms the final subunit in the 
hydrophobic slide, and this domain was crystallized with a detergent molecule bound in 
its hydrophobic cleft (Figure 1.17) (143, 147). This domain is located near the weak point 
in the β-barrel (147). 
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Figure 1.17: LptDE. A. Ribbon structure of LptDE complex (PDB: 4Q35) (147). LptD is colored blue, 
and LptE is colored red. A C8E detergent molecule is shown bound to the N-terminal β-jellyroll domain of 
LptD. B. Periplasmic view of A. C. LptE from the LptDE complex in A. Conserved basic residues shown 
to be important for LptE binding to LPS are highlighted (152). D. Hydrophobicity surface of B. 
Hydrophobicity is shown in an orange-blue scale with orange as the hydrophobic end. The ellipse marks 
the periplasmic entrance to the LptDE lumen.  
 
1.5 Conclusions and Research Goals 
This chapter has described the role of LPS in bacterial physiology and human disease, 
detailed how the structure of this important glycolipid was determined, and summarized 
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what is known about how LPS is synthesized and transported to the outer leaflet of the 
outer membrane. Throughout this chapter, the structures of the enzymes in the Raetz 
pathway, which produce the most conserved portion of LPS, and other important proteins 
involved in the synthesis and transport of LPS were highlighted (1). The discussion of 
these structures has served to demonstrate the great insight into biological processes that 
protein structures can provide, particularly when combined with additional biochemical 
analyses. Thus, the goals of my thesis research have been to solve and further 
characterize the structures of two of the enzymes in the Raetz pathway, LpxH and LpxB. 
The primary goal of solving the structures was accomplished by x-ray crystallography. 
The enzymology of LpxB and the enzymology and structural dynamics of LpxH were 
further explored. My research on each of these enzymes is detailed in the following 
chapters. 
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CHAPTER 2: STRUCTURAL DYNAMICS OF THE SUBSTRATE-BINDING 
CAPPING HELICES OF THE UDP-DIACYLGLUCOSAMINE 
PYROPHOSPHATASE, LpxH 
 
 
 
 
 
 
 
 
 
 
 
Content in this chapter is reproduced, as per journal policy 
http://www.jbc.org/site/misc/edpolicy.xhtml#pip, from the article published in the 
Journal of Biological Chemistry: Bohl, T. E., Ieong, P., Lee, J. K., Lee, T., Kankanala, J., 
Shi, K., Demir, Ö., Kurahashi, K., Amaro, R. E., Wang, Z., and Aihara, H. (2018) The 
substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly 
flexible, enabling facile substrate binding and product release. J. Biol. Chem. 293, 7969–
7981 
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2.1 Background 
Early experiments indicated that hydrolysis of the phospho-anhydride of UDP-
2,3-bis[O-(3R)-3-hydroxymyristoyl]-glucosamine (UDP-DAG) is the fourth step in the 
Raetz pathway (57, 153). The responsible pyrophosphatase in E. coli (LpxH) was 
identified as an essential Mn2+-dependent hydrolase that catalyzes the attack of water on 
the α-phosphate of UDP-DAG (81, 84, 86). Electron paramagnetic resonance was utilized 
to further characterize Mn2+ binding, and these data were consistent with the presence of 
a binuclear manganese center (84). 
Recently, LpxH was added to the list of structurally characterized enzymes in the 
Raetz pathway with the publication of structures of LpxH from Haemophilus influenzae 
and Pseudomonas aeruginosa bound to the 2,3-bis[(3R)-3-hydroxymyristoyl]-
glucosaminyl-1-phosphate (lipid X) product and in the unbound form (85, 154). LpxH 
has a Calcineurin-like metal-dependent phosphoesterase fold with the addition of a 
unique helical cap, comprising 3 major α-helices, that covers the active site and binds the 
lipid substrates (Figure 2.0) (85, 154). The core domain is composed of 2 five-stranded β-
sheets surrounded by 4 α-helices, and the helical cap domain is inserted between β-strand 
6 and the final α-helix (85, 154). The crystal structures confirm that LpxH has a binuclear 
manganese center in its active site (85, 154). In the P. aeruginosa structure (PDB: 5B49), 
the first Mn2+ is coordinated by D8, H10, D41 (bridges the Mn2+), H197, a bridging 
water, and a second water that completes the octahedral geometry and may represent the 
attacking water (85). Alternatively, the bridging water may act as the attacking water 
(155). The second Mn2+ is coordinated by D41, the bridging water, N79, H114, and 
H195, which leaves one open coordination site that may be filled by the α-phosphate in 
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the substrate-bound structure (Figure 2.0) (85, 155). The importance of several of the 
Mn2+-coordination residues was confirmed by enzymatic assays in H. influenzae LpxH 
(HiLpxH) that showed large (3-5 orders of magnitude) drops in specific activity when 
individual residues were mutated to Ala (84).  
 
Figure 2.0: Pseudomonas LpxH bound to lipid X product. A. Ribbon structure of PaLpxH bound to lipid 
X (PDB: 5B49) (85). Lipid X carbons are colored grey, and protein carbons are colored tan. Mn2+ are 
colored purple. Spectrum coloring begins with blue at the N-terminus. B. Residues involved in lipid X 
binding from A. Metal coordination is shown in purple with the following distances in Ångstroms: from 
Mn301 to H10 Nε (2.3), to H197 Nε (2.3), to D8 Oδ1 (2.2), to D41 Oδ2 (2.3), to bridging water (2.3), and 
to adjacent water (2.2); and from Mn302 to D41 Oδ2 (2.2), to N79 Oδ (2.1), to H195 Nδ (2.3), to H114 Nε 
(2.2), and to bridging water (2.2). Hydrogen-bond and salt-bridge interactions are shown in pink with 
distances in Ångstroms of 2.7 from H195 O to bridging water, 2.9 from 2-acyl chain β-hydrxyl to R157 
Nη1, 2.8 from glucosamine 4-hydroxyl to T164 Oγ and 2.9 to K167 Nζ, 3.3 from K167 Nζ to 3-acyl chain 
carbonyl and 2.8 to its β-hydroxyl, 2.8 from glucosamine 6-hydroxyl to H195 Nε, 2.8 from glucosamine 2-
amino to S160 Oγ, and 2.7 from 1-phosphate to bridging water and 3.4 to adjacent water and 2.6 to N79 Nδ 
and 2.8 and 3.1 respectively to R80 Nε and Nη2. 
Lipid X-bound structures show that the lipid X head group is recognized by 
extensive hydrogen-bonding interactions, and the acyl chains bind in the hydrophobic 
pocket formed by the capping domain and the interface with the core domain: the amide-
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linked chain is buried in the hydrophobic pocket while the ester-linked chain exits 
between the helices and extends across the top of the lid or into solvent (85, 154). In the 
P. aeruginosa LpxH (PaLpxH) structure (PDB: 5B49), the lipid X phosphate is bound by 
N79 and R80, which is a conserved residue particular to LpxH and is usually His in other 
metal-dependent phosphoesterases of the Calcineurin-like superfamily (85, 155).  
Consistent with the importance of this Arg, the Ala mutation in HiLpxH decreased 
activity 7000-fold (84). In addition, glucosamine is hydrogen-bonded to S160, T164, 
K167, and H195, and the β-hydroxyl groups of the acyl chains are hydrogen-bonded to 
R157 and K167 (Figure 2.0) (85). Finally, Y125 packs on top of the glucosamine ring 
(85). All of these residues noted from PaLpxH are conserved in E. coli LpxH (same 
numbering) and HiLpxH (numbering +1) with the exception of T164, which is Asn and 
Lys, respectively. 
While previous structures suggested that the capping domain is stably attached to 
the rest of the protein and only becomes slightly disordered in the absence of ligand (85), 
we provide multiple lines of evidence that the capping domain is highly dynamic in the 
absence of ligand. These results have implications for the mechanism of substrate binding 
and product release: although slight disordering of the third capping helix as observed 
previously could allow lipids to enter and exit the active site, a more extensive 
conformational change would enable facile binding and release of lipids through a wider 
opening between the capping helices. 
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2.2 Results and Discussion 
Crystal Structure 
 
Figure 2.1: E. coli LpxH crystal structure. A. The overall structure of LpxH4+4 shows a Calcineurin-like 
metal-dependent phosphoesterase fold with two Mn2+ bound in the active site and the partially resolved 
capping helices displaced from the core domain. Spectrum coloring begins with blue at the N-terminus. B. 
Two Mn2+ are coordinated in the active site with the following distances in Ångstroms: D8 Oδ1 to Mn1 
(2.1), H10 Nε to Mn1 (2.2), D41 Oδ2 to Mn1 (2.3) and to Mn2 (2.1), N79 Oδ to Mn2 (2.1), H114 Nε to 
Mn2 (2.1), H195 Nδ to Mn2 (2.2), H197 Nε to Mn1 (2.2), bridging water to Mn1 (1.9) and to Mn2 (2.1), 
and adjacent water to Mn2 (3.3). C. LpxH4+4 rendered by average B-factor. Wider tubes and colors closer 
to red indicate higher B-factors. Except where otherwise noted, comparison of structures and preparation of 
structures for figures was performed in UCSF Chimera (25). 
A solubilized version of E. coli LpxH including 4 solubilizing mutations (F141H, 
L142S, L146S, and F147H) and 4 surface entropy reduction mutations (E14A, E15A, 
K161T, and E162A) (LpxH4+4) was generated to improve protein expression and 
crystallization. LpxH4+4 crystallized in plate-shaped crystals that diffracted to 2.00 Å, 
and the structure was solved by molecular replacement (Table 2.1) (PDB: 5WLY). The 
core phosphoesterase domain of E. coli LpxH is composed of two 5-stranded β-sheets 
sandwiched together by α-helices, and this domain overlays very well with the previous 
LpxH structures (25, 85, 154) (Figures 2.1A and 2.2A).  
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Table 2.1: Diffraction and Refinement Statistics 
 
Statistics for the highest resolution shell are shown in parentheses. Each dataset was collected with a single 
crystal. 
Parameter LpxH4+4 (PDB: 5WLY) LpxH4+4 SeMet (SAD data) 
Diffraction   
Wavelength (Å) 0.97918 0.97918 
Resolution range (Å) 66.05-2.00 (2.06-2.00) 66.08-2.63 (2.75-2.63) 
Space group P 21 2 21 P 21 2 21 
Unit cell 
a,b,c (Å) 
α,β,γ (°) 
57.012 62.064 66.047   
90 90 90 
56.66 62.77 66.08 
90 90 90 
Total observations 96359 (6401) 49232 (6109) 
Total unique 16046 (1090) 7415 (890) 
Multiplicity 6 (5.9) 3.6 (3.9) 
Completeness (%) 98.6 (91) 99.5 (99.7) 
Mean I/σI 7.7 (0.8) 10.3 (1.2) 
Wilson B-factor 26.88 49.49 
R-merge 0.179 (1.973) 0.198 (1.932) 
R-meas 0.196 (2.162) 0.232 (2.257) 
R-pim 0.078 (0.867) 0.120 (1.160) 
CC1/2 0.994 (0.279) 0.992 (0.395) 
Refinement  Not fully refined 
Resolution Range (Å) 45.23-2.00 (2.16-2.00)  
Completeness (%) 90.44 (71.09)  
Reflections 14750 (2414)  
R-free Reflections 689 (117)  
R-work/R-free 0.1983/0.2271 
(0.3310/0.3626) 
 
Non-hydrogen atoms 1850  
     Protein 1687  
     Ligands/ions 10  
     Solvent 153  
RMS bond lengths (Å) 0.003  
RMS bond angles (°) 0.594  
Ramachandran favored (%) 94.86  
Ramachandran allowed (%) 4.67  
Ramachandran outliers (%) 0.47  
Rotamer outliers (%) 1.80  
Cβ-outliers 0  
Clashscore 2.38  
Average B-factor 42.45  
     Protein 42.46  
     Ligands/ions 48.43  
     Solvent 41.97  
Number of TLS groups 3  
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 However, the capping helices of E. coli LpxH were displaced from the position observed 
in previous structures and were largely disordered (Figure 2.2A). Residues 122-130 and 
162-172 from the capping helices are not visible. While the unbound form of P. 
aeruginosa LpxH (PaLpxH) did show increased disorder and an altered conformation 
where the capping helices bind the product head group and connect to the core domain, 
the rest of the helices remained packed on top of the active site (Figure 2.2D) (85). In E. 
coli LpxH, the helices are detached from the active site, and only the middle portion 
(residues 131-161) is visible. This conformation is fortuitously stabilized by crystal 
contacts (Supplementary Fig. 2.1) and is likely transient in solution. However, this 
structure suggests that the capping helices are much more flexible and disordered in the 
absence of substrate than was apparent from previous LpxH structures. This structure of 
E. coli LpxH was the impetus for further experiments to examine the movement of the 
cap. It is important to note that the capping helices of LpxH4+4, which contains 6 
mutations within the capping helices, or of E. coli LpxH in general may be inherently 
more flexible than those in H. influenzae or P. aeruginosa LpxH. On the other hand, in 
previous LpxH crystal structures, the closed conformation was stabilized by binding to 
lipid X and/or crystal contacts wherein the capping domains were often packed against 
each other, and this may explain the limited movement observed in the apo PaLpxH 
structure (85, 154).  Because the structures and sequences of LpxH from these species are 
highly similar (Figures 2.2 and Supplementary Fig. 2.2), the design and analysis of the 
following experiments were guided by the hypotheses that the motions of the capping 
helices are similar and that the conserved residues play the same roles in these different 
LpxH variants.  
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Figure 2.2: Comparison with HiLpxH and PaLpxH. A. Overlay of LpxH4+4 (PDB: 5WLY, blue) with 
HiLpxH (PDB: 5K8K, green), PaLpxH with no Mn2+ (PDB: 5B4A chain B, tan), and apo PaLpxH (PDB: 
5B4D chain A, pink). The RMSD values between the core domains are as follows: 0.784 Å between 180 
atom pairs for 5WLY and 5B4A, 0.782 Å between 181 atom pairs for 5WLY and 5B4D, and 0.730 Å 
between 164 atom pairs for 5WLY and 5K8K. While the core domains overlay well, the capping helices in 
LpxH4+4 are displaced from their position in the closed structures, and helix 5 is not visible in the electron 
density. In the apo structure of PaLpxH, the third helix of the capping domain is partially disordered and 
slightly above its position in the lipid X-bound structures, but the displacement is much less than in the 
LpxH4+4 structure. B. The surface rendering of PaLpxH bound to Mn2+ and lipid X (PDB: 5B49) shows 
that the capping helices (purple) are closed down on the core domain, but residues 84-88 (grey carbons), 
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which, in LpxH4+4, underwent hydrogen-deuterium exchange more rapidly than any part of the protein 
outside of the capping helices (Figures 2.3 and 2.4), remain largely exposed. In contrast, the loop between 
β-strand 2 and α-helix 2 (pink carbons) is largely covered by the cap in this conformation. The backbone 
nitrogens of these two loops are colored cyan, and the exposed nitrogens of residues 86 and 87 are circled. 
C. The surface rendering of LpxH4+4 shows that movement of the capping helices (yellow) exposes a large 
area of the core domain including the loop between strand 2 and helix 2 (black carbons). However, the 
exposure of residues 84-88 (grey carbons) is similar to that in the lipid X-bound conformation of PaLpxH. 
The backbone nitrogens of these loops are colored purple, and the exposed nitrogens of residues 86 and 87 
are circled. D. The surface rendering of apo PaLpxH (PDB: 5B4D) shows that the capping domain remains 
packed against the core domain even when with the partial disordering of helix 7. 
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) 
HDX-MS of LpxH4+4 showed that the capping domain has a relatively high 
exchange rate compared to the rest of the protein (Figures 2.3 and 2.4). Residues 146-
156, which constitute the first half of the third helix of the capping domain (helix 7), have 
the highest exchange rate (66.7% in 1 min) of any detectable portion of the protein 
(Figures 2.3 and 2.4). Residues 158-172 have the second highest exchange rate (53.8% 
for residues 158-169 and 55.9% for residues 170-172 in 1 min) and form the second half 
of helix 7 and the C-terminal loop of the capping domain. In the LpxH4+4 structure, only 
residues 158-161 were visible from this second region, and residues 159-165 were 
disordered in the apo PaLpxH structure (Figures 2.1 and 2.2) (85). Residues 84-88, which 
form a loop and the N-terminus of helix 3, have the highest exchange rate outside of the 
capping domain (47.0% in 1 min) (Figures 2.3 and 2.4). As these residues are largely 
surface exposed even in closed structures (85, 154), this provides little insight (Figure 
2.2). Unfortunately, the residues in the long loop between sheet 2 and helix 2, which are 
covered by the free end of the capping domain in the closed structures but surface-
exposed in our structure, were not observed by mass spectrometry (Figures 2.2 and 2.3).  
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Figure 2.3: Time-dependent hydrogen-deuterium exchange. Heat map of fraction of deuterium uptake 
plotted against the amino acid sequence at 0.167, 3, 10, 30, and 120 min. Gaps show where no uptake data 
were available because the amino acid was not observed or because the amino acid was only observed at 
the N-terminus of peptides. Uptake is most rapid for residues 146-156 followed by residues 158-172; both 
of these regions are part of the helical cap domain. The most rapid uptake outside of the cap is observed for 
residues 84-88, which are largely surface exposed in our structure and in the closed structures (85, 154). 
Nonetheless, the high exchange rate of the capping domain, particularly in the 146-156 
region that was ordered and attached to the catalytic core in previous structures, supports 
the hypothesis that this domain is highly dynamic rather than stably attached to the core 
domain. 
 
Figure 2.4: Fractional exchange at 10 min. The 10 minute fractional deuterium uptake values plotted 
onto our E. coli LpxH structure (coloring with low blue end and high red end). Regions with no exchange 
data are colored tan. Active site Mn2+ ions are shown in purple. 
Molecular Dynamics Simulations Show Cap Flexibility 
PaLpxH was selected for molecular dynamics (MD) simulations because 
structures of PaLpxH have been determined with and without lipid X bound (85). 
Moreover, simulations with E. coli LpxH would require a large portion of the cap to be 
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computationally built before molecular dynamics could be run; therefore, utilizing 
PaLpxH structures to minimize the amount of structure that needed to be computationally 
built gave more reliable starting models for MD simulations. 
 
Figure 2.5: Flexibility of the capping helices. A. Density map of the first principal component is shown. 
B. The open and closed forms of the cap found in MD simulations are shown. Cap residues (121 to 168) are 
colored in blue while the rest of the protein is shown in silver surface. Mn2+ ions are shown in pink. The 
loop containing F82 and L83 is colored orange, and the residues are colored with green carbons and a 
yellow surface. 
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MD simulations were performed on PaLpxH systems with lipid X bound (PDB: 5B49) 
(LpxHholo), with lipid X removed (PDB: 5B49) (LpxHapo_holo), and with the unbound 
structure (PDB: 5B4C) (LpxHapo_apo) (85). In our 3 μs simulations of LpxHholo, lipid X 
conserved its conformation in the active site. Principal component analysis showed that 
the cap mostly sampled the conformation observed in the crystal structure and rarely 
sampled other conformations with the cap slightly more open. In the presence of lipid X, 
the cap adopted the crystal structure conformation with only small deviations (Figure 
2.5A). In the absence of a ligand in PaLpxH (LpxHapo_apo and LpxHapo_holo), the cap 
became more flexible, sampling many conformations including an open configuration 
where residues 123 and 163 were farther apart (Figure 2.5A). LpxHapo_apo displayed an 
open cap where a large cavity formed near the Mn2+ active site that is large enough to 
accommodate the phosphate and glucosamine moieties of lipid X (Figure 2.5B). Overall, 
MD simulations agreed well with experimental results in that the cap is rather flexible in 
the absence of lipid X. 
The Role of Loop (Residues 80 to 83) in Cap Flexibility  
In our MD simulations of apo LpxH starting from the lipid X-bound conformation 
(LpxHapo_holo), we observed that the cap generally maintained its positioning as observed 
in the PaLpxH crystal structures. However, as a notable deviation from the crystal 
structure we found that residues 80 to 83, which formed a flexible loop underneath the 
cap, move upward to and protrude into the cap. In particular, F82 and L83 side chains 
interact with the cap residues via hydrophobic interactions. To further investigate the role 
of the loop, we simulated a F82G/L83G double mutant of PaLpxH (LpxHmut). Principle 
component analysis of the LpxHmut showed that the mutations caused the cap to collapse 
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on itself, adopting a closed conformation (Figure 2.5). Based on this, the loop may have a 
role in regulating the opening or closing of the cap and thus the exposure of the active 
site for ligand binding.  
We then studied the root-mean-square-deviation (RMSD) of the loop for 
individual systems to elucidate the dynamics of the loop. We aligned the trajectories 
against two reference conformations (loop-down and loop-up conformations) to identify 
which conformation the loop adopts over time. The loop-down conformation has the loop 
farther away from the cap as in the crystal structure, while the loop-up conformation has 
the loop protruded inside the cap as seen in simulations (Figure 2.6A). In both LpxHmut 
and LpxHholo systems, the loop adopted the down conformation away from the cap, while 
the loop in the LpxHapo_apo and LpxHapo_holo systems sampled both the up and down 
conformations and conformations in-between (Figure 2.6A).  
To test whether the loop-up and loop-down conformations of the loop correlate 
with the open and closed states of the cap, we calculated the distance between the cap and 
the loop and the distance between residues 123 and 163, the two residues at the opposite 
ends of the cap (Figure 2.5B). These two residues provide a good measure of the cap’s 
open and closed conformations. As seen in Figure 2.6B, the data indicated a negative 
correlation between the distance between residues 123 and 163 and the distance between 
the loop and the cap; thus, the loop-up conformation correlates with the open 
conformation. Taken together, our results suggest a mechanism where the loop protrudes 
into the cap to keep it open, forming a solvent-exposed cavity for ligand binding. 
Therefore, mutation of the residues 82 and 83 (F82G, L83G) would be expected to 
decrease activity by inhibiting substrate binding. 
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Figure 2.6: Correlation of loop movement and cap opening. A. A boxplot of the RMSD calculation 
aligned against the loop-up (teal) and loop-down (salmon) conformations. The loop-up and loop-down 
protein conformations in ribbon diagram are shown at the bottom on the right and left, respectively. The 
cap and the loop are highlighted in blue and orange, respectively, and F82 and L83 are shown with cyan 
carbons. From left to right, plots for LpxHmut, LpxHholo, and LpxHapo_holo/LpxHapo_apo are shown. 
B. Heatmap showing correlation of the cap opening with the cap-loop distance. The cap opening distance is 
measured between residues 123 and 163 (Figure 2.5) while the cap-loop distance is determined by the 
distance between the center of mass of the cap and the center of mass of the loop. Individual points 
represent frequency of conformations observed during the time-course of MD simulations. Lighter colors 
represent greater point density. 
To test this hypothesis, these conserved residues were mutated to Gly in the soluble E. 
coli LpxH forming LpxH4+4-GG, and its activity was tested in vitro as described below. 
Activity of E. coli LpxH Mutants 
Activity assays showed that the solubilized E. coli LpxH crystallized in this study 
was catalytically competent for hydrolyzing UDP-DAG to lipid X (Figure 2.7 and Table 
2.2). In fact, the crystallized form showed significantly more activity than the wild-type 
enzyme with a C-terminal mCherry fusion (LpxH-mCherry) (Table 2.2). These results 
indicate that none of the 8 mutated residues were important for activity on detergent-
solubilized substrate. The reason for increased activity is unknown but may simply reflect 
improved solubility: less aggregated protein is present. Alternatively, the 6 mutations in 
the capping helices may increase the flexibility of the cap and thus facilitate cap opening. 
The LpxH3+4-W136H mutant, wherein F141 was restored and W136 was mutated as an 
alternate solubilizing mutation, has similar activity to LpxH4+4. In H. influenzae LpxH 
(HiLpxH), the corresponding F142 contacts the amide-linked acyl chain of lipid X while 
the residue corresponding to W136 is surface exposed in all LpxH structures (Figure 2.8) 
(85, 154). The similar solubility and activity of these variants is more consistent with the 
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hypothesis that increased activity reflects improved solubility of the LpxH variants rather 
than effects on substrate binding. 
Table 2.2: LpxH Specific Activities 
Reactions were run in triplicate at ambient temperature (21oC) with 100 μM UDP-DAG and 5 to 20 nM 
LpxH (in 0.5 M NaCl, 20 mM Tris-HCl pH 7.5, 5 mM DTT, and 2.5 mM MnCl2), 0.1 M Tris-HCl pH 8.0, 
0.1% Triton X-100, and 1 mg/mL BSA. Inhibitor (3) was dissolved in DMSO resulting in a final 
concentration of 10% DMSO in these reactions. Activity was measured with a UMP/CMP-Glo kit 
(Promega), which quantifes UMP concentration with a luciferase-coupled assay. Specific activities with 
standard errors and confidence intervals were caculated by linear regression analysis of 3 time points within 
the linear range of the reactions in Graphpad Prism v7.03. 
However, mutating I47 and R149 to Cys (LpxH4+4-CC) decreased activity significantly 
placing it on par with LpxH-mCherry (Table 2.2): I47 forms part of the hydrophobic 
pocket that binds the hydrocarbon tails of the substrate, and R149 forms a salt-bridge 
with D50 in structures where the cap is positioned on top of the active site, not displaced 
LpxH Specific Activity ± 
Standard Error  
[μmol*min-1*μmol-1] 
95% Confidence Interval Percent of  
wtLpxH-mCherry 
(with DMSO) 
-mCherry 12.75 ± 1.84 8.41 to 17.1 100% 
4+4 62.17 ± 5.20 49.89 to 74.45 488% 
3+4-W136H 76.54 ± 6.04 62.25 to 90.83 600% 
4+4-CC 17.94 ± 2.81 11.28 to 24.59 141% 
4+4-GG 1.438 ± 0.226 0.9039 to 1.971 11.3% 
-mCherry (10% 
DMSO) 
14.22 ± 0.68 12.62 to 15.81 112% (100%) 
-mCherry (2 μM 
inhibitor) 
6.019 ± 0.353 5.185 to 6.853 47.2% (42.3%) 
-mCherry (6 μM 
inhibitor) 
2.993 ± 0.140 2.661 to 3.325 23.5% (21.0%) 
-mCherry (10 μM 
inhibitor) 
1.803 ± 0.247 1.219 to 2.388 14.1% (12.7%) 
-mCherry (50 μM 
inhibitor) 
1.497 ± 0.0860 1.293 to 1.7 11.7% (10.5%) 
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as in the LpxH4+4 structure (Figure 2.8). The loss of this salt-bridge that stabilizes the 
position of the cap may explain the decreased activity of LpxH4+4-CC. As described 
above, molecular dynamics simulations suggested that residues F82 and L83 are 
important for stabilizing an open cap conformation in which the active site is accessible 
to substrate. When both of these residues were mutated to Gly (LpxH4+4-GG), activity 
was decreased significantly below that of LpxH-mCherry consistent with the effect 
predicted by molecular dynamics simulations (Table 2.2). However, these mutations 
could also decrease substrate binding efficiency by decreasing the hydrophobic contacts 
available to the amide-linked acyl chain of lipid X. In addition, the melting temperature 
(Tm) of LpxH4+4-GG was decreased by 2.6oC relative to LpxH4+4, indicating that these 
mutations partially compromise protein stability (Supplementary Table 2.1). However, 
the Tm remained well above the temperature (21oC) at which activity assays were run. 
Finally, because even the most active LpxH variant tested here had a specific activity 
~2500-fold lower than that measured for wild-type HiLpxH (84), it is important to note 
that our reaction conditions were not identical. In particular, we determined specific 
activities with reactions run at 21oC versus 30oC used previously (84). 
Inhibition 
Nayar et al. (156) identified an inhibitor of E. coli LpxH via genetic screening. 
Thus, we tested the ability of this inhibitor (3) (Scheme 2.1) to inhibit LpxH in vitro. 
Luminescence-based assays gave an IC50 of 1.2±0.2 μM for LpxH-mCherry (Table 2.2 
and Supplementary Fig. 2.3). Thin layer chromatography (TLC) based assays also 
showed inhibition of LpxH-mCherry by 3, giving incomplete conversion of UDP-DAG to 
lipid X (Figure 2.7): in TLC-based assays, the IC50 appeared to be low micromolar (~5 
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μM) (Figure 2.7). On the other hand, the crystallized form of E. coli LpxH was not 
inhibited by 3 (Figure 2.7).  
 
Figure 2.7: Inhibition of LpxH. Reactions (10 μL) were run at 30oC with 62 μM UDP-DAG, 10 nM 
LpxH, 0.1 M Tris-HCl pH 8.0, 0.1% Triton X-100, 10% DMSO, and 1 mg/mL BSA at various 
concentrations of the inhibitor (3) (Scheme 2.1) (shown in micromolar). Reactions were quenched by 
spotting on HPTLC Silica gel 60 plates, which were run with 25/15/4/2 chloroform/methanol/water/acetic 
acid mobile phase and charred with 20% sulfuric acid in ethanol and a heat gun. Reactions prepared with 
UDP-DAG but no enzyme act as a negative control and UDP-DAG standard. Independently purified lipid 
X product is also included as a standard. LpxH-mCherry reactions were run for 30 min. The reaction 
proceeded to completion in the absence of inhibitor, but is slightly inhibited by 1 μM inhibitor. At 2-8 μM 
inhibitor, the reaction proceeds to about 50% completion, and it is mostly inhibited at 10 μM and above. 
These plates were not repeated. LpxH4+4 reactions were run for 20 min. No inhibition was observed up to 
1 mM inhibitor. This plate was replicated twice. LpxH3+4-W136H reactions were run for 40 min. A small 
amount of UDP-DAG remains at 100 μM and 1 mM inhibitor suggesting weak inhibition at high inhibitor 
concentrations. This plate was replicated thrice. Analysis of band intensities is presented in Supplementary 
Fig. 2.6, and the full plates are shown in Supplementary Fig. 2.7. 
This result is likely due in part to the F141H mutation because E. coli LpxH-F141L was 
previously identified as a resistant mutant (156). However, when F141 was reintroduced 
in LpxH3+4-W136H, inhibition was still weak at inhibitor concentrations as high as 1 
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mM (Figure 2.7). Thus, L142, L146, and/or F147 are likely also involved in inhibitor 
binding, possibly by influencing the position of F141. Influence on the position of F141 
may also explain the resistance of the LpxH-R149H mutant: the corresponding Arg packs 
against F142 in the HiLpxH structure (PDB: 5K8K) (Figure 2.8). The G48D and L84R 
resistance mutations likely function by introducing a charged residue into the 
hydrophobic pocket thus blocking inhibitor binding. The location of these mutations 
strongly suggest the inhibitor acts by competitively binding to LpxH and blocking 
binding of the hydrocarbon tails of the substrate (156) (Figure 2.8). When the inhibitor 
was docked into the HiLpxH active site with AutoDock Vina (157), it tended to occupy 
the same space as the amide-linked acyl chain (Figure 2.8D). In one compelling model, 
the inhibitor is engaged with the F142 (F141 in E. coli LpxH) by π-stacking, which could 
explain the resistance conferred by the otherwise conservative F141L mutation (Figure 
2.8D) (156). The HiLpxH structure was taken to be the best candidate for molecular 
docking because PaLpxH already contains L141. 
 
2.3 Conclusions and Future Directions 
In this work, we have provided multiple lines of evidence that the substrate-
binding cap of LpxH is more dynamic than was apparent from previously published 
crystal structures alone (85, 154). Molecular dynamics simulations showed how this 
dynamic nature of the cap can allow for facile substrate binding and product release 
between the helices of the cap. Furthermore, these simulations identified two residues 
that may act as a wedge to promote cap opening to allow substrate entry, and mutation of 
these residues was found to decrease LpxH activity as predicted. 
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Figure 2.8: Inhibitor binding and cap mobility. Residues that have been shown to be important or that 
may be important for inhibitor binding are shown. G48D, L84R, F141L, and R149H were found to provide 
E. coli with resistance to the inhibitor by Nayar et al. (156). In this study, LpxH4+4, which contains 
F141H, was also found to be resistant, but reintroduction of F141 in LpxH3+4W136H was not sufficient to 
allow low micromolar inhibition suggesting some contribution to resistance by one or more of L142S, 
L146S, and F147H. A. HiLpxH (PDB: 5K8K) (154) has residue numbering +1 that of E. coli LpxH and 
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PaLpxH. R150 is forming a ion pair with D51 (3.5 Å). The amide-linked acyl chain of lipid X is interacting 
with F142. B. PaLpxH (PDB: 5B49) (85) has Leu at 141 instead of Phe suggesting that Pseudomonas 
aeruginosa has a natural resistance to the inhibitor. Furthermore, L141 appears to allow the amide-linked 
acyl chain to assume a conformation different from that observed in HiLpxH. R149 is forming an ion pair 
with D50 (2.8 and 2.9 Å) C. The positions of these residues in the LpxH structure solved in this study. 
Displacement of the cap has broken the ion pair between R149 and D50. D. Docking of the inhibitor (tan 
carbons) into the HiLpxH structure with AutoDock Vina (157) shows that it may occupy the same space as 
the amide-linked acyl chain of lipid X (grey carbons). In the docking model selected (4th ranked of 9), the 
inhibitor is engaged in a π-stacking interaction with F142, which may explain the specificity for Phe over 
Leu at this position. An overlay of the top 4 docking models is shown in Supplementary Fig 2.8. E. 
Another view of the docking model in D. with mesh surface rendering, lipid X removed, and the inhibitor 
rendered in space-filling model. F. The 2D structure of the inhibitor, which was rendered in ChemBioDraw 
Ultra 14.0. 
Finally, we quantified the potency for a previously identified LpxH inhibitor and 
modeled a plausible binding mode consistent with identified resistance mutations (156). 
The greater understanding of the structure and dynamics of the LpxH substrate-binding 
pocket provided by this research will aid in the development of more effective inhibitors 
and antibiotic leads targeting this step in the synthesis of Gram-negative endotoxin.  
However, a few questions remain about the enzymology of LpxH: mainly, it has 
not been determined how LpxH binds the UMP portion of UDP-DAG or whether the 
bridging or adjacent active site water attacks the α-phosphate (85, 155). Structures of 
related Ser/Thr protein phosphatases with phosphate or sulfate bound in the active site 
suggested that the bridging water is the nucleophile, but structures of LpxH with lipid X 
bound were consistent with attack by either water (85, 154, 155). These questions could 
both be answered by the structure of LpxH bound to a non-hydrolyzable analogue of 
UDP-DAG. In addition, while our activity assays were consistent with collapse of the cap 
into a closed state in the F82G/L83G mutant, experimental data to directly corroborate 
the change in cap conformation predicted by molecular dynamics simulations are lacking. 
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A crystal structure of this mutant might confirm this change in conformation, and further 
hydrogen-deuterium exchange experiments could reveal any corresponding change in 
solvent accessibility. Moreover, protein NMR or electron paramagnetic resonance with 
site-directed labeling by nitroxide-containing spin labels could be used to explore 
changes in the structure and dynamics of the cap (158, 159). Finally, a crystal structure 
with inhibitor (3) (Scheme 2.1) bound would provide a much higher confidence model 
for the mechanism of inhibition than docking models, which would be more useful for 
development of antibiotic lead compounds based on (3). 
 
2.4 Experimental Procedures 
Cloning, Site Directed Mutagenesis, and Expression 
E. coli lpxH was PCR-amplified from DH5α cells (NEB) and inserted into the 
NdeI (NEB) and XhoI (NEB) sites of pET24a(+) (Novagen). Expression of wild-type 
LpxH was poor. To improve expression, LpxH was solubilized by the mutation of 
predicted surface-exposed hydrophobic residues. These residues were predicted from a 
homology model generated by the Phyre2 server with a distantly related hydrolase, 
Rv0805 (PDB: 3IB7, 17% identity)  (160, 161). Several mutations were tested, and 
F141H, L142S, L146S, and F147H were identified as the best mutations for improving 
solubility and expression. However, this protein failed to crystallize. To improve 
crystallization, surface entropy reduction mutations (E14A, E15A, K161T, and E162A) 
were introduced, which were identified by the SER server (162). This 8 residue mutant 
(LpxH4+4) was used for the remainder of experiments except where noted otherwise. A 
second 8 residue mutant (LpxH3+4-W136H) was also generated in which W136 was 
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mutated to His instead of F141 to test the effect of the F141H mutation on inhibitor 
binding as discussed below. In addition, I47C and R149C were added to the LpxH4+4 
mutant (LpxH4+4-CC) in an attempt to introduce a disulfide bond that could lock down 
the capping domain; however, only the presence of intermolecular disulfides was 
observed by SDS-PAGE (data not shown). Finally, F82G and L83G were added to 
LpxH4+4 (LpxH4+4-GG) to test the effect on activity as suggested by molecular 
dynamics simulations (discussed below). 
LpxH was expressed in BL21 DE3 cells (Lucigen) grown in Miller’s Luria Broth 
(RPI) (40 mg/L kanamycin [Teknova]) at 37oC to an OD600 of 0.8 and induced at 18oC 
with 1 mM isopropyl β-D-1-thiogalactopyranoside (GoldBio) overnight. The cells were 
pelleted at 4,500xg (4oC, 25 min) (Beckman J6-MI, JS-4.2), resuspended in lysis buffer 
(0.5 M NaCl [Fisher], 50 mM Tris-HCl pH 7.4 [Fisher], 5 mM β-mercaptoethanol [β-
ME] [EMD Millipore], and 1 mM MnCl2 [MP Biomedicals]), and frozen at -20oC until 
purification. 
Purification of Soluble LpxH 
The cells were thawed in a cool water bath and sonicated on ice with a Branson 
Sonifier (5 output, 50% duty) for three 2 min intervals. The lysate was centrifuged for 45 
min at 64,000xg (4oC, 45 min) (Beckman Avanti J-25 I, JA-25.50).  The lysate was 
batch-bound for 1 h (4oC) with 6 mL pre-equilibrated HisPur Ni-NTA resin (Thermo) 
with the addition of 10 mM imidazole (Chem-Impex Int’l). A gravity-flow column was 
used to collect the resin, which was then washed with 50 mL equilibration buffer (0.5 M 
NaCl, 50 mM Tris-HCl pH 7.4, and 5 mM β-ME) with 25 mM imidazole and 15 mL 
equilibration buffer with 40 mM imidazole. LpxH was eluted in 20 mL equilibration 
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buffer with 250 mM imidazole. Elutant was dialyzed against 500 mL 0.5 M NaCl, 20 
mM Tris-HCl pH 7.4, 5 mM dithiothreitol (DTT) (GoldBio), and 5 mM MnCl2 at 4oC in 
3.5 kDa cutoff tubing (Spectra/Por) overnight. Dialyzed elutant was concentrated 4-fold 
in a 10 kDa cutoff centrifugal filter (Millipore), and concentrated protein was run on 
HiLoad 26/60 Seperdex 200 column (GE Healthcare) in 0.5 M NaCl, 20 mM Tris-HCl 
pH 7.4, 5 mM DTT, and 2.5 mM MnCl2 at 4oC. Peak fractions corresponding to 
monomeric LpxH were concentrated to 14.2 mg/mL, as measured by A280 (ε= 28085 M-
1cm-1) (Nanodrop 8000 Thermo), flash frozen in liquid N2, and stored at -80oC. The 
selenomethionine (SeM) derivative of LpxH was produced by the Met synthesis 
inhibition method with 50-75 mg/L SeM (Chem-Impex Int’l) (163). The SeM derivative 
was purified as for the native protein except the concentrations of DTT and β-ME were 
increased to 10 mM. 
Differential Scanning Fluorimetry  
Differential scanning fluorimetry (DSF) was utilized to identify additives that 
would stabilize LpxH for crystallization. Thermal shift assays were performed in a 
CFX96 Real-Time System C1000 Touch Thermal Cycler (Bio-Rad). Samples (25 μL) 
were prepared in a 96-well plate with a final concentration of 0.484 mg/mL protein, 80x 
Sypro Orange (Life Technologies) (1.6% dimethyl sulfoxide [DMSO]), and 2-fold 
diluted Solubility and Stability Screen (HR2-072 Hampton Research). The temperature 
was increased from 20oC to 95oC at 0.5oC per cycle with a 30 s cycle. Sucrose (1 M) and 
10 mM GSH/GSSG glutathione were identified as strong stabilizing agents. 
DSF was also utilized to identify low salt conditions appropriate for hydrogen-deuterium 
exchange mass spectrometry of LpxH4+4 and to compare the stability of LpxH4+4 and 
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LpxH4+4-F82G/L83G, which was identified by molecular dynamics simulations as 
discussed below, in size-exclusion buffer. These experiments were performed as above 
except that the final concentration of LpxH was 5 μM and sample volume was 40 μL. 
Crystallization and X-ray Diffraction 
LpxH4+4 (7.1 mg/mL) with 20 mM reduced glutathione (Calbiochem) was 
crystallized in 1.5 μL hanging drops (2:1 protein to well solution) over 0.1 M Tris-HCl 
pH 8.2, 70-80 mM magnesium formate (Fluka), and 1-5% 2-propanol (Fisher) at 19oC. 
Plate-shaped crystals grew within 2 days. Crystals were cryo-protected with 0.25 M 
NaCl, 10 mM Tris-HCl pH 7.4, 2.5 mM DTT, 1.25 mM MnCl2, 50 mM Tris-HCl pH 8.2, 
0.5% 2-propanol, 35 mM magnesium formate, 10 mM reduced glutathione, and 30% 2-
methyl-2,4-pentanediol (ACROS Organics). The crystals were shot at the Advanced 
Photon Source (Argonne National Laboratory, Illinois) on the 24-ID-E beamline at 0.979 
Å and 100 K. The best crystals diffracted to 2.0 Å (Table 2.1). The SeM derivative was 
crystallized under the same conditions as the native protein with the exception of the 
addition of 5 mM tris(2-carboxyethyl)phosphine-NaOH (Soltec Ventures) pH 6.6 to the 
well solution. The SeM derivative formed plate-shaped crystals, which were cryo-
protected with the same solution as the native crystals. The best SeM derivative crystal 
diffracted to 2.63 Å at the APS on beamline 24-ID-E at 0.979 Å and 100 K (Table 2.1). 
The diffraction data were indexed, integrated, and scaled in the beamline’s Rapid 
Automated Processing of Data software (XDS(164) and CCP4(165)). 
Model Building 
  The structure of E. coli LpxH was solved in the P21221 space group by molecular 
replacement in PHENIX Phaser with a structure of P. aeruginosa LpxH (PDB: 5B4A) 
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(47% identity), which contained a mutation that eliminated Mn2+ binding but was still 
bound to lipid X, as the search model (85). One hundred and ninety-eight amino acids 
and one Mn2+ ion were built automatically by PHENIX (166). The rest of the structure 
was built manually in Coot with refinement and automated ligand placement performed 
in PHENIX (166, 167). Residues 122-130, 162-172, and the C-terminal His-tag are 
disordered and not visible in the electron density map. The structure was refined with 
Ramachandran statistics of 94.86% favored, 4.67% allowed, and 0.47% outliers. The 
SeM derivative data were used to create an anomalous difference map that confirmed the 
positions of the Se atoms in the structure (Supplementary Fig. 2.4). 
Hydrogen-Deuterium Exchange Mass Spectrometry 
LpxH was prepared at 20 μM for hydrogen-deuterium exchange in 0.1 M NaCl 
and 10 mM Tris-HCl pH 8.2. Protein was diluted 10-fold with D2O at 10oC (100 μL 
final). Exchange was quenched with an equal volume of quench buffer (1.25% formic 
acid, 1.5 M guanidine-HCl) at 0 s, 10 s, 1 min, 3 min, 5 min, 10min, 20 min, 30 min, 60 
min, and  120 min, and 100 μL was injected on a Waters ACQUITY HDX LC 
system.  The LC system was maintained at 0°C except for a separate chamber for the 
pepsin digestion (10°C). The samples were digested on a Prozyme pepsin cartridge (2.1 
mm x 3.0 mm, Applied Biosystems), trapped, and desalted  on a Waters ACQUITY BEH 
C18 VanGuard Pre-column (130 Å, 1.7 μm, 2.1 mm x 5 mm) for 3 min with a flow rate 
of 100 μL/min Buffer A (0.1 % formic acid in water).  The resulting peptic peptides were 
resolved on a Waters ACQUITY UPLC BEH C18 column (1.7 μm, 1.0 x 100 mm) with a 
linear gradient ranging from 5 to 60% acetonitrile with 0.1% formic acid in 6 min at 40 
μL/min, which was coupled to a Waters Synapt G2 HDMS q-TOF mass spectrometer. 
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Figure 2.9: Coverage of the mass spectrometry. Continuous blue bars represent the peptides detected. 
The maximum coverage was 9 different peptides around residue 200. Gaps show that residues 1-4, 37-61, 
and 138-140 were not present in any of the observed peptides. The overall coverage was 87.1% with 61 
peptides. 
Mass spectra were collected in positive ion MSE mode. Non-deuterated peptides were 
identified in PLGS 3.0 (Waters), and deuterated peptides were identified and quantified 
in DynamX 3.0 (Waters) with correction for deuterium incorporation during proteolysis 
as previously described (168). Hydrogen exchange was measured on 61 peptic peptides, 
which cover 87.1% primary sequence of LpxH with an average redundancy of 3.51 
(Figure 2.9). 
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Molecular Dynamics Simulations 
We performed triplicate molecular dynamics (MD) simulations for four systems: 
LpxH with lipid X in the binding site (LpxHholo), apo LpxH starting from the holo crystal 
structure (LpxHapo_holo), LpxH F82G/L83G mutant (LpxHmut), and apo LpxH starting 
from the apo crystal structure (LpxHapo_apo). The crystal structures of LpxH from 
Pseudomonas aeruginosa we used as starting structures are PDB: 5B49 (with bound lipid 
X) for the first three systems and PDB: 5B4C (with no ligand bound) for the last system 
(85). We used Gaussian09 (169) to generate RESP HF 6-31G* charges and the 
Antechamber module of the Amber14 suite (170) to parameterize Lipid X with the 
Generalized Amber Force Field (171). The systems were built with Amber ff14SB force 
field (172) in a TIP3P (173) water box. Chloride ions were added to neutralize the 
positively charged systems. Histidine protonation states were determined by the 
PROPKA program (174) implemented in the NBCR PDB2PQR webserver (175). 
All MD simulations were performed using the Amber GPU workflow (176). We first 
relaxed each system with multi-step minimizations followed by four consecutive 
restrained MD simulations. The first 2,000 minimization steps constrained all heavy 
atoms. The second 2,000 minimization steps constrained only the protein heavy atoms 
and ions. The third 2,000-step minimization was similar to the second minimization but 
with restraints on the Mn2+ ions removed. The fourth 10,000-step minimization held only 
the protein backbone atoms constrained. The final 20,000 steps minimized all atoms 
without any constraints. After minimizations, the systems were slowly heated from 0 K to 
310 K while keeping a positional restraint of all heavy atoms for 250 ps. Then the 
systems were subjected to three consecutive 250 ps restrained MD simulations 
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consecutively releasing the initial 3 kcal/(mol. Å2) restraint on heavy atoms to 2 and 1 
kcal/(mol. Å2). Finally, three independent copies of 1 μs production MD simulations with 
2 fs time steps were performed at 310 K and 1 atm for all four systems, resulting in 12 μs 
of MD simulations in total. The MD simulations were stable as shown in root-mean-
square-deviation (RMSD) plots (Supplementary Fig. 2.5).  
PCA and Distance Analysis 
Principle component analysis was performed on all the systems using Amber 
cpptraj (177). The motion of the cap (residues 121-168) and an interacting loop (residues 
80-83) was captured in a covariance matrix, diagonalized to find the eigenvalues, and the 
conformation variation of each system was shown by projecting onto the eigenvalues. 
Distances were calculated using VMD (178). R was used for plotting (179).  
Chemical Synthesis of LpxH Inhibitor 
General Procedures: All commercial chemicals were used as supplied unless 
otherwise indicated. Flash chromatography was performed on a Teledyne Combiflash 
RF-200 with RediSep columns (silica) and indicated mobile phase. All moisture sensitive 
reactions were performed under an inert atmosphere of ultrapure argon with oven-dried 
glassware. 1H was recorded on a Varian 600 MHz. Mass data was acquired on an Agilent 
1100 LC/MSD TOF mass spectrometer (G1969A). Analysis of sample purity was 
performed on a Varian Prepstar SD-1 HPLC system with a Phenomenex Gemini, 5 μm 
C18 column (250 mm × 4.6 mm). HPLC conditions: solvent A = H2O, solvent B = 
acetonitrile; flow rate = 1.0 mL/min; compounds were eluted with a gradient of 5% 
acetonitrile/H2O for 0−5 min and to 95% acetonitrile/H2O from 5 to 30 min followed by 
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100% acetonitrile from 35 to 40 min. Purity was determined by total absorbance at 254 
nm. Compound has a purity ≥95%. 
 
Scheme 2.1: Synthesis of LpxH inhibitor. 1-(5-((4-(3-(trifluoromethyl) phenyl) piperazin-1-yl) sulfonyl) 
indolin-1-yl) ethan-1-one (3) was synthesized from piperazine derivative (2), 1-acetylindoline-5-sulfonyl 
chloride (1), and triethylamine dissolved in dichloromethane. The reaction was performed at ambient 
temperature for 2 h with stirring. Following purification, the final yield was 79% at ≥95% purity. 
Synthesis of 1-(5-((4-(3-(trifluoromethyl) phenyl) piperazin-1-yl) sulfonyl) 
indolin-1-yl) ethan-1-one (3) (Scheme 2.1): To a solution of piperazine derivative (2) 
(100 mg, 0.43 mmol, 1.0 eq) in dichloromethane (5 mL) at 0 °C, 1-Acetylindoline-5-
sulfonyl chloride (1) (0.12 g, 0.48 mmol, 1.1 eq) and triethylamine (0.08 mL, 0.56 mmol, 
1.3 eq) was added dropwise and the reaction mixture was stirred for 2 h at room 
temperature. The reaction was diluted with dichloromethane (10 mL) and quenched with 
sodium bicarbonate (10 mL). The organic layer was separated and the aqueous layer was 
extracted with dichloromethane (2 x 10 mL). The combined organic layers were washed 
with brine, dried over sodium sulfate and evaporated in vacuo to yield the desired crude 
product. Purification of the crude using Combiflash with a gradient of 0-2% methanol in 
dichloromethane yielded the title compound as colorless crystals (0.16 g, 79%). 
1H NMR (600 MHz, DMSO-d6) δ 8.21 (d, J = 8.2 Hz, 1H), 7.59 (d, J = 11.0 Hz, 2H), 
7.40 (t, J = 7.9 Hz, 1H), 7.19 (d, J = 8.4 Hz, 1H), 7.15 (s, 1H), 7.09 (d, J = 7.5 Hz, 1H), 
4.17 (t, J = 8.4 Hz, 2H), 3.32 (s, 4H), 3.23 (t, J = 8.4 Hz, 2H), 2.99 (s, 4H), 2.19 (s, 3H). 
HRMS-ESI (+) m/z calculated for C21H23F3N3O3S, 454.1412 [M+H]-; found: 454.1406. 
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Purification of LpxH-mCherry 
In order to test the inhibition of wild-type LpxH, a C-terminal fusion with 
mCherry was designed. The lpxH and mCherry genes were fused together with a KpnI 
(NEB) site followed by 3 consecutive Gly codons. The gene fusion was ligated into the 
BamHI (NEB) and XhoI sites of pET24. This fusion allowed for the purification of 
enough LpxH-mCherry for enzymatic assays. The Ni-NTA portion of the purification 
process for this protein was the same as for the native soluble form of LpxH except that 
β-ME was decreased to 1 mM, Tris-HCl pH 7.4 was replaced with HEPES-NaOH pH 8.0 
(Fisher), and 10% glycerol (Fisher) was added to the buffer. The elutant (15 mL) was 
dialyzed against 500 mL 5% glycerol, 0.5 M NaCl, 50 mM HEPES-NaOH pH 8.0, 5 mM 
MnCl2, and 1 mM DTT at 4oC in 3.5 kDa cutoff tubing overnight. The dialyzed elutant 
was concentrated in a 30 kDa cutoff centrifugal filter (Millipore), and concentrated 
protein was run on a Seperdex 200 Increase 10/300 GL column in 5% glycerol, 0.5 M 
NaCl, 50 mM HEPES-NaOH pH 8.0, 5 mM β-ME, and 2.5 mM MnCl2 at 4oC. The most 
pure fractions were combined and the concentration was measured as 0.413 mg/mL (7.52 
μM) as measured by A280 (ε= 62340 M-1cm-1). 
Activity Assays 
For TLC-based assays, LpxH variants were prepared at 100 nM in 0.5 M NaCl, 
20 mM Tris pH 7.5, and 2.5 mM MnCl2. Reactions (10 μL) were prepared with 62 μM 
UDP-DAG (as measured by A260, ε= 9.9 mM-1cm-1), 10 nM LpxH or 1 μL dilution 
buffer, 100 mM Tris-HCl pH 8.0, 0.1% Triton X-100, and 1 mg/mL bovine serum 
albumin. UDP-DAG and lipid X were prepared as described in Chapter 3. Reactions were 
run at 30oC and were quenched by spotting onto an HPTLC Silica gel 60 plate (EMD 
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Millipore). The spots were dried with a Dual-Temp heat gun (Genesis) set on low 
(300oC). The plate was run with 25/15/4/2 chloroform/methanol/water/acetic acid mobile 
phase. After running, the plate was allowed to dry for one hour. Then the plate was 
developed by spraying with 20% sulfuric acid in ethanol and charring with the heat gun 
set on high (538oC) until bands appeared. Reactions to test the effect of the LpxH 
inhibitor contained 10% DMSO (TCI) and were run for the amount of time required for 
the uninhibited enzyme to reach completion (Supplementary Table 2.2) as determined 
above. 
While TLC-based assays have the benefit of directly showing changes in the 
substrate and product of interest, absolute quantification requires concurrently run 
standard curves (180, 181). To determine specific activities for more quantitative 
comparisons of LpxH variants, UMP concentration was quantified with a UMP/CMP-Glo 
Glycosyltransferase Assay kit (Promega) as described by the manufacturer. Reactions (10 
μL) were prepared as above except that enzyme dilution buffer included 5 mM DTT, 
reaction LpxH concentration was 5 nM (20 nM for LpxH4+4-GG), and UDP-DAG 
concentration was 0.1 mM. Reactions were run at ambient temperature (21oC) in a white 
384-well plate (Greiner Bio-One 781074). Reactions were quenched with 10 μL 
UMP/CMP Detection Reagent (Promega), and the plate was shaken 30 s at 1440 rpm and 
1 mm amplitude in a Spark 10M plate reader (Tecan). The luciferase reaction was 
incubated at ambient temperature 1 h, and then the total luminescence of each well was 
measured in a luminometer developed by Fluorescence Innovations (Minneapolis, MN). 
Concurrently run UMP standard wells allowed luminescence of LpxH reaction wells to 
be converted to UMP concentration. All reactions and standards were run in triplicate. To 
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determine specific activities, reactions were quenched at three time points within the 
early, linear product accumulation range of the LpxH reactions, and linear regression was 
performed in Graphpad Prism v7.03. To determine the IC50 of the LpxH inhibitor, 
specific activities of LpxH-mCherry (5nM) were determined as above with 10% DMSO 
and 2-50 μM inhibitor. These specific activities with standard errors were fit to a 3-
variable dose-response inhibition curve in Graphpad Prism v7.03: 
 𝑆𝑆𝑆𝑆 = 𝑆𝑆𝑆𝑆𝑚𝑚𝑚𝑚𝑚𝑚 + 𝑆𝑆𝑆𝑆𝑚𝑚𝑚𝑚𝑚𝑚−𝑆𝑆𝑆𝑆𝑚𝑚𝑚𝑚𝑚𝑚1+10log[𝑚𝑚𝑚𝑚ℎ𝑚𝑚𝑖𝑖𝑚𝑚𝑖𝑖𝑖𝑖𝑖𝑖]−log(𝐼𝐼𝐼𝐼50) . For the purpose of curve fitting, an inhibitor 
concentration of 0.1 nM was paired with the uninhibited (10% DMSO) LpxH-mCherry 
specific activity. 
Molecular Docking 
The LpxH inhibitor 1-(5-((4-(3-(trifluoromethyl) phenyl) piperazin-1-yl) sulfonyl) 
indolin-1-yl) ethan-1-one (3) (Scheme 2.1) (156) was docked into the HiLpxH (PDB: 
5K8K) structure (154) with AutoDock Vina (157). The protein and ligand structures were 
prepared for docking in AutoDockTools from the MGLTools 1.5.6 suite (182, 183). The 
active site was defined by a box centered at coordinates (0.2, 16.529, 13.923) with x, y, z 
lengths of 24, 18, and 36 Å. Exhaustiveness was set to 10; 9 structures were output. 
Data Availability 
The coordinates and structure factors of the crystal structure reported in this 
article are available at the Protein Data Bank under accession number 5WLY. All other 
data presented are available within this article or its supplementary information or from 
the corresponding authors by request. 
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2.5 Supplementary Information 
Supplementary Table 2.1: Thermal Stability 
LpxH Melting Temperature (oC) 
4+4 60.3±0.3 
4+4-GG 57.7±0.3 
LpxH variants and Sypro Orange were prepared at 5 μM and 80x, respectively, in 0.5 M NaCl, 20 mM Tris 
pH 7.5, 5 mM DTT, and 2.5 mM MnCl2. Fluorescence was measured as temperature was increased 
stepwise from 20oC to 95oC. Average Tm values with standard deviations are shown (n=3). 
 
Supplementary Table 2.2: TLC-Based Time to Reaction Completion 
LpxH Time to reaction completion 
-mCherry 20 min <t< 30 min 
4+4 15 min <t< 20 min 
3+4-W136H 30 min <t< 40 min 
4+4-CC 40 min <t< 50 min 
4+4-GG 5 h <t* 
Reactions (10 μL) were run at 30oC with 62 μM UDP-DAG, 10 nM LpxH, 0.1 M Tris-HCl pH 8.0, 0.1% 
Triton X-100, and 1 mg/mL BSA. *When LpxH concentration was increased to 100 nM, t was between 3 
and 4 h. 
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Supplementary Fig. 2.1: Crystal contacts that stabilize helical cap. A. The interactions between the first 
of the visible capping helices (helix 6) and the adjacent proteins in the crystal. K134 Nζ is interacting with 
D231 Oδ1 and Oδ2 at 3.3 and 3.0 Å, respectively. W136 is engaged in a cation-π stacking interaction with 
R108 (3.1 Å between Trp Nε and Arg Cζ and 3.3 Å between Trp Cε2 and Arg Nε). T139 is hydrogen-
bonding with W190 (2.6 Å between Thr Oγ and Trp Nε). B. The interactions between the second visible 
helix of the capping domain (helix 7) and the neighboring protein in the crystal. R155 Nη2 is interacting 
with D50 Oδ1 at 3.2 Å. N159 Oδ is interacting with D49 Oδ1 at 3.8 Å, and T161 Oγ is interacting with 
R87 Nη at 3.9 Å. C. Full view of protein chains. The box indicates the portion shown in B. 
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EcLpxH -MATLFIADLHLCVEEPAITAGFLRFLAGEARKADALYILGDLFEAWIGDDDPNPLHRKM 
PaLpxH -MSVLFISDLHLEAERPDITRAFLSFLDERARRAEALYILGDFFEAWIGDDGMDAFQRSI 
HiLpxH MKHSYFISDLHLSETQPELTALFVDFMQNLAPQAERLYILGDLFDFWIGDDEQSALIQQV 
           .** ****. ..*.:*  *:.*:   * .*: ******.*: *****  . . ..: 
 
EcLpxH AAAIKAVSDSGVPCYFIHGNRDFLLGKRFARESGMTLLPEEKVLELYGRRVLIMHGDTLC 
PaLpxH AQSLRQVADGGTRIYLMHGNRDFLIGKAFCREAGCTLLPDPSVIDLYGEPVLLMHGDSLC 
HiLpxH KDLIKFVSDQGVQCYFQHGNRDFLIGERFSKETGAQLLPDYQLITLYDKKILLCHGDTLC 
          :: * * *   *. *********. * :* * .***: .::.** . :*: ***:** 
 
EcLpxH TDDAGYQAFRAKVHKPWLQTLFLALPLFVRKRIAARMRANSKEANSSKSLAIMDVNQNAV 
PaLpxH TRDEAYMRLRRWLRNPLTLWVLRHLPLATRHKLARKLRKESRAQTRMKAVDIIDVTPEEV 
HiLpxH IDDEAYQQFRRRVHQKWLQRLFLCLPLKVRVIIAEKIRAKSNQDKQAKSQEIMDVNQAFT 
        .*  *  .*  :.. .   :.  ***  *  :* ::* .*.  .. *   *:**.     
 
EcLpxH VSAMEKHQVQWLIHGHTHRPAVHELIANQQPAFRVVLGAWHTE-GSMVKVTADDVELIHF 
PaLpxH PRVMRGHGVRTLIHGHTHRPAEHPLDIDGQPARRIVLGDWDRQ-GWALEIDANGHRQAPF 
HiLpxH AEKVQEFGVNLLIHGHTHREAIHQ----QEEFTRIVLGDWRKNYASILKMDESG----EF 
        . :.   *. ******** * *      :   *:*** *..:    :.:. .      * 
 
EcLpxH PF--- 
PaLpxH PL--- 
HiLpxH GFIKD 
        .    
Supplementary Fig. 2.2: LpxH sequence alignment. Protein sequences of E. coli, H. influenzae, and P. 
aeruginosa LpxH were aligned in MEGA6 by the Muscle algorithm with default parameters (184). The 
degree of conservation between the sequences is designated by “*” for conserved residues, “:” for similar 
residues (aliphatic, aromatic, basic, acidic, small hydrophilic, etc.), and “.” for residues of the same class 
(hydrophobic vs. hydrophilic). Yellow highlighting indicates residues mutated in LpxH4+4. Green 
highlighting indicates other residues mutated in this study. Red lettering corresponds to the helical cap 
domain. The sequence identity between E. coli and P. aeruginosa LpxH is 47.1%. The sequence identity 
between E. coli and H. influenzae LpxH is 46.1%. The overall sequence identity is 33.5%. 
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Supplementary Fig. 2.3: LpxH-mCherry inhibition. Specific activities with standard errors shown in 
Table 2.2 were fit to a 3-variable dose-response inhibition curve in Graphpad Prism v7.03. To allow 
inclusion of the uninhibited control, the specific activity of the DMSO control was paired with an inhibitor 
concentration of 0.1 nM. The best fit IC50 value of inhibitor 3 (Scheme 2.1) was 1.188±0.2 μM 
(Log10[IC50]= -5.925±0.077 with a 95% confidence interval of 0.4648 to 2.35 μM. 
 
Supplementary Fig. 2.4: Methionine positions. The selenium SAD data was utilized with the refined 
native model to generate an anomalous difference map. The contour mesh is displayed at 3.00 RMSD 
(0.0672 e/Å3) and confirms the location of the methionines built in native model. 
 
Supplementary Fig. 2.5: Molecular dynamics RMSD plots. RMSD of the simulated systems aligned by 
Cα atoms. 
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Supplementary Fig. 2.6: Quantification of lipid band intensities. Band intensities from Figure 2.7 were 
analyzed in ImageJ (185). Lanes containing the entirety of the bands were defined with rectangular 
selections, and the lanes were plotted as distance versus intensity. The areas under the peaks were 
determined and graphed with x-axis numbers indicating inhibitor concentration [μM]. A. and E. and B. and 
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F. correspond with LpxH-mCherry. C. and G. correspond with LpxH4+4. D. and H. correspond with 
LpxH3+4-W136H. 
 
Supplementary Fig. 2.7: Full TLC plates. Reactions (10 μL) were run at 30oC with 62 μM UDP-DAG, 
10 nM LpxH, 0.1 M Tris-HCl pH 8.0, 0.1% Triton X-100, 10% DMSO, and 1 mg/mL BSA at various 
concentrations of the inhibitor 3 (Scheme 2.1) (shown in micromolar). Reactions were quenched by 
spotting on HPTLC Silica gel 60 plates, which were run with 25/15/4/2 chloroform/methanol/water/acetic 
acid mobile phase and charred with 20% sulfuric acid in ethanol and a heat gun. Reactions prepared with 
UDP-DAG but no enzyme act as a negative control and UDP-DAG standard. Independently purified lipid 
X product is also included as a standard. A. and B. Plates for LpxH-mCherry. These reactions were run for 
30 min. The reaction proceeded to completion in the absence of inhibitor, but is slightly inhibited by 1 μM 
inhibitor. At 2-8 μM inhibitor, the reaction proceeds to about 50% completion, and it is mostly inhibited at 
10 μM and above. These plates were not repeated. C. LpxH4+4 reactions were run for 20 min. No 
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inhibition was observed up to 1 mM inhibitor. This plate was replicated twice. D. LpxH3+4-W136H 
reactions were run for 40 min. A small amount of UDP-DAG remains at 100 μM and 1 mM inhibitor 
suggesting weak inhibition at high inhibitor concentrations. This plate was replicated thrice. Analysis of 
band intensities is presented in Supplementary Fig. 2.6. 
 
Supplementary Fig. 2.8: Top ranked docking poses. The top 4 docking poses of inhibitor 3 (Scheme 2.1) 
predicted by AutoDock Vina (157) are overlaid with color-coding of carbon atoms: 1 pink, 2 grey, 3 black, 
and 4 tan. In model 4 (also shown in Figure 2.8), the molecule is rotated ~180o relative to the previous 
poses, allowing a putative π-stacking interaction between the bicyclic ring and F142.
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CHAPTER 3: CRYSTAL STRUCTURE OF THE LIPID A DISACCHARIDE 
SYNTHASE LpxB FROM Escherichia coli 
 
 
 
 
 
 
 
 
 
 
 
 
 
Content in this chapter is reproduced with modifications from the accepted version of the 
article published in Nature Communications as per journal policy: Bohl, T. E., Shi, K., 
Lee, J. K., and Aihara, H. (2018) Crystal structure of lipid A disaccharide synthase LpxB 
from Escherichia coli. Nat. Commun. 9, 377. This article is licensed under a Creative 
Commons Attribution 4.0 International License 
https://creativecommons.org/licenses/by/4.0/. 
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3.1 Background 
LpxB is a glycosyltransferase in the Raetz (lipid A synthesis) pathway that 
catalyzes nucleophilic attack of the 6-hydroxyl of lipid X on the anomeric carbon of 
UDP-diacyl-glucosamine (UDP-DAG) to form β(1-6)-tetraacyl-disaccharide 1-phosphate 
(lipid A disaccharide) (Figure 3.1) (39–41, 47, 186).  
 
Figure 3.1: LpxB reaction. LpxB catalyzes the nucleophilic attack of the 6'-hydroxyl of lipid X on the 
anomeric carbon of UDP-DAG with UDP as the leaving group (40). As for other inverting GT-B enzymes, 
this reaction is thought to proceed by an SN2 mechanism (98, 187). 
LpxB is essential for growth of E. coli and is among the most highly conserved enzymes 
in the Raetz pathway (7, 188). LpxB was first identified from a temperature sensitive 
mutant of E. coli (pgsB1) that was shown to accumulate lipid X and lipid Y (a 
palmitoylated form of lipid X) at 42oC (45, 46, 189). An lpxB mutant was also found to 
accumulate UDP-DAG, and characterization of the activity and products of LpxB 
brought about a breakthrough in the understanding of lipid A structure (40, 153). LpxB 
was fully purified and enzymatically characterized by Metzger and Raetz who showed 
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that LpxB is a membrane surface active enzyme (186). Despite being the founding 
member of the Raetz pathway, LpxB remained structurally uncharacterized until the 
present research (40). 
Of the enzymes present in the canonical Raetz pathway, 7 have been structurally 
characterized (LpxA (62), LpxC (72), LpxD (80), LpxH (85, 154), LpxK (91), WaaA 
(96), and LpxM (107)) and 2 have not (LpxB and LpxL). In addition, LpxI (a 
nonhomologous alternative to LpxH) has been structurally characterized by x-ray 
crystallography (82, 87). Antibiotic lead compounds that target LpxC (190–196), LpxH 
(156), LpxD (197), and LpxA (197, 198) have been developed, but none have been 
reported for LpxB. This article presents the first crystal structures of a soluble variant of 
E. coli LpxB in the apo form and bound to UDP, which reveals a novel 
glycosyltransferase-B (GT-B) dimer wherein the C-terminal tail of one subunit completes 
the fold of the other subunit. We further demonstrate the importance of LpxB 
dimerization via C-terminal swapping through functional analyses. 
 
3.2 Results 
Overall Structure of LpxB 
In order to crystallize LpxB, a soluble form of the enzyme was generated. We 
utilized the Phyre2 server (160) to create a homology model of LpxB based on UDP-N-
acetylglucosamine 2-epimerase from Thermus thermophilus HB8 (PDB: 1V4V). We 
compared the homology model to the structure of MurG (PDB: 1F0K and 1NLM) (97, 
101), which was found to have a hydrophobic patch likely involved in membrane 
association (97). 
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Table 3.1: Diffraction and Refinement Statistics 
Parameter LpxB7S (PDB: 
5W8S) 
LpxB7S SeMet 
(SAD data) 
LpxB7S+UDP 
(PDB: 5W8X) 
LpxB6S 
(PDB: 
5W8N) 
Diffraction     
Wavelength (Å) 0.97918 0.97912 0.9792 0.97919 
Resolution range (Å) 155.14-2.10 (2.16-
2.10) 
96.29-3.43 
(3.71-3.43) 
153.88-1.98 (2.03-
1.98) 
19.57-2.02 
(2.07-2.02) 
Space group P 32 2 1 P 64 P 32 2 1 P 32 2 1 
Unit cell 
a,b,c (Å) 
α,β,γ (°) 
68.02 68.02 155.1 
90 90 120 
111.2  111.2  
74.19 
90 90 120 
67.81  67.81  153.9 
90 90 120 
67.78  67.78  
154.50 
90 90 120 
Total observations 87521 (7195) 143695 (30114) 118812 (7310) 180372 
(11983) 
Total unique 24865 (2012) 7129 (1469) 29131 (1983) 27746 (1958) 
Multiplicity 3.5 (3.6) 10.4 (10.4) 4.1 (3.7) 6.5 (6.1) 
Completeness (%) 99.4 (99.9) 100 (100) 99.1 (97.8) 99.6 (97.0) 
Mean I/σI 13.5 (1.6) 21.6 (1.9) 13.2 (1) 14.2 (1.2) 
Wilson B-factor 40.03 33.07 35.15 38.57 
R-merge 0.066 (0.997) 0.097 (1.926) 0.063 (1.272) 0.112 (1.686) 
R-meas 0.078 (1.176) 0.102 (2.025) 0.073 (1.485) 0.122 (1.838) 
R-pim 0.041 (0.615) 0.032 (0.623) 0.035 (0.753) 0.047 (0.717) 
CC1/2 0.998 (0.55) 0.999 (0.732) 0.999 (0.45) 0.997 (0.530) 
Refinement  Not fully refined   
Resolution Range (Å) 55.07-2.10 (2.15-
2.10) 
 54.86-1.98 (2.05-
1.98) 
19.57-2.02 
(2.09-2.02) 
Completeness (%) 98.97 (99)  90.65 (75) 99.62 (98) 
Reflections 24788 (1737)  26651 (2153) 27680 (2650) 
R-free Reflections 2007 (141)  1373 (102) 1385 (131) 
R-work/R-free 0.1951/0.2226 
(0.3344/0.3789) 
 0.1990/0.2309  
(0.3512/0.3278) 
0.1872/0.2129 
(0.3043/0.343
9) 
Non-hydrogen atoms 2953  2964 3043 
Protein 2800  2817 2859 
Ligands/ions 3  25 0 
Solvent 150  122 184 
RMS bond lengths (Å) 0.003  0.003 0.005 
RMS bond angles (°) 0.507  0.572 0.623 
Ramachandran favored 
(%) 
98.63  98.34 99.18 
Ramachandran allowed 
(%) 
1.10  1.10 0.55 
Ramachandran outliers 
(%) 
0.27  0.55 0.27 
Rotamer outliers (%) 0.00  0.69 1.01 
Cβ-outliers 0  0 0 
Clashscore 0.71  1.76 0.70 
Average B-factor 45.6  46.12 46.06 
Protein 45.39  46.06 45.80 
Ligands/ions 51.25  52.67  
Solvent 49.44  46.15 50.20 
Number of TLS groups 1  5 4 
Statistics for highest resolution shell are shown in parentheses. Each dataset corresponds to one crystal.  
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We identified, and mutated to Ser, 6 Val and Leu residues (V66, V68, L69, L72, L75, 
and L76) in a nearby region of the LpxB homology model. These mutations improved 
solubility and yield of LpxB, and the LpxB with all 6 mutations (LpxB6S) showed the 
least aggregation on a size exclusion column (Supplementary Fig. 3.1). LpxB6S was used 
for initial crystallization screening and optimization. An additional mutation (M207S) 
was added for selenomethionine derivative crystallization giving LpxB7S (Table 3.1). 
LpxB6S was crystallized with one molecule in the asymmetric unit. However, the 
biological assembly is a highly intertwined, C-terminally swapped homodimer. Each half 
of the LpxB dimer consists of two Rossmann-like domains with a parallel β-sheet core 
sandwiched between α-helices (Figure 3.2 and Supplementary Fig. 3.2). Both 
polypeptides within the LpxB dimer contribute to the fold of each domain. The first 
Rossmann-like domain is composed of the N-terminal half of one subunit [residues 1-
166] and the last helix [369-382] from the C-terminus of the other subunit. This domain 
is connected via short antiparallel helical linkers to the second domain, which is 
composed of residues 177-295 of the first subunit and 296-345 of the second subunit. 
While the tertiary structure of LpxB is typical for the glycosyltransferase-B (GT-B) 
family, the quaternary structure is unique (98, 187). LpxB forms a two-fold symmetric 
dimer in which the polypeptide chains crossover at helix 14 around the dyad axis to swap 
the remainder of the polypeptide chain. The reciprocally swapped C-terminal segments 
wrap around the opposing subunit in an interlocked arrangement. These extensive 
interactions bury a total surface area of 12,650 Å2, forming an LpxB dimer with an 
overall “bowtie”-shape. Supplementary Fig. 3.2 presents the isolated monomer and a 2D 
depiction (199) of the dimer. 
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Figure 3.2: Overall structure of LpxB. A. The overall structure of LpxB7S shows that LpxB forms a 
dimer in which the C-terminus of one subunit completes the fold of the opposite subunit. The polypeptides 
are exchanged at helix 14. Each domain forms a Rossmann-like fold with a parallel β-sheet surrounded by 
α-helices. UDP is bound to the C-terminal domain showing the position of the UDP-binding pocket where 
the sugar donor substrate, UDP-DAG, binds. Lipid X likely binds to the N-terminal domain which includes 
the predicted catalytic base D98 (186). LpxB appears to be in an open conformation. Catalysis may involve 
partial closing of the cleft between the domains by a hinge-like movement of the N-terminal domain similar 
to conformational changes observed for MurG (101), PimA (102), and other GT-B enzymes (98). B. 
Columbic surface rendering (blue for positive and red for negative) corresponding to the adjacent ribbons 
in A. The surface near the dimer interface is highly basic and is likely involved in membrane association. 
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Figure 3.3: LpxB nucleotide-binding pocket. The uracil of UDP binds in a hydrophobic pocket formed 
by L197, P198, P231, and V233. Putative hydrogen-bond distances in Ångstroms are as follows: G199 N to 
uracil O4 (2.7), G199 O to water to uracil O4 (2.8, 3.2), V233 N to water to uracil O4 (3.0, 3.2), P231 O to 
uracil N3 (2.5), G261 N to water to uracil O2 (2.9, 2.9), E281 Oε2 to ribose O2' (2.5), E281 Oε2 to ribose 
O3' (2.4), S200 Oγ to α-phosphate O1 (3.2), S200 Oγ to α-phosphate O2 (2.9), T277 Oγ to bridging 
pyrophosphate O (2.9), and T277 Oγ to β-phosphate O2 (2.9). R201, which is critical for activity (186), is 
interacting with the α-phosphate O2 and β-phosphate O1 at 3.8, via its η-nitrogens and  appears to be 
positioned to stabilize the UDP leaving-group. A. Image generated in LigPlot+ (78). B. Image generated in 
Coot (167), showing the electron density maps for UDP and the surrounding residues. The 2mFo-DFc map 
(blue mesh) is shown at 0.4317 e/Å3 (0.99 RMSD), and the mFo-DFc map (cyan mesh for positive and 
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yellow mesh for negative) is shown at 0.45 e/Å3 (3.01 RMSD). See Supplementary Fig. 3.6 for stereo view. 
C. Image generated in UCSF Chimera (25). 
UDP Binding Site 
The ligand-bound structure of LpxB was obtained by soaking crystals with 10 
mM UDP-N-acetylglucosamine (UDP-GlcNAc), a mimic of one of the reactants, UDP-
DAG (Figure 3.3). Only the UDP portion of the molecule is resolved in the electron 
density map (Figure 3.3B) suggesting that the GlcNAc moiety is highly flexible or that 
UDP-GlcNAc was hydrolyzed during soaking as has been observed before for 
nucleotide-charged sugars soaked or co-crystallized with GT-B enzymes (200–202). The 
uracil base binds in a hydrophobic pocket formed by L197, P198, P231, and V233, which 
is on the second Rossmann-fold domain and facing the deep inter-domain cleft. The P231 
carbonyl oxygen also hydrogen-bonds with N3 of uracil, and the G199 amide nitrogen 
hydrogen-bonds with the O4 carbonyl of uracil. In addition, two water molecules connect 
active site residues to uracil: the first water connects the G199 carbonyl oxygen and the 
V233 amide nitrogen to O4 of uracil, and the second water connects the G261 amide 
nitrogen to the O2 carbonyl of uracil. The ribose 2'- and 3'-hydroxyls both hydrogen-
bond with the E281 side chain. The α- and β-phosphates hydrogen-bond with the S200 
and T277 side chains, respectively. R201 also contacts both the α- and β-phosphates of 
UDP, albeit at a slightly longer distance (3.8 Å). R201 was shown to be critical for LpxB 
enzymatic activity, and this Arg side chain likely plays a catalytic role in stabilizing the 
negatively charged transition state of the UDP leaving group (186). 
Membrane Association of LpxB 
We assessed the activity of solubilized LpxB (LpxB6S) by in vitro enzymatic 
assays as well as by genetic knockout and complementation. In vitro activity assays 
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suggested that the ability of LpxB6S to catalyze the reaction of Triton X-100-solubilized 
substrates was completely abolished. Even after the reactions proceeded for over 17 h, 
the amount of UDP released was not above that of a zero enzyme control. Thus, the 
activity of LpxB6S was below the detection limit under these conditions (Table 3.2). In 
contrast, the specific activity of wild-type LpxB was measured at 6.17 ±0.53 μmol*min-
1*μmol-1 (Table 3.2). However, when the substrates were solubilized with 0.9 M 3-(1-
pyridinio)-1-propanesulfonate (NDSB 201), residual lipid A disaccharide synthesis was 
observable for LpxB6S by TLC (Supplementary Fig. 3.3), but LpxB6S activity remained 
below the detection limit for UDP-release assays even with the addition of NDSB 201 
(Table 3.2). These results demonstrate that LpxB6S remains catalytically competent and 
suggest that this solubilized form of the enzyme fails to extract lipid substrates from 
detergent micelles. To probe which of the residues mutated in LpxB6S are more 
important, we tested the in vitro activity of less mutated versions of LpxB. We tested two 
sets of triple mutants: V66S/V68S/L69S (VVL), which are located in the disordered loop 
(residues 62-71), and L72S/L75S/L76S (LLL), which is located in the following helix 
(Figure 3.2). Both triple mutants were active with detergent solubilized substrates, but 
they showed significantly different activities (Table 3.2): the specific activity of 
LpxBVVL was measured at 0.053% of wild-type while that of LpxBLLL was 0.0010% 
of wild-type (Table 3.2). The lower activity of the LLL mutant suggested that this later 
group of residues is more important for substrate binding. However, double mutants 
carrying any pair of L72S, L75S, and L76S retained more activity than LpxBVVL with 
LpxB-L72S/L75S showing the greatest decrease in activity (1.74% of wild-type versus 
approximately 1/3 of wild-type for the other two) (Table 3.2). These data support the 
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hypothesis that the hydrophobicity of this surface patch is required for extraction of lipid 
substrates from detergent micelles as greater decrease in overall hydrophobicity, rather 
than mutation of a specific residue, correlated with decrease of activity (Table 3.2). 
Table 3.2: LpxB Specific Activities 
LpxB Specific Activity 
±Standard Error 
[μmol*min-1*μmol-1] 
95% Confidence 
Interval 
Percent of Wild-
type 
Wild-type 6.17 ±5.3*10-1 4.99 to 7.34 100 
L72S/L75S 1.08*10-1 ±2.3*10-2 5.62*10-2 to 1.59*10-1 1.74 
L72S/L76S 1.99 ±3.3*10-1 1.21 to 2.76 32.2 
L75S/L76S 1.89 ±2.3*10-1 1.35 to 2.42 30.6 
V66S/V68S/L69S 
(VVL) 
3.26*10-3 ±5.5*10-4 2.02*10-3 to 4.49*10-3 5.28*10-2 
L72S/L75S/L76S 
(LLL) 
6.34*10-5  ±1.04*10-5 4.03*10-5 to 8.66*10-5 1.03*10-3 
6S Below detection limit N/A N/A 
N316A 2.11*10-2 ±1.5*10-3 1.78*10-2 to 2.45*10-2 3.42*10-1 
F298E/N316A (FN) 4.80*10-4 ±6.2*10-5 3.33*10-4 to 6.28*10-4 7.79*10-3 
R201A 3.16*10-4 ±2.3*10-5 2.66*10-4 to 3.66*10-4 5.12*10-3 
FN+RA (50% FN) 1.06*10-2 ±9*10-4 8.50*10-3 to 1.27*10-2 1.72*10-1 
FN+RA (37% FN) 3.63*10-3 ±3.7*10-4 2.76*10-3 to 4.50*10-3 5.89*10-2 
FN+RA (24% FN) 2.91*10-3 ±1.6*10-4 2.55*10-3 to 3.27*10-3 4.71*10-2 
FN+RA (15% FN) 2.35*10-3 ±2.6*10-4 1.74*10-3 to 2.95*10-3 3.81*10-2 
FN+RA (7.3% FN) 1.03*10-3 ±1.5*10-4 6.70*10-4 to 1.38*10-3 1.66*10-2 
NA+RA1:1 1.06*10-2 ±1.3*10-3 7.56*10-3 to 1.35*10-2 1.71*10-1 
Wild-type (NDSB-
201) 
3.42 ±6.0*10-1 1.994 to 4.84 55.4 
6S (NDSB-201) Below detection limit N/A N/A 
Reactions were performed in triplicate with 1 nM to 10 μM LpxB (as appropriate per variant), 31 μM UDP-
DAG, ~0.13 mM lipid X, 1 mg/mL BSA, 0.1 M Tris-HCl pH 8.0, and 0.1% Triton X-100 at ambient 
temperature (21oC). Reactions were quenched and UDP was quantified using a UDP-Glo 
Glycosyltransferase Assay kit (Promega), which quantifies free UDP by a luciferase coupled reaction. 
Specific activities with standard errors and 95% confidence intervals were calculated by linear regression 
of UDP concentrations at three or four time points for each LpxB variant in Graphpad Prism v7.03. 
Activities of Previously Characterized Mutants 
Wild-type LpxB and two mutants (N316A and R201A) made for this study have 
been previously characterized by Metzger and Raetz (186). However, the reaction 
conditions utilized for comparison of specific activities in this study were quite different 
from those utilized previously (186). Most importantly, the substrate concentrations were 
31 μM UDP-DAG and ~130 μM lipid X in this study (versus 600 and 400 μM in ref. 
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(186)), and reactions were run at ambient temperature (~21oC) in this study (versus 30oC 
in ref. (186)). Thus, the specific activity of the wild-type was much lower (~1200-fold) 
under the conditions of this study. However, the relative activities were consistent: the 
specific activity of LpxB-N316A was measured at 0.34% of wild-type here and at 0.1% 
previously, and the specific activity of R201A was measured at 0.0051%, consistent with 
the <0.01% reported previously (186) (Table 3.2). The comparatively high activity of 
LpxB-N316A is consistent with the observed environment of N316 in the crystal 
structure. Rather than being positioned to interact with the substrates, the N316 side-
chain hydrogen-bonds with the backbone of residues 323 and 324 and appears to stabilize 
the positioning of helix 15 (Figure 3.4B). LpxB-F298E/N316A (LpxBFN) showed further 
reduced activity (0.0078% of wild-type) (Table 3.2). Like N316, F298 is from the 
swapped C-terminal segment, and it makes cation-π stacking in trans with the side chain 
of critical active site residue R201 (Figures 3.3C and 3.4A). However, differential 
scanning fluorimetry showed no significant difference in the melting temperatures (Tm) 
of LpxBVVL, LpxBVVL-N316A, and LpxBVVL-R201A, and LpxBVVL-
F298E/N316A had a Tm only 0.5oC lower than that of LpxBVVL (Supplementary Table 
3.1). Therefore, the loss of activity in LpxB-N316A and LpxBFN is not simply related to 
protein unfolding. 
The genetic complementation experiments generally support the conclusions of 
the in vitro assays. The genomic copy of lpxB was knocked out with a DNA fragment 
containing a kanamycin resistance gene flanked by the 3'-end of lpxB and the region 
upstream of the 5'-end in the presence of the wild-type, N316A, or F298E/N316A lpxB 
genes expressed from its own operon’s promoter (203) on a plasmid. 
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Figure 3.4: Interactions that stabilize the dimeric structure. A. Position of F298 in relation to the 
critical residue R201. These residues appear to be engaged in a cation-π stacking interaction with a distance 
of 3.6 Å between Nη1 and Cζ, a distance of 3.5 Å between Nη2 and Cε1, and a distance of 3.6 Å between 
Nε and Cδ2. However, the R201 side chain is not fully resolved in the electron density (Figure 3.2). The 
position of helix 15, which contains N316, is also visible. B. Position of N316 relative to the crossover 
helix (helix 14), showing how N316 appears to stabilize the turn from helix 15 to the final strand of the C-
terminal β-sheet (strand 13). N316 hydrogen-bonds with the backbone of residues 323 and 324. The 
interaction distances in Ångstroms are as follows: N316 Oδ to L323 N (2.8), N316 Oδ to V324 N (2.8), and 
N316 Nδ to V324 O (2.9). C. Interactions between the N-terminal domain and the adjacent C-terminal 
domain. R129 forms a salt-bridge with E331 (3.5 Å between Nη1 and Oε2). E330 forms a salt-bridge with 
R132 (3.4 Å between Oε1 and Nη2) and a hydrogen-bond with W128 (3.0 Å between Oε1 and Nε). 
In contrast, the knockout was not obtained when the gene for LpxB6S, LpxB6S-R201A, 
or LpxB-R201A was substituted on the plasmid. These results suggest that the 
hydrophobic patch (V66, V68, L69, L72, L75, and L76) is essential for productive 
membrane association or substrate binding. In addition, these results suggest there may 
be a greater difference between the activity of LpxBFN and LpxB-R201A under 
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physiological conditions than what was observed by UDP-release assays, wherein the 
specific activities were not significantly different (Table 3.2). These results appear to be 
consistent with TLC-based assays: LpxBFN produced a detectable amount of lipid A 
disaccharide after 3 h (Supplementary Fig. 3.4), but the lipid A disaccharide band in 
LpxB-R201A reactions only became unambiguous when the reactions were run overnight 
(Supplementary Fig. 3.3). Regardless, the cause of this incongruity between the genetic 
complementation experiments and the specific activities is unclear. 
Oligomerization of LpxB in Solution 
Determination of the oligomeric state of LpxB in solution has been hampered by 
the tendency of LpxB to form large, soluble aggregates. These aggregates are visible on a 
size-exclusion chromatogram (Supplementary Fig. 3.1), and this aggregated state was 
described as an apparent octamer that could be broken into an apparent dimer with DDM 
detergent by Metzger and Raetz (186). The elongated shape of LpxB further hinders the 
ability of size exclusion to distinguish between the monomer and dimer. In spite of this, 
analytical ultracentrifugation supported dimerization giving a size between 71 (right 
wells) and 79 kDa (left wells) (Supplementary Fig. 3.5). The total dataset did not 
converge, but the χ2 residuals were minimized when the highest speed right well was 
excluded giving a mass of 78.9 kDa, which is most consistent with the expected 84.5 kDa 
dimer. 
To functionally validate the C-terminal swap model, 6His-LpxB-R201A was co-
expressed with LpxB-N316A or LpxBFN, which carry mutations in the C-terminus. We 
hypothesized that the formation of an intact active site via C-terminal swap of the R201A 
mutant with one of these other mutants would result in increased activity in the co-
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purified protein if the second mutant were much less active than the wild-type and if the 
expression levels of the mutants were approximately equal. The ability of His-tagged 
LpxB-R201A to pull down more active LpxB-N316A in the presence of 0.2-2% Triton 
X-100 supports the formation of a stable oligomer (Supplementary Fig. 3.4). In addition, 
we mixed purified LpxB-R201A with purified LpxB-N316A or LpxBFN. However, 
combining 50% LpxB-R201A with 50% LpxB-N316A decreased the specific activity by 
approximately half indicating that the extent of heterodimer formation was not sufficient 
to overcome the initial ~50% dilution in activity (Table 3.2). Because these LpxB 
mutants lost activity when left overnight at 4oC (data not shown), dimerization could not 
be allowed to reach equilibrium; therefore, the change in activity depends on the kinetics 
of subunit exchange as well as the difference in activity of mutant and intact active sites. 
Hence, the failure of 50% LpxB-N316A with 50% LpxB-R201A to show increased 
activity over 100% LpxB-N316A likely reflects slow dimer exchange since the activity of 
LpxB-N316A was measured well below 25% of wild-type (Table 3.2). In order to obtain 
a sufficiently impaired mutant to observe an increase in activity upon sub-equilibrium 
dimer exchange, a second mutation was made in the swapped C-terminus (F298E) 
producing LpxBFN as discussed above. The F298E mutation was selected based on the 
hypothesis that R201 stabilizes the negative charge of the UDP leaving group during 
catalysis (186). Because F298 already forms a cation-π interaction with R201, E298 is 
hypothesized to form a salt-bridge with R201 thereby balancing this critical positive 
charge and altering the conformation of R201 from that required for catalysis. When 50% 
LpxB-R201A was combined with 50% LpxBFN, the sample showed significantly more 
activity than freshly thawed 100% LpxBFN (Table 3.2). Increased activity was also 
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observed with 63%, 76%, 85%, and 92.7% LpxB-R201A, and this activity decreased 
with increasing LpxB-R201A concentration (Table 3.2). These data support the C-
terminal swap model because the C-terminal swap would form one intact active site per 
R201A-F298E/N316A dimer. A R201A-F298E/N316A heterodimer with one intact 
active site would be expected to produce more activity than an LpxBFN homodimer 
because LpxBFN has only 0.0078% of wild-type activity (Table 3.2). Since minimal loss 
of protein stability was associated with the F298E/N316A mutations (Supplementary 
Table 3.1), this increase in activity is consistent with the formation of C-terminally 
swapped heterodimers. 
 
3.3 Discussion 
The tertiary structure of LpxB is similar to many previously characterized GT-B 
enzymes (96, 99, 101, 200, 202, 204); however, LpxB has a unique quaternary structure 
wherein the protein fold is completed by the last 87 residues of the opposite subunit in the 
dimer. This C-terminal swap has not been observed before in this protein superfamily, 
but a sialyltransferase from this superfamily involved in LPS synthesis in Neisseria 
meningitidis shows a distinct N-terminal swap of the first 130 residues (202). These 
unique domain arrangements likely contribute to the stability of the enzyme dimer and 
may potentially help coordinate activities between the two molecules. 
LpxB utilizes similar active site residues as previously characterized GT-B 
enzymes (Table 3.3), in particular MurG (101) (18% overall sequence identity) 
(Supplementary Fig. 3.6). The most conserved binding motif is the use of Glu (LpxB 
E281) to hydrogen-bond with the 2'- and 3'-hydroxyls of the ribose of the sugar donor 
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substrate. In addition, S17, which was shown to be important for LpxB activity (186), is 
positioned similarly to the critical residue T16 in MurG (101). Finally, while the 
predicted catalytic base of LpxB (D98) (186) is not close in primary sequence to that of 
MurG (H19) (101), the side chains of these residues are close in space when the 
structures are overlaid (25) (Figure 3.5A). 
Table 3.3: Comparison of GT-B Active Sites 
Enzyme PDB inverting
/ 
retaining 
  Catal
ytic 
base 
  Pyro 
phos. 
 Pyr
o 
phos
. 
ribo
se 
LpxB 5W8X I E15 S17 D98 P198 G199 S200 R201 T27
7 
E281 
MurG 1NLM I  N/A T16 H19 G190 G191 S192 N/A T26
6 
E269 
Δ24PmST1 2IHZ I N/A S36 D141 N/A N/A N/A N/A N/A E338 
MshA 3C4V R N/A N/A N/A N/A N/A N/A N/A N/A E324 
NST 2YK7 I N/A N/A D258 N/A N/A S322 N/A N/A E300 
PimA 2GEJ R Y9 N/A N/A N/A N/A N/A R196 N/A E282 
WaaA 2XCU I N/A N/A E31 N/A N/A N/A R212 N/A E276 
Residues shown are those found to be analogous to LpxB active site residues by comparison of listed 
crystal structures. N/A indicates that an analogous residue could not be unambiguously assigned. 
However, there are also important differences between the sugar donor binding 
site of LpxB and MurG. LpxB T277 appears to correspond to T266 in MurG, but T277 
hydrogen-bonds with the β-phosphate while T266 hydrogen-bonds with the α-phosphate 
(101). Conversely, MurG S192 and LpxB S200 hydrogen-bond with the β- and α-
phosphates, respectively. MurG S192 is part of a conserved GGS loop (101) while S200 
is part of a conserved PGSR loop that also includes the essential residue R201 (186). 
Binding of the uracil moiety similarly shows variations between the enzymes: LpxB 
G261 is positioned similarly to MurG I245, which hydrogen-bonds uracil N3 and O4 via 
its backbone amide nitrogen and carbonyl (101), but the amide of LpxB G261 hydrogen 
bonds to uracil O2 via an intervening water. In LpxB, uracil N3 and O4 are hydrogen-
bound by the backbone amides of P231, G199, and a water bound to the V233 and G199 
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amides. In MurG, the uracil O2 is bound by R164, a residue in the first linker between the 
N- and C-terminal domains (101). Finally, MurG Q288, Q289, and N128 contact the 3'- 
and 4'-hydroxyls of GlcNAc; however, the corresponding helix is involved in the 
beginning of the C-terminal swap in LpxB and is thus not positioned to contact a 
glucosamine bound to UDP. These structural differences suggest that LpxB also has a 
distinct mode of binding for the glucosamine moiety of the natural substrate, UDP-DAG. 
The β-hydroxymyristoyl moieties on the 2'-amine and 3'-hydroxyl of the glucosamine in 
UDP-DAG, likely play key roles in substrate binding. This may explain some of the 
differences in binding modes of the LpxB and MurG structures.  
LpxB in our crystal structure appears to be in an open conformation. As observed 
for MurG (97, 101), PimA (99, 102), and other GT-B enzymes (98), the active site cleft 
of LpxB probably closes during productive substrate binding to bring the substrates into 
the correct conformation for nucleophilic attack by the lipid X 6'-hydroxyl on the 
anomeric carbon of UDP-DAG. In MurG, this involves a ~10o change in the relative 
positions of the globular domains with the linker region acting as the hinge (101). While 
the intertwined dimerization mode may limit the movement of the C-terminal domain of 
LpxB, the contacts between the N-terminal domain and the adjacent C-terminal domain 
are more limited, consisting of salt bridges between R129 and E331 and between R132 
and E330 and a hydrogen-bond between W128 and E330 (Figure 3.4C). Therefore, a 
similar hinge-like movement of the N-terminal domain may be possible. A large 
conformational change associated with hydrolytic removal of UMP from UDP-DAG was  
observed for LpxI, an enzyme that generates lipid X in a subset of Gram-negative 
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bacteria (82, 87). Thus, further studies are needed to capture different structural states of 
LpxB to fully understand its catalytic mechanism. 
Previous structural studies of E. coli MurG revealed the presence of a surface-
exposed hydrophobic patch (I75, L79, F82, W85, and W116) surrounded by a basic 
horseshoe (K69, K72, R80, R86, R89, and K140) (97). As mentioned above, the 
comparison of MurG to a homology model (160) of LpxB enabled the prediction of the 
LpxB hydrophobic patch. These residues form a similar hydrophobic and basic face in 
the two proteins; however, the exact positions of the residues is not well conserved 
(Figure 3.5C). PimA, which is a retaining glycosyltransferase that transfers mannose to 
phosphatidylinositol (16% identity to LpxB), also has a similar hydrophobic and basic 
face (99) (Figure 3.5C). One particularly similar feature is the flexible loop containing 
predicted membrane-binding hydrophobic residues followed by an amphipathic helix 
with a highly basic N-terminal end (Figure 3.5B). In PimA, the flexible loop includes 
residues 59-70, and the following surface-exposed basic residues are H76, R77, K78, 
K80, and K81 (99). In LpxB, the disordered loop is residues 62-71, and the basic residues 
are R73, R74, H77, K84, and R85 (Supplementary Fig. 3.7). Deletion of the loop or 
mutation of the basic residues to Ser prevented catalysis by PimA (99). Likewise, 
mutation of hydrophobic residues in this region of LpxB decreased the activity of LpxB. 
In PimA, the relevance of this helix to membrane association was further demonstrated 
by Förster resonance energy transfer between W82 in the helix and fluorescently labeled 
lipids in small unilamellar vesicles and by blue-shifting of the fluorescence emission of 
W82 upon association with vesicles (100). 
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Figure 3.5: Membrane association. A. Overlay of the N-terminal domains of  LpxB7S (purple) with 
MurG (grey) (PDB: 1F0K) (97) and PimA (orange) (PDB:2GEJ) (99). The catalytic bases of LpxB and 
MurG, D98 and H19 respectively, are also shown. B. Region of the LpxB-PimA membrane-binding face of 
particular interest. Deletion of the hydrophobic, flexible loop or mutation of basic residues in this helix to 
Ser inactivated PimA (99), and mutation of hydrophobic residues in this loop and helix to Ser (visible 
residues highlighted) decreased LpxB activity. In addition, W82 in the PimA helix was shown to interact 
with negatively charged lipid membranes (100). C. Side-by-side comparison of the 3 proteins, showing 
residues that may be important for defining the membrane association surface. While the specific residues 
are not well conserved, they appear to form a similar hydrophobic and basic surface in all 3 enzymes. The 
regions of LpxB and PimA shown in B. are boxed. 
These data showed that the amphipathic helix associates with vesicles containing 
negatively charged lipids, particularly the acceptor substrate, phosphatidylinositol (100). 
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The membrane-association role of the amphipathic helix is likely conserved in LpxB 
(98). While we found LpxB6S to be inactive toward lipids in mixed micelles, the soluble 
enzyme remained catalytically competent when the substrates were solubilized with non-
detergent sulfobetaine 201. In addition, the mutated versions of PimA and LpxB were 
still able to bind the nucleotide of their sugar-donor substrates (99). Therefore, the data 
support the hypothesis that membrane surface-active GT-B enzymes require surface-
exposed hydrophobic and basic residues to extract their lipid substrates from the 
membrane (98, 100). 
The distance (~15 Å) of the predicted catalytic base (D98) from the putative 
membrane-binding region (loop 62-71 and helix 4) suggests that LpxB mostly or fully 
extracts its lipid substrates from the membrane. The preceding enzyme, LpxH, and its 
alternative, LpxI, were observed to fully bind their substrates (85, 87, 154). In contrast, 
the following enzyme in the pathway, LpxK, was observed to primarily bind lipid head 
groups with the hydrocarbon tails disordered and extending into solvent (92). Regardless, 
LpxB, LpxH, and LpxK do not exhibit strong selectivity for chain length (80, 89). LpxB 
can even utilize lipid X derivatives with a single chain or a third chain attached to the 
hydroxyl of the 2'-β-hydroxymyristate, albeit with 2-3 orders of magnitude less activity 
than for lipid X (88, 205). Thus, the presence of the acyl chains may help the substrates 
orient productively in the active site of LpxB, but the substrates probably are not 
subjected to molecular ruler binding as observed in LpxA (62) and LpxD (80).  
Molecular docking (157) was utilized to generate plausible models for the binding of the 
natural donor substrate of LpxB, UDP-DAG (Figure 3.6). The models are largely 
consistent with the observed position of UDP in the crystal structure (Figure 3.6). In both 
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models shown, the lipid tails extend toward a hydrophobic groove lined by V125, W126, 
and W128; in addition, the anomeric carbon is exposed for nucleophilic attack from 
above and towards the N-terminal domain in both models. This suggests that lipid X 
binds second and on top of UDP-DAG, possibly with its lipid tails extending farther 
along the hydrophobic groove, which would explain why we were unable to obtain a 
plausible docking model for lipid X binding. However, the top ranked model (1 of 9) 
(Figure 3.6A) places the anomeric carbon 8.8 Å from the predicted catalytic base (D98). 
A hinge-like movement of the N-terminal domain might position D98 to accept a proton 
from the nucleophilic 6'-hydroxyl of lipid X. On the other hand, a lower ranked model (7 
of 9) (Figure 3.6B) places the anomeric carbon 5.4 Å from D98, which should allow D98 
to accept a proton from the attacking hydroxyl with minimal movement of the domain. 
 
3.4 Conclusions and Future Directions 
We have solved the structure of LpxB, revealing a new twist on the conserved 
GT-B fold wherein LpxB forms a dimer with the C-terminus of one subunit completing 
the fold of the second subunit. Soaking with UDP-GlcNAc revealed the location of the 
nucleotide-binding region of the active site and explained the role of previously identified 
conserved residues that are important for activity (186). Furthermore, our activity assays 
of solubilized forms of LpxB helped to provide more insight into the mode of membrane 
association of surface-active membrane proteins such as LpxB, PimA, and MurG. This 
structure should aid in the rational and computational development of new antibiotics 
targeting LpxB to combat the increasing problem of antibiotic resistance. 
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Figure 3.6: Molecular docking model of UDP-DAG binding. UDP-DAG (tan carbons) was docked into 
the LpxB active site cleft with AutoDock Vina (157). The software correctly identified the nucleotide-
binding site overlaying reasonably well with the position of UDP (grey carbons) observed in the crystal 
structure. The lipid tails were predicted to extend toward a hydrophobic groove lined by V125, W126, and 
W128. The break in the chain corresponding to the disordered loop is circled. A. The top ranked model 
places the anomeric carbon 8.8 Å from the predicted catalytic base, D98. B. A lower ranked model [7 of 9] 
places the anomeric carbon 5.4 Å from D98, which would require less movement of the protein in order to 
correctly orient D98 and the 6'-hydroxyl of lipid X for proton transfer and nucleophilic attack on the 
anomeric carbon. 
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We are currently working in collaboration with Rommie Amaro’s lab at University of 
California: San Diego to identify inhibitors of LpxB that could become antibiotic lead 
compounds. We will test the in vitro inhibition of LpxB by compounds that they identify 
as possible inhibitors by molecular dynamics simulations. 
 However, some questions on the enzymology of LpxB reamin to be answered. 
Most importantly, the mechanism of binding of the lipidic substrates has not been fully 
elucidated. Indeed, even the location of the binding site of lipid X remains vague. A 
crystal structure with the native substrates or lipid A dissacharide product bound would 
show how the substrates bind, and further activity assays could support the role of 
residues observed to be involved in substrate binding. In addition, the role of the putative 
membrane-association helix (Figure 3.5) could be tested by the mutation of basic residues 
within this helix (99). Finally, the role of D98 as the catalytic base (186) could be tested 
by further mutations of this residue. D98N would maintain the size and hydrogen-
bonding capacity of D98 but prevent it from accepting a proton from the glucosamine 6'-
hydroxyl while D98L would only maintain the size of D98, and both would be expected 
to severly decrease LpxB activity if D98 is the catalytic base. Conversely, D98H or D98C 
might be expected to largely maintain the activity of LpxB if D98 is the catalytic base 
with a possible shift in the optimal pH, particularly for D98C. 
 
3.5 Methods 
Cloning and Purification of LpxB 
The LpxB coding sequence was amplified from E. coli BL21 cells with Phusion 
DNA polymerase (NEB) using the forward and reverse primers carrying BsaI (NEB) and 
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XbaI (NEB) restriction sites, respectively. The LpxB coding sequence was inserted into 
pE-SUMO expression vector (LifeSensors) to attach an N-terminally His-tagged SUMO 
to the N-terminus of LpxB. Following purification, the His-tagged SUMO was removed 
by proteolytic cleavage with the SUMO protease Ulp1. Alternatively for co-expression 
and purification of two mutants of LpxB, LpxB genes were inserted into pRSF-Duet-1 
(Novagen) at the EcoRI (TaKaRa) and HindIII (NEB) sites of MCS1 and at the NdeI 
(NEB) and KpnI (NEB) sites of MCS2 thus encoding one N-terminally His-tagged 
protein and one untagged protein. 
BL21 (DE3) cells (Lucigen) were used to express LpxB: transformed cells were 
grown in Miller’s Luria Broth (RPI) to an OD600 0.5-0.9 at 37oC and then were cooled to 
18oC and induced with 1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) (GoldBio) 
overnight. For producing selenomethionine derivative proteins, the cells were grown in 
M9 media, and methionine synthesis was inhibited by addition of an amino acid cocktail 
in addition to 50-75 mg/L selenomethionine (Chem-Impex Int’l) 15 minutes prior to 
induction with IPTG (163). Cells were pelleted at 4,540xg (4oC) for 25 min (Beckman 
J6-MI, JS-4.2) and then resuspended in lysis buffer (0.5 M NaCl (Fisher), 50 mM Tris-
HCl (Fisher) pH 7.4, 10% glycerol (v/v) (Fisher), 5-10 mM β-mercaptoethanol (EMD 
Millipore)). Cells were lysed via sonication with a Branson Sonifier 450 (50% duty cycle, 
output 5, 6 min in three 2 min internals) while on ice. For cells expressing SUMOylated 
wild-type LpxB, 1% n-dodecyl-β-D-maltopyranoside (DDM) (w/v) (Anatrace D310) was 
added to lysate and mixed for 1 h (4oC) to solubilize SUMO-LpxB. Lysate was 
centrifuged at 63,988xg (4oC) for 45 min (Beckman Avanti J-25 I, JA-25.50) to remove 
cell debris. Supernatant was batch bound for 1 h (4oC) to HisPur Ni-NTA resin (Thermo) 
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from 4-5 mL of slurry that had been equilibrated with 20 mL lysis buffer with 10 mM 
imidazole (Chem-Impex Int’l). Resin was collected with a gravity-flow column (room 
temperature) and washed with ice cold lysis buffer with 25 mM (50 mL) and 40 mM (15 
mL) imidazole. SUMO-LpxB was eluted from the column with 15 mL lysis buffer with 
250 mM imidazole. After addition of Ulp1, the elutant was dialyzed against 500 mL 
storage buffer (0.3 M NaCl, 20 mM Tris-HCl pH 7.4, 5% glycerol, 5-10 mM DTT 
(GoldBio), [0.05% DDM for wild-type LpxB]) overnight (4oC) in 3.5 kDa cutoff tubing 
(Spectra/Por). Cleaved SUMO-LpxB was run back through the Ni-NTA column to 
remove His-tagged SUMO. 
LpxB was concentrated with a 30 kDa cutoff centrifugal filter (Amicon). LpxB 
was then further purified via size exclusion chromatography on a Superdex 200 column 
(GE Healthcare) equilibrated in storage buffer. Poorly expressing wild-type LpxB was 
run through a 10/300 GL column. Mutant forms of LpxB with improved expression 
(described in Crystallization of LpxB) were run through a HiLoad 26/60 prep grade 
column. One or 2 mL fractions were collected, respectively. LpxB fractions were 
concentrated to 10 mg/mL, as measured by A280 (ε= 32805 M-1cm-1) (Nanodrop 8000 
(Thermo)), for robotic crystal screening. 
Protein Mass Spectrometry 
The identity of purified LpxB was confirmed via liquid chromatography tandem 
mass spectrometry. Samples of soluble LpxB (LpxB6S described in Crystallization of 
LpxB) were submitted to Novatia (Newtown, PA). Mass/charge peaks for the expected 
LpxB6S molecular weight and what appears to be a cysteinylated form of LpxB6S were 
observed (Supplementary Fig. 3.8). 
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Crystallization of LpxB 
Extensive sitting drop (200 nL) robotic screening (Rigaku) of wild-type LpxB 
revealed no successful crystallization conditions. Thus, we sought to form a crystallizable 
mutant of LpxB. We reasoned that the DDM micelles required to solubilize wild-type 
LpxB may interfere with crystal packing, so we sought to create a soluble form of LpxB. 
A homology model of LpxB was produced via the Phyre2 server using UDP-N-
acetylglucosamine 2-epimerase from Thermus thermophilus HB8 (PDB: 1V4V) for 
sequence threading (160). Comparison of the LpxB model with the crystal structures of 
MurG (PDB: 1F0K and 1NLM) (97, 101), another inverting glycosyltransferase (18% 
identity), allowed us to identify a putative surface-exposed hydrophobic patch (V66, V68, 
L69, L72, L75, and L76). 
Each of these residues was mutated to Ser using the Stratagene QuickChange 
protocol (Pfu Turbo polymerase (Agilent), DpnI (NEB)), and the expression and behavior 
on a size exclusion column of various combinations of these mutations was tested 
(Supplementary Fig. 3.1). The fully mutated form of the enzyme (LpxB6S) appeared 
least prone to aggregation and was selected for further robotic crystal screening. 
Bipyramidal and hexagonal rod shaped LpxB6S crystals grew in several conditions. The 
best condition (0.8 M LiCl, 32% PEG 4000, 0.1 M Tris pH 8.5) (MCSG-1 C9 Microlytic) 
was optimized in 2 μL hanging drops over 500 μL well solution with 1:1 8 mg/mL 
LpxB6S and well solution. The optimized condition for LpxB6S crystallization was 0.6-
0.8 M LiCl (MP Biomedicals), 35-40% PEG 4000 (Hampton Research, HR2-529), 0.1 M 
Tris-HCl pH 8.6. This condition led to the formation of both crystal forms in the same 
drop. Unfortunately, the bipyramidal crystals that diffracted to higher resolution were 
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much rarer than the hexagonal rods. Additive screening (HR2-428 Hampton Research) 
showed that 10 mM trimethyl-ammonium chloride in the hanging drop, but not in the 
well solution, selected for the formation of bipyramidal crystals. 
Although native LpxB6S bipyramidal crystals diffracted beyond 2.4 Å (Table 
3.1), selenomethionine (SeM) derivative LpxB6S crystals that diffracted well enough for 
phasing by single-wavelength anomalous diffraction could not be grown. E. coli LpxB 
has 13 Met, more than adequate for phasing a 42 kDa protein. We hypothesized that one 
or more of these methionines was interfering with crystallization in the SeM derivative, 
possibly by being surface exposed and decreasing protein solubility. Thus, we further 
utilized the Phyre2 homology model of LpxB to predict possible culprits. Three Met 
residues were identified and mutated to Ser; however, only M207S preserved the stability 
of LpxB6S as judged by size exclusion chromatography (Supplementary Fig. 3.1). M46S 
and M295S increased protein aggregation. Thus, the SeM derivative of LpxB6S-M207S 
(LpxB7S) was selected for further crystal screening. Hexagonal rod crystals of the 
LpxB7S SeM derivative that diffracted to 3.43 Å (Table 3.1) were obtained in a 2 μL 
drop of 8 mg/mL LpxB7S (0.9 μL), well solution (0.9 μL), and 0.2 μL 100 mM 
trimethyl-ammonium chloride (Acros Organics) hanging over 500 μL 28% PEG 4000, 
0.35 M LiBr (Sigma-Aldrich), and 0.1 M Tris-HCl pH 8.6. Switching from LiCl to LiBr 
was essential for obtaining harvestable LpxB7S SeM derivative crystals. 
Diffraction Data Collection and Model Building 
All data sets used for model building and refinement were collected at the 
Advanced Photon Source at Argonne National Lab on beamlines 24-ID-C and 24-ID-E at 
100 K and 0.979 Å. The data were indexed, integrated, and scaled by the RAPD beamline 
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software (XDS (164) and CCP4 (165)) or in HKL2000 (206) (Table 3.1). The PHENIX 
program suite was utilized for initial phasing, model building, and refinement (166). 
Manual model building and further refinement were performed in Coot (167) and 
PHENIX Refine. 
The selenomethionine anomalous diffraction data were used to calculate the initial 
phases and to build a crude model: AutoSol found 11 Se sites with a figure of merit of 
0.348 in space group P64 and built 201 residues in 16 fragments with an R-work of 
0.3786 and an R-free of 0.4692. Once the R-free of this model dropped below 0.4, this 
model was used as a molecular replacement model to phase the higher resolution native 
data in PHENIX Phaser. Sixteen fragments totaling 324 residues were built automatically 
in PHENIX AutoBuild in space group P3221 with an R-Work of 0.2930 and an R-Free of 
0.3775. The rest of the structure was built manually in Coot with iterative refinement in 
PHENIX Refine. In the higher resolution crystal form, there is one LpxB molecule in the 
asymmetric unit. Three structures were refined. The apo LpxB6S (PDB: 5W8N) structure 
was refined with Ramachandran statistics of 99.18% favored, 0.55% allowed, and 0.27% 
outliers. The apo LpxB7S structure (PDB: 5W8S) was refined with 98.63% favored, 
1.10% allowed, and 0.27% outliers. The UDP-bound LpxB7S structure (PDB: 5W8X) 
was refined with 98.34% favored, 1.10% allowed, and 0.55% outliers. 
Analytical Ultracentrifugation  
Samples of LpxB6S were submitted to the Spectroscopy and Biophysics Core at 
University of Nebraska-Lincoln for analytical ultracentrifugation. LpxB6S (120 μL at 
1.0, 0.5, and 0.25 mg/mL) was centrifuged at 5000, 7000, 9000, 12000, or 16000 rpm 
(2016, 3951, 6532, 11612, or 20644 xg) for 10 h in a ProteomeLab XL-A ultracentrifuge 
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(Beckman), and absorbance was measured at 280 nm. Only the 1 mg/mL protein 
produced usable data. The experiment was run in triplicate, but the middle wells 
contained an absorbance spike, and these wells were excluded from modeling. A solvent 
density of 1.0 g/mL and a protein partial specific volume of 0.73 mL/g were utilized for 
modeling the protein mass. 
Enzymatic Assays 
Genetic knockout/complementation assays of LpxB were performed in the 
BW25113/pKD46 strain of E. coli containing Lambda Red recombinase under L-
arabinose induction. The cells were made chemically competent (207) and transformed 
with a pACYC-Duet plasmid (Novagen) containing the genes for wild-type LpxB, LpxB-
R201A, LpxB-N316A, LpxB-F298E/N316A, LpxB6S, or LpxB6S-R201A. The plasmids 
contained the wild-type promoter for lpxB operon (104 bp upstream of the fabZ start 
codon) (Operon Database v3 (203)) ligated into the BamHI (NEB) and EcoRI sites and 
the LpxB genes ligated into the EcoRI and HindIII sites of MCS1. For experiments 
testing the ability of different mutants to complement each other by C-terminal swapped 
dimerization, a second LpxB gene was ligated into the NdeI and KpnI sites of MCS2. 
These strains were then grown in the presence of 1 mM L-arabinose (GeneMate), 100 
mg/L ampicillin (Cayman Chemical Company), and 30 mg/L chloramphenicol (Sigma); 
made chemically competent (207); and transformed with a DNA fragment containing a 
kanamycin resistance gene flanked by 50 bp upstream of lpxB and the last 24 bp of lpxB 
followed by 51 more bp downstream. Chloramphenicol (30 mg/L), carbenicilin 
(GoldBio) (100 mg/L), and L-arabinose (1 mM) were also included in the growth step of 
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transformation, which was extended to 3 h. Knockout strains were selected on Miller LB 
agar (BD Difco) plates with 40 mg/L kanamycin (Teknova). 
In vitro enzymatic assays were performed with various soluble and membrane-
associated mutants of LpxB and with lipid X and UDP-DAG purified from Ni-NTA 
purified wild-type and D225A CcLpxI (87), respectively. For enzymatic assays, insoluble 
versions of LpxB were purified using Triton X-100 (Acros) instead of DDM (2% for 
solubilization, 0.2% for Ni-affinity column, and 0.1% for size exclusion). LpxI was 
expressed in C41 DE3 E. coli (Lucigen) and purified as for soluble LpxB except that the 
LpxI lysis buffer was 50 mM NaCl and 20 mM HEPES-NaOH pH 8.0. Eluted protein 
was then concentrated in 10 kDa cutoff centrifugal filters (Amicon). Wild-type LpxI was 
dialyzed against 500 mL LpxI lysis buffer, and LpxID225A was dialyzed against 50 mM 
NaCl and 20 mM Bis-Tris (Sigma) pH 6.0. LpxI precipitated during dialysis, but the 
substrates remained bound. Two volumes of methanol (Fisher) were added to the 
dialyzed protein, which was vortexed and then centrifuged at 3000xg (4oC) for 30 min 
(Eppendorf 5702 R) to remove precipitate. For UDP-DAG the supernatant was 
concentrated in a Savant ISS110 SpeedVac (Thermo) set on medium (43oC) and no 
further purification was performed. For lipid X, the supernatant was adjusted to pH 2 
with HCl (Fisher), and dichloromethane (Sigma-Aldrich) (volume equal to methanol 
volume) was combined with the supernatant in a separatory funnel. Lipid X was extracted 
into the lower (CH2Cl2) phase, which was collected and then evaporated under vacuum. 
Lipid X residue was suspended in LpxI lysis buffer. The identities of the purified lipids 
were confirmed by mass spectrometry with an Agilent 1100 LC/MSD TOF mass 
spectrometer (G1969A) (Supplementary Fig. 3.9). 
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For TLC-based assays, substrates and enzyme were diluted into 2x reaction buffer 
(40 mM Tris-HCl pH 7.8, 0.1% Triton X-100, and 1 mg/mL BSA (Sigma)) unless 
otherwise noted, and 10 μL reactions were run at 30oC (Bio-Rad DNAEngine). UDP-
DAG was used at 0.11 mM (as measured by UDP A260 (Nanodrop 8000) with ε~9.9 mM-
1cm-1), and lipid X was used at ~0.13 mM as determined by lipid X depletion after 
reaction with 0.13 mM UDP-DAG. LpxB was used at 0.5 mg/mL, and the final pH was 
adjusted to 8 with 100 mM Tris-HCl pH 8.0. Reactions were quenched by spotting on 
HPTLC Silica gel 60 plates (EMD Millipore). Once dry (~1 h after spotting), TLC plates 
were run with 25/15/4/2 chloroform (Macron)/methanol/water/acetic acid (Fisher) 
(v/v/v/v). TLC plates were then allowed to dry at least one hour before they were sprayed 
with 20% sulfuric acid (Sigma-Aldrich) in ethanol (Decon) and charred with a Dual-
Temp Heat Gun (Genesis) set on high (538oC). The reactants and lipid A disaccharide 
product appeared as darker bands. In addition, fluorescent (F254) TLC Silica gel 60 plates 
(EMD Millipore) allowed the visualization of UDP-DAG as a fluorescent shadow by UV 
transmission (Bio-Rad Gel Doc EZ Imager) prior to charring. 
Semi-quantitative comparisons of the relative activities of LpxB mutants were 
generated by performing the TLC analysis for reactions run for various times. Reactions 
were judged to have reached completion when the product was visible and the limiting 
reagent (UDP-DAG) was no longer visible. The maximum time when the reactions were 
not complete and the minimum time when the reactions were complete are presented as 
ranges (Supplementary Table 3.2). In addition, the amount of the lipids present on each 
plate could be compared by analyzing band intensity in ImageJ (185). TLC plate charring 
is an established methodology for lipid quantification though absolute quantification 
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requires standard curves of the lipids on interest to be run on the same plate as the 
samples (180, 181). The positive correlation between lipid amount and band intensity was 
confirmed for this study by running different amounts of UDP-DAG and lipid X and by 
reacting different amount of these reactants to completion with wild-type LpxB 
(Supplementary Fig. 3.10). The correlation was found to be positive and linear 
(Supplementary Fig. 3.10C and 3.10F). 
While TLC-based assays have the benefit of visualizing the product of interest, 
they require standard curves for quantification. Thus, to produce more quantitative 
comparisons of LpxB activity, UDP release was quantified using a UDP-Glo 
Glycosyltransferase Assay kit (Promega) as described by the manufacture. A two-fold 
UDP (Promega) dilution series was prepared in 0.1 M Tris-HCl, 0.1% Triton X-100, and 
1 mg/mL BSA. Reactions (10 μL) were run under these buffering conditions with 31 μM 
UDP-DAG, ~0.13 mM lipid X, and 1 nM to 10 μM LpxB at ambient temperature 
(~21oC) in a white 384-well plate (Greiner Bio-One 781074). LpxB reactions were 
quenched with 10 μL UDP Detection Reagent (Promega), and the plate was shaken 30 s 
at 1440 rpm (1 mm amplitude) with a Spark 10M plate reader (Tecan). The luciferase 
coupled reaction was placed at ambient temperature for 1 hr. The resulting luminescence 
was then measured at 555 nm with the Spark 10M using the TR-FRET setting: 900 nm 
excitation, 100 μs lag time between excitation and reading, 2 ms integration of 555 nm 
emission, and 200 reads averaged together. Luminescence was converted to UDP 
concentration with concurrently run UDP standard curves prepared with 10 μL aliquots 
from the UDP dilution series and 10 μL UDP Detection Reagent. Reactions without 
LpxB served as a negative control: UDP detected at or below the concentration in these 
134 
 
samples was assumed to result from UDP-DAG hydrolysis rather than formation of lipid 
A disaccharide. Of note, the UDP concentration of negative controls only measured 
significantly above 0 in overnight reactions, and never measured above 0.5 μM. 
Reactions and standard curve samples were prepared in triplicate. Reactions were 
quenched at various time points to obtain at least 3 time points per LpxB variant within 
the early, linear product accumulation range of the reactions. Specific activities with 
standard errors and 95% confidence intervals were obtained by linear regression analysis 
of these data in Graphpad Prism v7.03. 
Differential Scanning Fluorimetry 
DSF was performed with SYPRO Orange (Life Technologies) and soluble 
versions of LpxB diluted into soluble LpxB storage buffer to final concentrations of 80x 
SYPRO Orange (1.6% DMSO) and 0.8 mg/mL LpxB. Aliquots (40 μL) were heated from 
20 to 95oC on a C1000 Touch Thermal Cycler and fluorescence was measured with the 
FRET channel of a CFX96 Real-Time System (Bio-Rad). The step size of the 
temperature ramp was 0.5oC, and the time at each temperature before fluorescence 
scanning was 30 s. Melting curves were analyzed in Bio-Rad’s CFX Manager software to 
get the melting temperatures (Tm) of the LpxB mutants. 
Molecular Docking 
UDP-DAG was docked into the LpxB active site cleft with AutoDock Vina 1.1.2 
(157). The apo LpxB7S structure (PDB: 5W8S) and the UDP-DAG molecule were 
prepared for docking in AutoDockTools (182, 183) from the MGLTools 1.5.6 suite. For 
docking, the active site was defined as a box centered at coordinates (-36.232, 20.151, 
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12.865) with x, y, z lengths of 24, 36, and 32 Å. Exhaustiveness was set to 8. Nine 
models were output. 
Data Availability 
The coordinates and structure factors of the crystals structures generated from this 
research are available at the Protein Data Bank under accession numbers 5W8N 
(LpxB6S), 5W8S (LpxB7S), and 5W8X (LpxB7S bound to UDP). All other relevant data 
are available in this article and its Supplementary Information files, or from the 
corresponding author upon request. 
 
3.6 Supplementary Information 
Supplementary Table 3.1: LpxB Melting Temperature 
LpxB Tm (oC) 
V66S/V68S/L69S (VVL) 49.0 ± 0.4 
VVL-R201A 49.5 ± 0.4 
VVL-N316A 49.2 ± 0.5 
VVL-F298E/N316A 48.5 ± 0.0 
Melting was observed by SYPRO Orange fluorescence. Tm values are the temperatures at the inflection 
points of the melting curves plus or minus the standard deviations (n= 4). 
 
Supplementary Table 3.2: Semi-quantitative Comparison of LpxB Activities by TLC 
LpxB Time to Reaction Completion 
wild-type 1 min<t<5 min 
L72S/L75S 10 min<t<30 min 
L72S/L76S 1 min<t<5 min 
L75S/L76S 1 min<t<5 min 
V66S/V68S/L69S (VVL) 1 h<t<2 h 
L72S/L75S/L76S (LLL) 5 h<t< 6 h 
6S 18.75 h*<t 
N316A 30 min<t<1 h  
F298E/N316A 15.5 h‡<t 
R201A 18.75 h<t 
6S-R201A No activity detected 
Reactions were performed with 0.5 mg/mL LpxB, 0.11 mM UDP-DAG, ~0.13 mM lipid X, 0.5 mg/mL 
BSA, 0.05-0.06% Triton X-100 and 0.1 M Tris-HCl pH 8 at 30oC. *LpxB6S showed no activity under 
standard conditions but was active when 0.9 M NDSB 201 was added. ‡Reactions with LpxBFN appeared 
mostly complete by 4.5 h, but were never observed to go to completion. 
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Supplementary Fig. 3.1: Size exclusion chromatography. Ni-NTA purified LpxB mutants were run on 
10/300 GL Superdex 200 columns (GE Healthcare). The top 6 UV traces are from protein run on an 
“Increase” model column at 0.5 mL/min. The bottom 4 UV traces are from protein run on the standard 
model column. Crystallizable LpxB appeared as a peak in fractions 7-8 (indicated by arrows). Large 
amounts of LpxB ended up in the void/soluble aggregate fractions preceding fraction 7. The quality of 
various mutants was judged by the peak heights of the aggregated and fraction 7-8 peaks. LpxB6S has 
relatively little protein in the void peak compared to soluble forms with fewer mutations. M207S preserves 
the behavior of LpxB6S while M46S and M295S lead to more protein aggregation. 
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Supplementary Fig. 3.2: LpxB forms an intertwined dimer. A. shows the isolated UDP-bound LpxB 
monomer. Spectrum coloring ends with red at the C-terminus. B. shows the 2D depiction of the LpxB 
dimer generated with Pro-origami (199). The rainbow coloring of secondary structural elements is similar 
to that in A, and the numbering of secondary structural elements is sequential for each subunit (a and b). 
Colored boxes indicate strands (arrows) in the same sheet and the final helices (cylinders) that wrap around 
the bottom of the other subunit. 
 
Supplementary Fig. 3.3: Activity of LpxB6S mutant. A. Products from overnight (18.75 h) reactions 
under standard conditions (left 3) or with 0.9 M NDSB 201 (right 3) were run on a Silica gel 60 HPTLC 
plate. Charring shows product in the all lanes except the no enzyme control. Lipid X is visible in all lanes, 
and UDP-DAG is visible in the left LpxB-R201A lane, the LpxB6S lane, and the negative control lane. 
These results were replicated once. The intensity of the bands in A were analyzed in ImageJ (185): defined 
lanes were plotted as distance versus intensity, and the area under the peak was determined. B. shows the 
curves for the reactant bands, and C. shows the curves for the product band. D. shows a graphical depiction 
of the areas under the peaks in B and C. 
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Supplementary Fig. 3.4: Dimerization of R201A with F298E/N316A and N316A. A. Three hour 
reactions included wild-type LpxB, LpxB-R201A, and LpxBFN combined in shown ratios with LpxB-
R201A (constant total protein). Consistent with the UDP-release assays, UDP-DAG bands are fainter and 
product bands appear darker in 1:2 and 1:4 lanes than in the 100% LpxBFN lane. The increase in activity of 
the 1:2 mixture relative to 100% LpxBFN was replicated 4 times. TLC analysis of the 1:4 and 1:9 mixtures 
was not repeated. B. Reactant band intensity was analyzed in ImageJ (185): lanes were plotted as distance 
versus intensity and the areas under the peaks were determined. C. The same analysis of product bands. 
The irregular shape of these bands gives poor peak resolution, making quantification more difficult. D. 
When only the central, darkest potion of the product bands is selected, peak resolution is improved. E. The 
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quantification of the peak areas. The decrease in lipid X and UDP-DAG intensities 1:2 and 1:4 mixtures 
support the increase in activity produced by combining LpxBFN and LpxB-R201A observed in UDP-
release assays. As in the UDP-release assays, activity appears to decrease with increasing percent LpxB-
R201A. When the product band intensity is quantified with the smaller, central selection, the wild-type and 
1:2 mixture lanes show a corresponding increase in product band intensity. However, when the full band 
was selected, there was little difference between wild-type, LpxBFN, and the 1:2 mixture, and the 1:4 
mixture even showed decreased product band intensity. The 1:9 mixture shows weaker product band 
intensity in either case. Regardless, these data support the conclusion from the UDP-release assays that 
LpxBFN and LpxB-R201A form a complementary dimer. F. One hour reactions of LpxB-R201A, LpxB-
N316A, and co-purified His-tagged LpxB-R201A with untagged LpxB-N316A. While LpxB-R201A did 
not produce a detectable amount of product, LpxB-N316A and the co-purified proteins show production of 
lipid A disaccharide with corresponding depletion of reactants indicating that LpxB-R201A can pull down 
LpxB-N316A. These results were replicated five times. G. H. Analysis was performed as for the plate in A. 
 
Supplementary Fig. 3.5: Analytical ultracentrifugation. Raw and fitted analytical ultracentrifugation 
data are shown. LpxB6S (120 μL) was centrifuged at 5000, 7000, 9000, 12000, or 16000 rpm for 10 h in a 
ProteomeLab XL-A ultracentrifuge. Absorbance was measured at 280 nm. Fitting of distance versus 
absorbance data is shown for the left wells. Fitting with a solvent density of 1.0 g/mL and a protein partial 
volume of 0.73 mL/g gave a protein mass of 71-79 kDa, most consistent with the expected 84.5 kDa dimer. 
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Supplementary Fig. 3.6: MurG active site. A. B. The MurG active site from PDB entry 1NLM (101) is 
provided for comparison to Figure 3. C. Stereo view of LpxB UDP-binding pocket. The 2mFo-DFc map 
(blue mesh) is shown at 0.4317 e/Å3 (0.99 RMSD), and the mFo-DFc map (cyan mesh for positive and 
yellow mesh for negative) is shown at 0.45 e/Å3 (3.01 RMSD). 
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MurG/1-364      1 MMSGQG..........................KRLMVMA.G.....GTGG  
PimA/-19-386  -19 ............MGSSHHHHHHSSGLVPRGSHMRIGMVCPYSFDVPG..G  
LpxB/1-382      1 ......MTEQRP....................LTIALVAGE.....T..S  
                                                    : ::.          . 
 
MurG/1-364     19 HVFPGLAVAHHLM.A..Q.GWQVRWLGTADRMEA.DLVPKHGI.EIDFI.  
PimA/-19-386   17 VQSHVLQLAEVLRDA....GHEVSVLAPA...SPHVK.L..PD.YVVSG.  
LpxB/1-382     18 GDILGAGLIRAL..KEHVPNARFVGVA.....G..PRMQ.AEGCEAWYEM  
                         : . *       . ..  :.                        
 
MurG/1-364     62 R.IS........................GLRGKGIKALIAAPLRIFNAWR  
PimA/-19-386   55 GK.A...........VPIPYNGSVARLRF.............G..PATHR  
LpxB/1-382     58 EE.LAVMGISESSGR.............S.............RRSSHIRA  
                                                                     
 
MurG/1-364     87 QARAIMKAYKPDVVLGMGG...YVSGPGGLAAWSLGIPVVLHEQNGI...  
PimA/-19-386   78 KVKKWIAEGDFDVLHIHEPNAPSLSMLALQAAE...GPIVATFHT.STTK  
LpxB/1-382     81 DLTKRFGELKPDVFVGIDAP.DF.NITLEGNLKKQGIKTIHYVS..P...  
                  .    :   . **.          .              :           
 
MurG/1-364    131 .AGLTN..K....W.LAK..IATKVMQAFPGA..FPN......AEVVGNP  
PimA/-19-386  124 SLT...LSVFQGILRPYHE.KIIGRIAVSDLARRWQMEALGSDAVEIPNG  
LpxB/1-382    124 .SVW....AWRQKRVFKIGRATDLVLAFLPFEKAFYDK.YNVPCRFIGHT  
                                           :        :        .  : :  
 
MurG/1-364    163 ..VRTD...VLALPLPQQRLAGREGPVRVL..............VVGGSQ  
PimA/-19-386  170 ..VDVASF.A....................DAPLLDGYPREGRTVLFLGR  
LpxB/1-382    168 MADA....MP.....L...D.......PDK....................  
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MurG/1-364    194 G.....ARILNQTMPQVAAKLGDSVTIWH..QSGKGSQQSVEQAYAEAGQ  
PimA/-19-386  197 YDEPRKGMAVLLAALPK.......................L...V...AR  
LpxB/1-382    179 ..........................NAARDVL........G..I....P  
                                                                     
 
MurG/1-364    237 PQH.KVTE..........................................  
PimA/-19-386  218 FP.DVEILIVG.......................................  
LpxB/1-382    189 ..H........DAHCLALLPGSRGAEVESLSADFLKTAQLLRQTYPDLEI  
                                                                     
 
MurG/1-364    244 .................................................F  
PimA/-19-386  228 ....RGD.ED.E...LRE...........QAGDLAGHLRF.LGQVDDATK  
LpxB/1-382    229 VVPLVNAK..RREQFE..RIKAEVAPDLSVH...L..L.DG........M  
                                                                     
 
MurG/1-364    245 ..IDD................................MA..AAYAWADVV  
PimA/-19-386  257 ASAMRSADVYCA.P.....H.L...GG.ESFGIVLVEAMAAGTA..V..V  
LpxB/1-382    261 .........GREAMVASDAALLASGTAAL..E..................  
 
 
MurG/1-364    259 VCRSG.ALTV.SEIAAAG....L.PALFVPFQ......... 283 
PimA/-19-386  292 ASDL.DA..FRR..V..LADGDAGRLV.....P.V...... 313 
LpxB/1-382    282 .CM......L.......S.......KC.....P.MVVGYRM 295 
                                                                     
 
MurG/1-364    284 HKDR.QQY.WNA..........LPLEK.A...GAAKII.EQP...QLSV.  
PimA/-19-386      .................................................. 
LpxB/1-382    296 KPFTF...WL..AKRLVKTDYVSLPNLLAGRELV.KELL...QEEC...E  
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MurG/1-364    313 D..AVAN.TLA.G..W..SRETLLTMAE.R..ARAAS..IPDATERVANE  
PimA/-19-386  346 .....................................RYDWSVVSAQIMR  
LpxB/1-382    334 PQKL..AA...ALLPLLANGKTSHAMHDTFRELHQQI..RCNADEQAAQA  
                                                           .. .      
 
MurG/1-364    350 VSRVARALEHHHHHH..................... 364 
PimA/-19-386  359 VYETVS.G.......AGIKVQVSGAANRDETAGESV 386 
LpxB/1-382    377 VLELAQ.............................. 382 
                  * . .                                 
Supplementary Fig. 3.7: Structural alignment of LpxB (PDB: 5W8S), MurG (PDB: 1F0K), and PimA (PDB: 2GEJ). Purple arrows and blue ovals show 
the positions of β-sheets and α-helices in the LpxB sequence. Yellow highlighting marks the disordered loops in LpxB and PimA, and green highlighting marks 
the amphipathic helices involved in membrane association (99, 100). Magenta highlighting marks helices 14 and 15 in LpxB which contain F298 and N316, 
respectively. Cyan highlighting marks the final 3 helices in LpxB. Red lettering marks the locations of point mutations made in LpxB. 
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Supplementary Fig. 3.8: Liquid chromatography-mass spectrometry. LCMS of LpxB6S gives a peak 
corresponding to a mass of 42266.5 Da, which corresponds well with the calculated molecular mass of 
42270.01 Da from the ProtParam server <http://web.expasy.org/protparam/>. A second peak at 42385.7 
(119.2 Da larger) probably corresponds to a cyteinylated form of LpxB. Indeed, electron density at C367 of 
the unbound LpxB7S structure suggests some modification (data not shown). This is likely a result of 
oxidation stress in the E. coli. 
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Supplementary Fig. 3.9: Mass spectra of LpxB reactants. UDP-DAG and Lipid X were extracted from 
CcLpxI, wild-type and D225A respectively (87). The identity of the purified lipids was confirmed by their 
[M-H]- peaks, which correspond well with the predicted exact masses of lipid X (711.43 Da) and UDP-
DAG (1017.46 Da). The mass spectra were collected in negative ion mode with direct infusion of the 
diluted lipids and ionization by electrospray or atmospheric pressure chemical ionization. 
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Supplementary Fig. 3.10: Linear relationship between lipid amount and band intensity. A. Different 
volumes [μL] of UDP-DAG (0.31 mM) and lipid X (~0.31 mM) were run on an HPTLC Silica gel 60 plate. 
Once dry, the plate was charred with 20% sulfuric acid in ethanol and a heat gun. This plate was replicated 
once. B. Band intensities were analyzed in ImageJ (185): lanes were plotted as distance versus intensity and 
the areas under the peaks were determined. C. Volumes run were plotted versus peak areas, and the data 
were fitted by a line in MS Excel. Both reactants show increasing band intensity with increasing lipid 
amount, and the relationships are quite linear: R2 of 0.9802 for lipid X and 0.9383 for UDP-DAG. D. 
Different volumes [μL] of UDP-DAG (0.31 mM) and lipid X (1.3 mM) were reacted to completion with 
0.5 g/L wild-type LpxB in 0.1 M Tris-HCl pH 8.0, 0.1% Triton X-100, and 1 mg/mL BSA at 30oC for 1 hr. 
TLC of products was performed as in A. This plate was not repeated. E. Band intensities of lipid A 
disaccharide product and remaining lipid X were analyzed as in C. F. Volumes reacted were plotted versus 
the band intensities, and the data were fitted by a line in MS Excel. Band intensities increase with 
increasing lipid amounts. The lipid A disaccharide data are quite linear (R2 of 0.9613), and the lipid X data 
are reasonably linear (R2 of 0.8831). 
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